https://www.usps.com/This value set includes codes based on the following rules:
This value set includes codes based on the following rules:
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 363346000 (Malignant tumor)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| C00.0 | Malignant neoplasm of external upper lip |
| C00.1 | Malignant neoplasm of external lower lip |
| C00.2 | Malignant neoplasm of external lip, unspecified |
| C00.3 | Malignant neoplasm of upper lip, inner aspect |
| C00.4 | Malignant neoplasm of lower lip, inner aspect |
| C00.5 | Malignant neoplasm of lip, unspecified, inner aspect |
| C00.6 | Malignant neoplasm of commissure of lip, unspecified |
| C00.8 | Malignant neoplasm of overlapping sites of lip |
| C00.9 | Malignant neoplasm of lip, unspecified |
| C01 | MALIGNANT NEOPLASM OF BASE OF TONGUE |
| C02.0 | Malignant neoplasm of dorsal surface of tongue |
| C02.1 | Malignant neoplasm of border of tongue |
| C02.2 | Malignant neoplasm of ventral surface of tongue |
| C02.3 | Malignant neoplasm of anterior two-thirds of tongue, part unspecified |
| C02.4 | Malignant neoplasm of lingual tonsil |
| C02.8 | Malignant neoplasm of overlapping sites of tongue |
| C02.9 | Malignant neoplasm of tongue, unspecified |
| C03.0 | Malignant neoplasm of upper gum |
| C03.1 | Malignant neoplasm of lower gum |
| C03.9 | Malignant neoplasm of gum, unspecified |
| C04.0 | Malignant neoplasm of anterior floor of mouth |
| C04.1 | Malignant neoplasm of lateral floor of mouth |
| C04.8 | Malignant neoplasm of overlapping sites of floor of mouth |
| C04.9 | Malignant neoplasm of floor of mouth, unspecified |
| C05.0 | Malignant neoplasm of hard palate |
| C05.1 | Malignant neoplasm of soft palate |
| C05.2 | Malignant neoplasm of uvula |
| C05.8 | Malignant neoplasm of overlapping sites of palate |
| C05.9 | Malignant neoplasm of palate, unspecified |
| C06.0 | Malignant neoplasm of cheek mucosa |
| C06.1 | Malignant neoplasm of vestibule of mouth |
| C06.2 | Malignant neoplasm of retromolar area |
| C06.80 | Malignant neoplasm of overlapping sites of unspecified parts of mouth |
| C06.89 | Malignant neoplasm of overlapping sites of other parts of mouth |
| C06.9 | Malignant neoplasm of mouth, unspecified |
| C07 | MALIGNANT NEOPLASM OF PAROTID GLAND |
| C08.0 | Malignant neoplasm of submandibular gland |
| C08.1 | Malignant neoplasm of sublingual gland |
| C08.9 | Malignant neoplasm of major salivary gland, unspecified |
| C09.0 | Malignant neoplasm of tonsillar fossa |
| C09.1 | Malignant neoplasm of tonsillar pillar (anterior) (posterior) |
| C09.8 | Malignant neoplasm of overlapping sites of tonsil |
| C09.9 | Malignant neoplasm of tonsil, unspecified |
| C10.0 | Malignant neoplasm of vallecula |
| C10.1 | Malignant neoplasm of anterior surface of epiglottis |
| C10.2 | Malignant neoplasm of lateral wall of oropharynx |
| C10.3 | Malignant neoplasm of posterior wall of oropharynx |
| C10.4 | Malignant neoplasm of branchial cleft |
| C10.8 | Malignant neoplasm of overlapping sites of oropharynx |
| C10.9 | Malignant neoplasm of oropharynx, unspecified |
| C11.0 | Malignant neoplasm of superior wall of nasopharynx |
| C11.1 | Malignant neoplasm of posterior wall of nasopharynx |
| C11.2 | Malignant neoplasm of lateral wall of nasopharynx |
| C11.3 | Malignant neoplasm of anterior wall of nasopharynx |
| C11.8 | Malignant neoplasm of overlapping sites of nasopharynx |
| C11.9 | Malignant neoplasm of nasopharynx, unspecified |
| C12 | MALIGNANT NEOPLASM OF PYRIFORM SINUS |
| C13.0 | Malignant neoplasm of postcricoid region |
| C13.1 | Malignant neoplasm aryepiglottic fold, hypopharyngeal aspect |
| C13.2 | Malignant neoplasm of posterior wall of hypopharynx |
| C13.8 | Malignant neoplasm of overlapping sites of hypopharynx |
| C13.9 | Malignant neoplasm of hypopharynx, unspecified |
| C14.0 | Malignant neoplasm of pharynx, unspecified |
| C14.2 | Malignant neoplasm of Waldeyer's ring |
| C14.8 | Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx |
| C15.3 | Malignant neoplasm of upper third of esophagus |
| C15.4 | Malignant neoplasm of middle third of esophagus |
| C15.5 | Malignant neoplasm of lower third of esophagus |
| C15.8 | Malignant neoplasm of overlapping sites esophagus |
| C15.9 | Malignant neoplasm of esophagus, unspecified |
| C16.0 | Malignant neoplasm of cardia |
| C16.1 | Malignant neoplasm of fundus of stomach |
| C16.2 | Malignant neoplasm of body of stomach |
| C16.3 | Malignant neoplasm of pyloric antrum |
| C16.4 | Malignant neoplasm of pylorus |
| C16.5 | Malignant neoplasm of lesser curvature of stomach, unspecified |
| C16.6 | Malignant neoplasm of greater curvature of stomach, unspecified |
| C16.8 | Malignant neoplasm of overlapping sites of stomach |
| C16.9 | Malignant neoplasm of stomach, unspecified |
| C17.0 | Malignant neoplasm of duodenum |
| C17.1 | Malignant neoplasm of jejunum |
| C17.2 | Malignant neoplasm of ileum |
| C17.3 | Meckel's diverticulum, malignant |
| C17.8 | Malignant neoplasm of overlapping sites of small intestine |
| C17.9 | Malignant neoplasm of small intestine, unspecified |
| C18.0 | Malignant neoplasm of cecum |
| C18.1 | Malignant neoplasm of appendix |
| C18.2 | Malignant neoplasm of ascending colon |
| C18.3 | Malignant neoplasm of hepatic flexure |
| C18.4 | Malignant neoplasm of transverse colon |
| C18.5 | Malignant neoplasm of splenic flexure |
| C18.6 | Malignant neoplasm of descending colon |
| C18.7 | Malignant neoplasm of sigmoid colon |
| C18.8 | Malignant neoplasm of overlapping sites of colon |
| C18.9 | Malignant neoplasm of colon, unspecified |
| C19 | MALIGNANT NEOPLASM OF RECTOSIGMOID JUNCTION |
| C20 | MALIGNANT NEOPLASM OF RECTUM |
| C21.0 | Malignant neoplasm of anus, unspecified |
| C21.1 | Malignant neoplasm of anal canal |
| C21.2 | Malignant neoplasm of cloacogenic zone |
| C21.8 | Malignant neoplasm of overlapping sites of rectum, anus and anal canal |
| C22.0 | Liver cell carcinoma |
| C22.1 | Intrahepatic bile duct carcinoma |
| C22.2 | Hepatoblastoma |
| C22.3 | Angiosarcoma of liver |
| C22.4 | Other sarcomas of liver |
| C22.7 | Other specified carcinomas of liver |
| C22.8 | Malignant neoplasm of liver, primary, unspecified as to type |
| C22.9 | Malignant neoplasm of liver, not specified as primary or secondary |
| C23 | MALIGNANT NEOPLASM OF GALLBLADDER |
| C24.0 | Malignant neoplasm of extrahepatic bile duct |
| C24.1 | Malignant neoplasm of Ampulla of Vater |
| C24.8 | Malignant neoplasm of overlapping sites of biliary tract |
| C24.9 | Malignant neoplasm of biliary tract, unspecified |
| C25.0 | Malignant neoplasm of head of pancreas |
| C25.1 | Malignant neoplasm of body of pancreas |
| C25.2 | Malignant neoplasm of tail of pancreas |
| C25.3 | Malignant neoplasm of pancreatic duct |
| C25.4 | Malignant neoplasm of endocrine pancreas |
| C25.7 | Malignant neoplasm of other parts of pancreas |
| C25.8 | Malignant neoplasm of overlapping sites of pancreas |
| C25.9 | Malignant neoplasm of pancreas, unspecified |
| C26.0 | Malignant neoplasm of intestinal tract, part unspecified |
| C26.1 | Malignant neoplasm of spleen |
| C26.9 | Malignant neoplasm of ill-defined sites within the digestive system |
| C30.0 | Malignant neoplasm of nasal cavity |
| C30.1 | Malignant neoplasm of middle ear |
| C31.0 | Malignant neoplasm of maxillary sinus |
| C31.1 | Malignant neoplasm of ethmoidal sinus |
| C31.2 | Malignant neoplasm of frontal sinus |
| C31.3 | Malignant neoplasm of sphenoid sinus |
| C31.8 | Malignant neoplasm of overlapping sites of accessory sinuses |
| C31.9 | Malignant neoplasm of accessory sinus, unspecified |
| C32.0 | Malignant neoplasm of glottis |
| C32.1 | Malignant neoplasm of supraglottis |
| C32.2 | Malignant neoplasm of subglottis |
| C32.3 | Malignant neoplasm of laryngeal cartilage |
| C32.8 | Malignant neoplasm of overlapping sites of larynx |
| C32.9 | Malignant neoplasm of larynx, unspecified |
| C33 | MALIGNANT NEOPLASM OF TRACHEA |
| C34.00 | Malignant neoplasm of unspecified main bronchus |
| C34.01 | Malignant neoplasm of right main bronchus |
| C34.02 | Malignant neoplasm of left main bronchus |
| C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
| C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
| C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
| C37 | MALIGNANT NEOPLASM OF THYMUS |
| C38.0 | Malignant neoplasm of heart |
| C38.1 | Malignant neoplasm of anterior mediastinum |
| C38.2 | Malignant neoplasm of posterior mediastinum |
| C38.3 | Malignant neoplasm of mediastinum, part unspecified |
| C38.4 | Malignant neoplasm of pleura |
| C38.8 | Malignant neoplasm of overlapping sites of heart, mediastinum and pleura |
| C39.0 | Malignant neoplasm of upper respiratory tract, part unspecified |
| C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
| C40.00 | Malignant neoplasm of scapula and long bones of unspecified upper limb |
| C40.01 | Malignant neoplasm of scapula and long bones of right upper limb |
| C40.02 | Malignant neoplasm of scapula and long bones of left upper limb |
| C40.10 | Malignant neoplasm of short bones of unspecified upper limb |
| C40.11 | Malignant neoplasm of short bones of right upper limb |
| C40.12 | Malignant neoplasm of short bones of left upper limb |
| C40.20 | Malignant neoplasm of long bones of unspecified lower limb |
| C40.21 | Malignant neoplasm of long bones of right lower limb |
| C40.22 | Malignant neoplasm of long bones of left lower limb |
| C40.30 | Malignant neoplasm of short bones of unspecified lower limb |
| C40.31 | Malignant neoplasm of short bones of right lower limb |
| C40.32 | Malignant neoplasm of short bones of left lower limb |
| C40.80 | Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb |
| C40.81 | Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb |
| C40.82 | Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb |
| C40.90 | Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb |
| C40.91 | Malignant neoplasm of unspecified bones and articular cartilage of right limb |
| C40.92 | Malignant neoplasm of unspecified bones and articular cartilage of left limb |
| C41.0 | Malignant neoplasm of bones of skull and face |
| C41.1 | Malignant neoplasm of mandible |
| C41.2 | Malignant neoplasm of vertebral column |
| C41.3 | Malignant neoplasm of ribs, sternum and clavicle |
| C41.4 | Malignant neoplasm of pelvic bones, sacrum and coccyx |
| C41.9 | Malignant neoplasm of unspecified bones and articular cartilage of limb |
| C43.0 | Malignant melanoma of lip |
| C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
| C43.111 | Malignant melanoma of right upper eyelid, including canthus |
| C43.112 | Malignant melanoma of right lower eyelid, including canthus |
| C43.121 | Malignant melanoma of left upper eyelid, including canthus |
| C43.122 | Malignant melanoma of left lower eyelid, including canthus |
| C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
| C43.21 | Malignant melanoma of right ear and external auricular canal |
| C43.22 | Malignant melanoma of left ear and external auricular canal |
| C43.30 | Malignant melanoma of unspecified part of face |
| C43.31 | Malignant melanoma of nose |
| C43.39 | Malignant melanoma of other parts of face |
| C43.4 | Malignant melanoma of scalp and neck |
| C43.51 | Malignant melanoma of anal skin |
| C43.52 | Malignant melanoma of skin of breast |
| C43.59 | Malignant melanoma of other part of trunk |
| C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
| C43.61 | Malignant melanoma of right upper limb, including shoulder |
| C43.62 | Malignant melanoma of left upper limb, including shoulder |
| C43.70 | Malignant melanoma of unspecified lower limb, including hip |
| C43.71 | Malignant melanoma of right lower limb, including hip |
| C43.72 | Malignant melanoma of left lower limb, including hip |
| C43.8 | Malignant melanoma of overlapping sites of skin |
| C43.9 | Malignant melanoma of skin, unspecified |
| C44.131 | Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus |
| C44.1321 | Sebaceous cell carcinoma of skin of right upper eyelid, including canthus |
| C44.1322 | Sebaceous cell carcinoma of skin of right lower eyelid, including canthus |
| C44.1391 | Sebaceous cell carcinoma of skin of left upper eyelid, including canthus |
| C44.1392 | Sebaceous cell carcinoma of skin of left lower eyelid, including canthus |
| C44.90 | Unspecified malignant neoplasm of skin, unspecified |
| C44.99 | Other specified malignant neoplasm of skin, unspecified |
| C45.0 | Mesothelioma of pleura |
| C45.1 | Mesothelioma of peritoneum |
| C45.2 | Mesothelioma of pericardium |
| C45.7 | Mesothelioma of other sites |
| C45.9 | Mesothelioma, unspecified |
| C46.0 | Kaposi's sarcoma of skin |
| C46.1 | Kaposi's sarcoma of soft tissue |
| C46.2 | Kaposi's sarcoma of palate |
| C46.3 | Kaposi's sarcoma of lymph nodes |
| C46.4 | Kaposi’s sarcoma of gastrointestinal sites |
| C46.50 | Kaposi's sarcoma of unspecified lung |
| C46.51 | Kaposi's sarcoma of right lung |
| C46.52 | Kaposi's sarcoma of left lung |
| C46.7 | Kaposi's sarcoma of other sites |
| C46.9 | Kaposi's sarcoma, unspecified |
| C47.0 | Malignant neoplasm of peripheral nerves of head, face and neck |
| C47.1 | Malignant neoplasm of peripheral nerves of upper limb, including shoulder |
| C47.10 | Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder |
| C47.11 | Malignant neoplasm of peripheral nerves of right upper limb, including shoulder |
| C47.12 | Malignant neoplasm of peripheral nerves of left upper limb, including shoulder |
| C47.20 | Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip |
| C47.21 | Malignant neoplasm of peripheral nerves of right lower limb, including hip |
| C47.22 | Malignant neoplasm of peripheral nerves of left lower limb, including hip |
| C47.3 | Malignant neoplasm of peripheral nerves of thorax |
| C47.4 | Malignant neoplasm of peripheral nerves of abdomen |
| C47.5 | Malignant neoplasm of peripheral nerves of pelvis |
| C47.6 | Malignant neoplasm of peripheral nerves of trunk, unspecified |
| C47.8 | Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system |
| C47.9 | Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified |
| C48.0 | Malignant neoplasm of retroperitoneum |
| C48.1 | Malignant neoplasm of specified parts of peritoneum |
| C48.2 | Malignant neoplasm of peritoneum, unspecified |
| C48.8 | Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum |
| C49.0 | Malignant neoplasm of connective and soft tissue of head, face and neck |
| C49.10 | Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder |
| C49.11 | Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder |
| C49.12 | Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder |
| C49.20 | Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip |
| C49.21 | Malignant neoplasm of connective and soft tissue of right lower limb, including hip |
| C49.22 | Malignant neoplasm of connective and soft tissue of left lower limb, including hip |
| C49.3 | Malignant neoplasm of connective and soft tissue of thorax |
| C49.4 | Malignant neoplasm of connective and soft tissue of abdomen |
| C49.5 | Malignant neoplasm of connective and soft tissue of pelvis |
| C49.6 | Malignant neoplasm of connective and soft tissue of trunk, unspecified |
| C49.8 | Malignant neoplasm of overlapping sites of connective and soft tissue |
| C49.9 | Malignant neoplasm of connective and soft tissue, unspecified |
| C49.A0 | Gastrointestinal stromal tumor, unspecified site |
| C49.A1 | Gastrointestinal stromal tumor of esophagus |
| C49.A2 | Gastrointestinal stromal tumor of stomach |
| C49.A3 | Gastrointestinal stromal tumor of small intestine |
| C49.A4 | Gastrointestinal stromal tumor of large intestine |
| C49.A5 | Gastrointestinal stromal tumor of rectum |
| C49.A9 | Gastrointestinal stromal tumor of other site |
| C4A.0 | Merkel cell carcinoma of lip |
| C4A.10 | Merkel cell carcinoma of unspecified eyelid, including canthus |
| C4A.111 | Merkel cell carcinoma of right upper eyelid, including canthus |
| C4A.112 | Merkel cell carcinoma of right lower eyelid, including canthus |
| C4A.121 | Merkel cell carcinoma of left upper eyelid, including canthus |
| C4A.122 | Merkel cell carcinoma of left lower eyelid, including canthus |
| C4A.20 | Merkel cell carcinoma of unspecified ear and external auricular canal |
| C4A.21 | Merkel cell carcinoma of right ear and external auricular canal |
| C4A.22 | Merkel cell carcinoma of left ear and external auricular canal |
| C4A.30 | Merkel cell carcinoma of unspecified part of face |
| C4A.31 | Merkel cell carcinoma of nose |
| C4A.39 | Merkel cell carcinoma of other parts of face |
| C4A.4 | Merkel cell carcinoma of scalp and neck |
| C4A.51 | Merkel cell carcinoma of anal skin |
| C4A.52 | Merkel cell carcinoma of skin of breast |
| C4A.59 | Merkel cell carcinoma of other part of trunk |
| C4A.60 | Merkel cell carcinoma of unspecified upper limb, including shoulder |
| C4A.61 | Merkel cell carcinoma of right upper limb, including shoulder |
| C4A.62 | Merkel cell carcinoma of left upper limb, including shoulder |
| C4A.70 | Merkel cell carcinoma of unspecified lower limb, including hip |
| C4A.71 | Merkel cell carcinoma of right lower limb, including hip |
| C4A.72 | Merkel cell carcinoma of left lower limb, including hip |
| C4A.8 | Merkel cell carcinoma of overlapping sites |
| C4A.9 | Merkel cell carcinoma, unspecified |
| C50.011 | Malignant neoplasm of nipple and areola, right female breast |
| C50.012 | Malignant neoplasm of nipple and areola, left female breast |
| C50.019 | Malignant neoplasm of nipple and areola, unspecified female breast |
| C50.021 | Malignant neoplasm of nipple and areola, right male breast |
| C50.022 | Malignant neoplasm of nipple and areola, left male breast |
| C50.029 | Malignant neoplasm of nipple and areola, unspecified male breast |
| C50.111 | Malignant neoplasm of central portion of right female breast |
| C50.112 | Malignant neoplasm of central portion of left female breast |
| C50.119 | Malignant neoplasm of central portion of unspecified female breast |
| C50.121 | Malignant neoplasm of central portion of right male breast |
| C50.122 | Malignant neoplasm of central portion of left male breast |
| C50.129 | Malignant neoplasm of central portion of unspecified male breast |
| C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
| C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
| C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
| C50.221 | Malignant neoplasm of upper-inner quadrant of right male breast |
| C50.222 | Malignant neoplasm of upper-inner quadrant of left male breast |
| C50.229 | Malignant neoplasm of upper-inner quadrant of unspecified male breast |
| C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
| C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
| C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
| C50.321 | Malignant neoplasm of lower-inner quadrant of right male breast |
| C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast |
| C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast |
| C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
| C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
| C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
| C50.421 | Malignant neoplasm of upper-outer quadrant of right male breast |
| C50.422 | Malignant neoplasm of upper-outer quadrant of left male breast |
| C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast |
| C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
| C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
| C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
| C50.521 | Malignant neoplasm of lower-outer quadrant of right male breast |
| C50.522 | Malignant neoplasm of lower-outer quadrant of left male breast |
| C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast |
| C50.611 | Malignant neoplasm of axillary tail of right female breast |
| C50.612 | Malignant neoplasm of axillary tail of left female breast |
| C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
| C50.621 | Malignant neoplasm of axillary tail of right male breast |
| C50.622 | Malignant neoplasm of axillary tail of left male breast |
| C50.629 | Malignant neoplasm of axillary tail of unspecified male breast |
| C50.811 | Malignant neoplasm of overlapping sites of right female breast |
| C50.812 | Malignant neoplasm of overlapping sites of left female breast |
| C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
| C50.821 | Malignant neoplasm of overlapping sites of right male breast |
| C50.822 | Malignant neoplasm of overlapping sites of left male breast |
| C50.829 | Malignant neoplasm of overlapping sites of unspecified male breast |
| C50.911 | Malignant neoplasm of unspecified site of right female breast |
| C50.912 | Malignant neoplasm of unspecified site of left female breast |
| C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
| C50.921 | Malignant neoplasm of unspecified site of right male breast |
| C50.922 | Malignant neoplasm of unspecified site of left male breast |
| C50.929 | Malignant neoplasm of unspecified site of unspecified male breast |
| C51.0 | Malignant neoplasm of labium majus |
| C51.1 | Malignant neoplasm of labium minus |
| C51.2 | Malignant neoplasm of clitoris |
| C51.8 | Malignant neoplasm of other specified female genital organs |
| C51.9 | Malignant neoplasm of vulva, unspecified |
| C52 | MALIGNANT NEOPLASM OF VAGINA |
| C53.0 | Malignant neoplasm of endocervix |
| C53.1 | Malignant neoplasm of exocervix |
| C53.8 | Malignant neoplasm of overlapping sites of cervix uteri |
| C53.9 | Malignant neoplasm of cervix uteri, unspecified |
| C54.0 | Malignant neoplasm of isthmus uteri |
| C54.1 | Malignant neoplasm of endometrium |
| C54.2 | Malignant neoplasm of myometrium |
| C54.3 | Malignant neoplasm of fundus uteri |
| C54.8 | Malignant neoplasm of overlapping sites of corpus uteri |
| C54.9 | Malignant neoplasm of corpus uteri, unspecified |
| C55 | MALIGNANT NEOPLASM OF UTERUS, PART UNSPECIFIED |
| C56.1 | Malignant neoplasm of right ovary |
| C56.2 | Malignant neoplasm of left ovary |
| C56.9 | Malignant neoplasm of unspecified ovary |
| C57.00 | Malignant neoplasm of unspecified fallopian tube |
| C57.01 | Malignant neoplasm of right fallopian tube |
| C57.02 | Malignant neoplasm of left fallopian tube |
| C57.10 | Malignant neoplasm of unspecified broad ligament |
| C57.11 | Malignant neoplasm of right broad ligament |
| C57.12 | Malignant neoplasm of left broad ligament |
| C57.20 | Malignant neoplasm of unspecified round ligament |
| C57.21 | Malignant neoplasm of right round ligament |
| C57.22 | Malignant neoplasm of left round ligament |
| C57.3 | Malignant neoplasm of parametrium |
| C57.4 | Malignant neoplasm of uterine adnexa, unspecified |
| C57.7 | Malignant neoplasm of overlapping sites of vulva |
| C57.8 | Malignant neoplasm of overlapping sites of female genital organs |
| C57.9 | Malignant neoplasm of female genital organ, unspecified |
| C58 | MALIGNANT NEOPLASM OF PLACENTA |
| C60.0 | Malignant neoplasm of prepuce |
| C60.1 | Malignant neoplasm of glans penis |
| C60.2 | Malignant neoplasm of body of penis |
| C60.8 | Malignant neoplasm of overlapping sites of penis |
| C60.9 | Malignant neoplasm of penis, unspecified |
| C61 | MALIGNANT NEOPLASM OF PROSTATE |
| C62.00 | Malignant neoplasm of unspecified undescended testis |
| C62.01 | Malignant neoplasm of undescended right testis |
| C62.02 | Malignant neoplasm of undescended left testis |
| C62.10 | Malignant neoplasm of unspecified descended testis |
| C62.11 | Malignant neoplasm of descended right testis |
| C62.12 | Malignant neoplasm of descended left testis |
| C62.90 | Malignant neoplasm of unspecified testis, unspecified whether descended or undescended |
| C62.91 | Malignant neoplasm of right testis, unspecified whether descended or undescended |
| C62.92 | Malignant neoplasm of left testis, unspecified whether descended or undescended |
| C63.00 | Malignant neoplasm of unspecified epididymis |
| C63.01 | Malignant neoplasm of right epididymis |
| C63.02 | Malignant neoplasm of left epididymis |
| C63.10 | Malignant neoplasm of unspecified spermatic cord |
| C63.11 | Malignant neoplasm of right spermatic cord |
| C63.12 | Malignant neoplasm of left spermatic cord |
| C63.2 | Malignant neoplasm of scrotum |
| C63.7 | Malignant neoplasm of other specified male genital organs |
| C63.8 | Malignant neoplasm of overlapping sites of male genital organs |
| C63.9 | Malignant neoplasm of male genital organ, unspecified |
| C64.1 | Malignant neoplasm of right kidney, except renal pelvis |
| C64.2 | Malignant neoplasm of left kidney, except renal pelvis |
| C64.9 | Malignant neoplasm of unspecified kidney, except renal pelvis |
| C65.1 | Malignant neoplasm of right renal pelvis |
| C65.2 | Malignant neoplasm of left renal pelvis |
| C65.9 | Malignant neoplasm of unspecified renal pelvis |
| C66.1 | Malignant neoplasm of right ureter |
| C66.2 | Malignant neoplasm of left ureter |
| C66.9 | Malignant neoplasm of unspecified ureter |
| C67.0 | Malignant neoplasm of trigone of bladder |
| C67.1 | Malignant neoplasm of dome of bladder |
| C67.2 | Malignant neoplasm of lateral wall of bladder |
| C67.3 | Malignant neoplasm of anterior wall of bladder |
| C67.4 | Malignant neoplasm of posterior wall of bladder |
| C67.5 | Malignant neoplasm of bladder neck |
| C67.6 | Malignant neoplasm of ureteric orifice |
| C67.7 | Malignant neoplasm of urachus |
| C67.8 | Malignant neoplasm of overlapping sites of bladder |
| C67.9 | Malignant neoplasm of bladder, unspecified |
| C68.0 | Malignant neoplasm of urethra |
| C68.1 | Malignant neoplasm of paraurethral glands |
| C68.8 | Malignant neoplasm of overlapping sites of urinary organs |
| C68.9 | Malignant neoplasm of urinary organ, unspecified |
| C69.00 | Malignant neoplasm of unspecified conjunctiva |
| C69.01 | Malignant neoplasm of right conjunctiva |
| C69.02 | Malignant neoplasm of left conjunctiva |
| C69.10 | Malignant neoplasm of unspecified cornea |
| C69.11 | Malignant neoplasm of right cornea |
| C69.12 | Malignant neoplasm of left cornea |
| C69.20 | Malignant neoplasm of unspecified retina |
| C69.21 | Malignant neoplasm of right retina |
| C69.22 | Malignant neoplasm of left retina |
| C69.30 | Malignant neoplasm of unspecified choroid |
| C69.31 | Malignant neoplasm of right choroid |
| C69.32 | Malignant neoplasm of left choroid |
| C69.40 | Malignant neoplasm of unspecified ciliary body |
| C69.41 | Malignant neoplasm of right ciliary body |
| C69.42 | Malignant neoplasm of left ciliary body |
| C69.50 | Malignant neoplasm of unspecified lacrimal gland and duct |
| C69.51 | Malignant neoplasm of right lacrimal gland and duct |
| C69.52 | Malignant neoplasm of left lacrimal gland and duct |
| C69.60 | Malignant neoplasm of unspecified orbit |
| C69.61 | Malignant neoplasm of right orbit |
| C69.62 | Malignant neoplasm of left orbit |
| C69.80 | Malignant neoplasm of overlapping sites of unspecified eye and adnexa |
| C69.81 | Malignant neoplasm of overlapping sites of right eye and adnexa |
| C69.82 | Malignant neoplasm of overlapping sites of left eye and adnexa |
| C69.90 | Malignant neoplasm of unspecified site of unspecified eye |
| C69.91 | Malignant neoplasm of unspecified site of right eye |
| C69.92 | Malignant neoplasm of unspecified site of left eye |
| C70.0 | Malignant neoplasm of cerebral meninges |
| C70.1 | Malignant neoplasm of spinal meninges |
| C70.9 | Malignant neoplasm of meninges, unspecified |
| C71.0 | Malignant neoplasm of cerebrum, except lobes and ventricles |
| C71.1 | Malignant neoplasm of frontal lobe |
| C71.2 | Malignant neoplasm of temporal lobe |
| C71.3 | Malignant neoplasm of parietal lobe |
| C71.4 | Malignant neoplasm of occipital lobe |
| C71.5 | Malignant neoplasm of cerebral ventricle |
| C71.6 | Malignant neoplasm of cerebellum |
| C71.7 | Malignant neoplasm of brain stem |
| C71.8 | Malignant neoplasm of overlapping sites of brain |
| C71.9 | Malignant neoplasm of brain, unspecified |
| C72.0 | Malignant neoplasm of spinal cord |
| C72.1 | Malignant neoplasm of cauda equina |
| C72.20 | Malignant neoplasm of unspecified olfactory nerve |
| C72.21 | Malignant neoplasm of right olfactory nerve |
| C72.22 | Malignant neoplasm of left olfactory nerve |
| C72.30 | Malignant neoplasm of unspecified optic nerve |
| C72.31 | Malignant neoplasm of right optic nerve |
| C72.32 | Malignant neoplasm of left optic nerve |
| C72.40 | Malignant neoplasm of unspecified acoustic nerve |
| C72.41 | Malignant neoplasm of right acoustic nerve |
| C72.42 | Malignant neoplasm of left acoustic nerve |
| C72.50 | Malignant neoplasm of unspecified cranial nerve |
| C72.59 | Malignant neoplasm of other cranial nerves |
| C72.9 | Malignant neoplasm of central nervous system, unspecified |
| C73 | MALIGNANT NEOPLASM OF THYROID GLAND |
| C74.00 | Malignant neoplasm of cortex of unspecified adrenal gland |
| C74.01 | Malignant neoplasm of cortex of right adrenal gland |
| C74.02 | Malignant neoplasm of cortex of left adrenal gland |
| C74.10 | Malignant neoplasm of medulla of unspecified adrenal gland |
| C74.11 | Malignant neoplasm of medulla of right adrenal gland |
| C74.12 | Malignant neoplasm of medulla of left adrenal gland |
| C74.90 | Malignant neoplasm of unspecified part of unspecified adrenal gland |
| C74.91 | Malignant neoplasm of unspecified part of right adrenal gland |
| C74.92 | Malignant neoplasm of unspecified part of left adrenal gland |
| C75.0 | Malignant neoplasm of parathyroid gland |
| C75.1 | Malignant neoplasm of pituitary gland |
| C75.2 | Malignant neoplasm of craniopharyngeal duct |
| C75.3 | Malignant neoplasm of pineal gland |
| C75.4 | Malignant neoplasm of carotid body |
| C75.5 | Malignant neoplasm of aortic body and other paraganglia |
| C75.8 | Malignant neoplasm with pluriglanduar involvement, unspecified |
| C75.9 | Malignant neoplasm of endocrine gland, unspecified |
| C76.0 | Malignant neoplasm of head, face and neck |
| C76.1 | Malignant neoplasm of thorax |
| C76.2 | Malignant neoplasm of abdomen |
| C76.3 | Malignant neoplasm pelvis |
| C76.40 | Malignant neoplasm of unspecified upper limb |
| C76.41 | Malignant neoplasm of right upper limb |
| C76.42 | Malignant neoplasm of left upper limb |
| C76.50 | Malignant neoplasm of unspecified lower limb |
| C76.51 | Malignant neoplasm of right lower limb |
| C76.52 | Malignant neoplasm of left lower limb |
| C76.8 | Malignant neoplasm of overlapping sites of other and ill-defined sites |
| C7A.00 | Malignant carcinoid tumor of unspecified site |
| C7A.010 | Malignant carcinoid tumor of the duodenum |
| C7A.011 | Malignant carcinoid tumor of the jejunum |
| C7A.012 | Malignant carcinoid tumor of the ileum |
| C7A.019 | Malignant carcinoid tumor of the small intestine, unspecified portion |
| C7A.020 | Malignant carcinoid tumor of the appendix |
| C7A.021 | Malignant carcinoid tumor of the cecum |
| C7A.022 | Malignant carcinoid tumor of the ascending colon |
| C7A.023 | Malignant carcinoid tumor of the transverse colon |
| C7A.024 | Malignant carcinoid tumor of the descending colon |
| C7A.025 | Malignant carcinoid tumor of the sigmoid colon |
| C7A.026 | Malignant carcinoid tumor of the rectum |
| C7A.029 | Malignant carcinoid tumor of the large intestine, unspecified portion |
| C7A.090 | Malignant carcinoid tumor of the bronchus and lung |
| C7A.091 | Malignant carcinoid tumor of thymus |
| C7A.092 | Malignant carcinoid tumor of the stomach |
| C7A.093 | Malignant carcinoid tumor of the kidney |
| C7A.094 | Malignant carcinoid tumors of the foregut NOS |
| C7A.095 | Malignant carcinoid tumors of the midgut NOS |
| C7A.096 | Malignant carcinoid tumors of the hindgut NOS |
| C7A.098 | Malignant carcinoid tumors of other sites |
| C7A.1 | Malignant poorly differentiated neuroendocrine tumors |
| C7A.8 | Other malignant neuroendocrine tumors |
| C80.0 | Disseminated malignant neoplasm, unspecified |
| C80.1 | Malignant (primary) neoplasm, unspecified |
| C80.2 | Malignant neoplasm associated with transplanted organ |
| C81.00 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site |
| C81.01 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.02 | Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.03 | Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.04 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.05 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.06 | Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.07 | Nodular lymphocyte predominant Hodgkin lymphoma, spleen |
| C81.08 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.09 | Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites |
| C81.10 | Nodular sclerosis classical Hodgkin lymphoma, unspecified site |
| C81.11 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.12 | Nodular sclerosis classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.13 | Nodular sclerosis classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.14 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.15 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.16 | Nodular sclerosis classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.17 | Nodular sclerosis classical Hodgkin lymphoma, spleen |
| C81.18 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.19 | Nodular sclerosis classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.20 | Mixed cellularity classical Hodgkin lymphoma, unspecified site |
| C81.21 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.22 | Mixed cellularity classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.23 | Mixed cellularity classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.24 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.25 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.26 | Mixed cellularity classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.27 | Mixed cellularity classical Hodgkin lymphoma, spleen |
| C81.28 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.29 | Mixed cellularity classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.30 | Lymphocyte depleted classical Hodgkin lymphoma, unspecified site |
| C81.31 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.32 | Lymphocyte depleted classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.33 | Lymphocyte depleted classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.34 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.35 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.36 | Lymphocyte depleted classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.37 | Lymphocyte depleted classical Hodgkin lymphoma, spleen |
| C81.38 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.39 | Lymphocyte depleted classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.40 | Lymphocyte-rich classical Hodgkin lymphoma, unspecified site |
| C81.41 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.42 | Lymphocyte-rich classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.43 | Lymphocyte-rich classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.44 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.45 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.46 | Lymphocyte-rich classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.47 | Lymphocyte-rich classical Hodgkin lymphoma, spleen |
| C81.48 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.49 | Lymphocyte-rich classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.70 | Other classical Hodgkin lymphoma, unspecified site |
| C81.71 | Other classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.72 | Other classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.73 | Other classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.74 | Other classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.75 | Other classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.76 | Other classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.77 | Other classical Hodgkin lymphoma, spleen |
| C81.78 | Other classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.79 | Other classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.90 | Hodgkin lymphoma, unspecified, unspecified site |
| C81.91 | Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
| C81.92 | Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
| C81.93 | Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
| C81.94 | Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C81.95 | Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C81.96 | Hodgkin lymphoma, unspecified, intrapelvic lymph nodes |
| C81.97 | Hodgkin lymphoma, unspecified, spleen |
| C81.98 | Hodgkin lymphoma, unspecified, lymph nodes of multiple sites |
| C81.99 | Hodgkin lymphoma, unspecified, extranodal and solid organ sites |
| C82.00 | Follicular lymphoma grade I, unspecified site |
| C82.01 | Follicular lymphoma grade I, lymph nodes of head, face, and neck |
| C82.02 | Follicular lymphoma grade I, intrathoracic lymph nodes |
| C82.03 | Follicular lymphoma grade I, intra-abdominal lymph nodes |
| C82.04 | Follicular lymphoma grade I, lymph nodes of axilla and upper limb |
| C82.05 | Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb |
| C82.06 | Follicular lymphoma grade I, intrapelvic lymph nodes |
| C82.07 | Follicular lymphoma grade I, spleen |
| C82.08 | Follicular lymphoma grade I, lymph nodes of multiple sites |
| C82.09 | Follicular lymphoma grade I, extranodal and solid organ sites |
| C82.10 | Follicular lymphoma grade II, unspecified site |
| C82.11 | Follicular lymphoma grade II, lymph nodes of head, face, and neck |
| C82.12 | Follicular lymphoma grade II, intrathoracic lymph nodes |
| C82.13 | Follicular lymphoma grade II, intra-abdominal lymph nodes |
| C82.14 | Follicular lymphoma grade II, lymph nodes of axilla and upper limb |
| C82.15 | Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb |
| C82.16 | Follicular lymphoma grade II, intrapelvic lymph nodes |
| C82.17 | Follicular lymphoma grade II, spleen |
| C82.18 | Follicular lymphoma grade II, lymph nodes of multiple sites |
| C82.19 | Follicular lymphoma grade II, extranodal and solid organ sites |
| C82.20 | Follicular lymphoma grade III, unspecified, unspecified site |
| C82.21 | Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck |
| C82.22 | Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes |
| C82.23 | Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes |
| C82.24 | Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb |
| C82.25 | Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb |
| C82.26 | Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes |
| C82.27 | Follicular lymphoma grade III, unspecified, spleen |
| C82.28 | Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites |
| C82.29 | Follicular lymphoma grade III, unspecified, extranodal and solid organ sites |
| C82.30 | Follicular lymphoma grade IIIa, unspecified site |
| C82.31 | Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck |
| C82.32 | Follicular lymphoma grade IIIa, intrathoracic lymph nodes |
| C82.33 | Follicular lymphoma grade IIIa, intra-abdominal lymph nodes |
| C82.34 | Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb |
| C82.35 | Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb |
| C82.36 | Follicular lymphoma grade IIIa, intrapelvic lymph nodes |
| C82.37 | Follicular lymphoma grade IIIa, spleen |
| C82.38 | Follicular lymphoma grade IIIa, lymph nodes of multiple sites |
| C82.39 | Follicular lymphoma grade IIIa, extranodal and solid organ sites |
| C82.40 | Follicular lymphoma grade IIIb, unspecified site |
| C82.41 | Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck |
| C82.42 | Follicular lymphoma grade IIIb, intrathoracic lymph nodes |
| C82.43 | Follicular lymphoma grade IIIb, intra-abdominal lymph nodes |
| C82.44 | Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb |
| C82.45 | Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb |
| C82.46 | Follicular lymphoma grade IIIb, intrapelvic lymph nodes |
| C82.47 | Follicular lymphoma grade IIIb, spleen |
| C82.48 | Follicular lymphoma grade IIIb, lymph nodes of multiple sites |
| C82.49 | Follicular lymphoma grade IIIb, extranodal and solid organ sites |
| C82.50 | Diffuse follicle center lymphoma, unspecified site |
| C82.51 | Diffuse follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.52 | Diffuse follicle center lymphoma, intrathoracic lymph nodes |
| C82.53 | Diffuse follicle center lymphoma, intra-abdominal lymph nodes |
| C82.54 | Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.55 | Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.56 | Diffuse follicle center lymphoma, intrapelvic lymph nodes |
| C82.57 | Diffuse follicle center lymphoma, spleen |
| C82.58 | Diffuse follicle center lymphoma, lymph nodes of multiple sites |
| C82.59 | Diffuse follicle center lymphoma, extranodal and solid organ sites |
| C82.60 | Cutaneous follicle center lymphoma, unspecified site |
| C82.61 | Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.62 | Cutaneous follicle center lymphoma, intrathoracic lymph nodes |
| C82.63 | Cutaneous follicle center lymphoma, intra-abdominal lymph nodes |
| C82.64 | Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.65 | Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.66 | Cutaneous follicle center lymphoma, intrapelvic lymph nodes |
| C82.67 | Cutaneous follicle center lymphoma, spleen |
| C82.68 | Cutaneous follicle center lymphoma, lymph nodes of multiple sites |
| C82.69 | Cutaneous follicle center lymphoma, extranodal and solid organ sites |
| C82.80 | Other types of follicular lymphoma, unspecified site |
| C82.81 | Other types of follicular lymphoma, lymph nodes of head, face, and neck |
| C82.82 | Other types of follicular lymphoma, intrathoracic lymph nodes |
| C82.83 | Other types of follicular lymphoma, intra-abdominal lymph nodes |
| C82.84 | Other types of follicular lymphoma, lymph nodes of axilla and upper limb |
| C82.85 | Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C82.86 | Other types of follicular lymphoma, intrapelvic lymph nodes |
| C82.87 | Other types of follicular lymphoma, spleen |
| C82.88 | Other types of follicular lymphoma, lymph nodes of multiple sites |
| C82.89 | Other types of follicular lymphoma, extranodal and solid organ sites |
| C82.90 | Follicular lymphoma, unspecified, unspecified site |
| C82.91 | Follicular lymphoma, unspecified, lymph nodes of head, face, and neck |
| C82.92 | Follicular lymphoma, unspecified, intrathoracic lymph nodes |
| C82.93 | Follicular lymphoma, unspecified, intra-abdominal lymph nodes |
| C82.94 | Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C82.95 | Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C82.96 | Follicular lymphoma, unspecified, intrapelvic lymph nodes |
| C82.97 | Follicular lymphoma, unspecified, spleen |
| C82.98 | Follicular lymphoma, unspecified, lymph nodes of multiple sites |
| C82.99 | Follicular lymphoma, unspecified, extranodal and solid organ sites |
| C83.00 | Small cell B-cell lymphoma, unspecified site |
| C83.01 | Small cell B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.02 | Small cell B-cell lymphoma, intrathoracic lymph nodes |
| C83.03 | Small cell B-cell lymphoma, intra-abdominal lymph nodes |
| C83.04 | Small cell B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.05 | Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.06 | Small cell B-cell lymphoma, intrapelvic lymph nodes |
| C83.07 | Small cell B-cell lymphoma, spleen |
| C83.08 | Small cell B-cell lymphoma, lymph nodes of multiple sites |
| C83.09 | Small cell B-cell lymphoma, extranodal and solid organ sites |
| C83.10 | Mantle cell lymphoma, unspecified site |
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C83.12 | Mantle cell lymphoma, intrathoracic lymph nodes |
| C83.13 | Mantle cell lymphoma, intra-abdominal lymph nodes |
| C83.14 | Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C83.15 | Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.16 | Mantle cell lymphoma, intrapelvic lymph nodes |
| C83.17 | Mantle cell lymphoma, spleen |
| C83.18 | Mantle cell lymphoma, lymph nodes of multiple sites |
| C83.19 | Mantle cell lymphoma, extranodal and solid organ sites |
| C83.30 | Diffuse large B-cell lymphoma, unspecified site |
| C83.31 | Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.32 | Diffuse large B-cell lymphoma, intrathoracic lymph nodes |
| C83.33 | Diffuse large B-cell lymphoma, intra-abdominal lymph nodes |
| C83.34 | Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.35 | Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.36 | Diffuse large B-cell lymphoma, intrapelvic lymph nodes |
| C83.37 | Diffuse large B-cell lymphoma, spleen |
| C83.38 | Diffuse large B-cell lymphoma, lymph nodes of multiple sites |
| C83.39 | Diffuse large B-cell lymphoma, extranodal and solid organ sites |
| C83.50 | Lymphoblastic (diffuse) lymphoma, unspecified site |
| C83.51 | Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck |
| C83.52 | Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes |
| C83.53 | Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes |
| C83.54 | Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb |
| C83.55 | Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb |
| C83.56 | Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes |
| C83.57 | Lymphoblastic (diffuse) lymphoma, spleen |
| C83.58 | Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites |
| C83.59 | Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites |
| C83.70 | Burkitt lymphoma, unspecified site |
| C83.71 | Burkitt lymphoma, lymph nodes of head, face, and neck |
| C83.72 | Burkitt lymphoma, intrathoracic lymph nodes |
| C83.73 | Burkitt lymphoma, intra-abdominal lymph nodes |
| C83.74 | Burkitt lymphoma, lymph nodes of axilla and upper limb |
| C83.75 | Burkitt lymphoma, lymph nodes of inguinal region and lower limb |
| C83.76 | Burkitt lymphoma, intrapelvic lymph nodes |
| C83.77 | Burkitt lymphoma, spleen |
| C83.78 | Burkitt lymphoma, lymph nodes of multiple sites |
| C83.79 | Burkitt lymphoma, extranodal and solid organ sites |
| C83.80 | Other non-follicular lymphoma, unspecified site |
| C83.81 | Other non-follicular lymphoma, lymph nodes of head, face, and neck |
| C83.82 | Other non-follicular lymphoma, intrathoracic lymph nodes |
| C83.83 | Other non-follicular lymphoma, intra-abdominal lymph nodes |
| C83.84 | Other non-follicular lymphoma, lymph nodes of axilla and upper limb |
| C83.85 | Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C83.86 | Other non-follicular lymphoma, intrapelvic lymph nodes |
| C83.87 | Other non-follicular lymphoma, spleen |
| C83.88 | Other non-follicular lymphoma, lymph nodes of multiple sites |
| C83.89 | Other non-follicular lymphoma, extranodal and solid organ sites |
| C83.90 | Non-follicular (diffuse) lymphoma, unspecified, unspecified site |
| C83.91 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck |
| C83.92 | Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes |
| C83.93 | Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes |
| C83.94 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C83.95 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C83.96 | Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes |
| C83.97 | Non-follicular (diffuse) lymphoma, unspecified, spleen |
| C83.98 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites |
| C83.99 | Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites |
| C84.00 | Mycosis fungoides, unspecified site |
| C84.01 | Mycosis fungoides, lymph nodes of head, face, and neck |
| C84.02 | Mycosis fungoides, intrathoracic lymph nodes |
| C84.03 | Mycosis fungoides, intra-abdominal lymph nodes |
| C84.04 | Mycosis fungoides, lymph nodes of axilla and upper limb |
| C84.05 | Mycosis fungoides, lymph nodes of inguinal region and lower limb |
| C84.06 | Mycosis fungoides, intrapelvic lymph nodes |
| C84.07 | Mycosis fungoides, spleen |
| C84.08 | Mycosis fungoides, lymph nodes of multiple sites |
| C84.09 | Mycosis fungoides, extranodal and solid organ sites |
| C84.10 | Sezary disease, unspecified site |
| C84.11 | Sezary disease, lymph nodes of head, face, and neck |
| C84.12 | Sezary disease, intrathoracic lymph nodes |
| C84.13 | Sezary disease, intra-abdominal lymph nodes |
| C84.14 | Sezary disease, lymph nodes of axilla and upper limb |
| C84.15 | Sezary disease, lymph nodes of inguinal region and lower limb |
| C84.16 | Sezary disease, intrapelvic lymph nodes |
| C84.17 | Sezary disease, spleen |
| C84.18 | Sezary disease, lymph nodes of multiple sites |
| C84.19 | Sezary disease, extranodal and solid organ sites |
| C84.40 | Peripheral T-cell lymphoma, not classified, unspecified site |
| C84.41 | Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck |
| C84.42 | Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes |
| C84.43 | Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes |
| C84.44 | Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb |
| C84.45 | Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb |
| C84.46 | Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes |
| C84.47 | Peripheral T-cell lymphoma, not classified, spleen |
| C84.48 | Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites |
| C84.49 | Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites |
| C84.60 | Anaplastic large cell lymphoma, ALK-positive, unspecified site |
| C84.61 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck |
| C84.62 | Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes |
| C84.63 | Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes |
| C84.64 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb |
| C84.65 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb |
| C84.66 | Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes |
| C84.67 | Anaplastic large cell lymphoma, ALK-positive, spleen |
| C84.68 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites |
| C84.69 | Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites |
| C84.70 | Anaplastic large cell lymphoma, ALK-negative, unspecified site |
| C84.71 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck |
| C84.72 | Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes |
| C84.73 | Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes |
| C84.74 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb |
| C84.75 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb |
| C84.76 | Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes |
| C84.77 | Anaplastic large cell lymphoma, ALK-negative, spleen |
| C84.78 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites |
| C84.79 | Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites |
| C84.90 | Mature T/NK-cell lymphomas, unspecified, unspecified site |
| C84.91 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck |
| C84.92 | Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes |
| C84.93 | Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes |
| C84.94 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb |
| C84.95 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb |
| C84.96 | Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes |
| C84.97 | Mature T/NK-cell lymphomas, unspecified, spleen |
| C84.98 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites |
| C84.99 | Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites |
| C84.A0 | Cutaneous T-cell lymphoma, unspecified, unspecified site |
| C84.A1 | Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck |
| C84.A2 | Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes |
| C84.A3 | Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes |
| C84.A4 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C84.A5 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C84.A6 | Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes |
| C84.A7 | Cutaneous T-cell lymphoma, unspecified, spleen |
| C84.A8 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites |
| C84.A9 | Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites |
| C84.Z0 | Other mature T/NK-cell lymphomas, unspecified site |
| C84.Z1 | Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck |
| C84.Z2 | Other mature T/NK-cell lymphomas, intrathoracic lymph nodes |
| C84.Z3 | Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes |
| C84.Z4 | Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb |
| C84.Z5 | Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb |
| C84.Z6 | Other mature T/NK-cell lymphomas, intrapelvic lymph nodes |
| C84.Z7 | Other mature T/NK-cell lymphomas, spleen |
| C84.Z8 | Other mature T/NK-cell lymphomas, lymph nodes of multiple sites |
| C84.Z9 | Other mature T/NK-cell lymphomas, extranodal and solid organ sites |
| C85.10 | Unspecified B-cell lymphoma, unspecified site |
| C85.11 | Unspecified B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.12 | Unspecified B-cell lymphoma, intrathoracic lymph nodes |
| C85.13 | Unspecified B-cell lymphoma, intra-abdominal lymph nodes |
| C85.14 | Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.15 | Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.16 | Unspecified B-cell lymphoma, intrapelvic lymph nodes |
| C85.17 | Unspecified B-cell lymphoma, spleen |
| C85.18 | Unspecified B-cell lymphoma, lymph nodes of multiple sites |
| C85.19 | Unspecified B-cell lymphoma, extranodal and solid organ sites |
| C85.20 | Mediastinal (thymic) large B-cell lymphoma, unspecified site |
| C85.21 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.22 | Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes |
| C85.23 | Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes |
| C85.24 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.25 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.26 | Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes |
| C85.27 | Mediastinal (thymic) large B-cell lymphoma, spleen |
| C85.28 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites |
| C85.29 | Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites |
| C85.80 | Other specified types of non-Hodgkin lymphoma, unspecified site |
| C85.81 | Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C85.82 | Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes |
| C85.83 | Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes |
| C85.84 | Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C85.85 | Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C85.86 | Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.87 | Other specified types of non-Hodgkin lymphoma, spleen |
| C85.88 | Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites |
| C85.89 | Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites |
| C85.90 | Non-Hodgkin lymphoma, unspecified site |
| C85.91 | Non-Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C85.92 | Non-Hodgkin lymphoma, intrathoracic lymph nodes |
| C85.93 | Non-Hodgkin lymphoma, intra-abdominal lymph nodes |
| C85.94 | Non-Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C85.95 | Non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C85.96 | Non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.97 | Non-Hodgkin lymphoma, spleen |
| C85.98 | Non-Hodgkin lymphoma, lymph nodes of multiple sites |
| C85.99 | Non-Hodgkin lymphoma, extranodal and solid organ sites |
| C86.0 | Extranodal NK/T-cell lymphoma, nasal type |
| C86.1 | Hepatosplenic T-cell lymphoma |
| C86.2 | Enteropathy-type (intestinal) T-cell lymphoma |
| C86.3 | Subcutaneous panniculitis-like T-cell lymphoma |
| C86.4 | Blastic NK-cell lymphoma |
| C86.5 | Angioimmunoblastic T-cell lymphoma |
| C86.6 | Primary cutaneous CD30-positive T-cell proliferation |
| C88.0 | Waldenstrom's macroglobulinemia |
| C88.2 | Heavy chain disease |
| C88.3 | Immunoproliferative small intestinal diseases |
| C88.4 | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] |
| C88.8 | Other malignant immunoproliferative diseases |
| C88.9 | Malignant immunoproliferative disease, unspecified |
| C90.00 | Multiple myeloma not having achieved remission |
| C90.01 | Multiple myeloma in remission |
| C90.02 | Multiple myeloma in relapse |
| C90.10 | Plasma cell leukemia not having achieved remission |
| C90.11 | Plasma cell leukemia in remission |
| C90.12 | Plasma cell leukemia in relapse |
| C90.20 | Extramedullary plasmacytoma not having achieved remission |
| C90.21 | Extramedullary plasmacytoma in remission |
| C90.22 | Extramedullary plasmacytoma in relapse |
| C90.30 | Solitary plasmacytoma not having achieved remission |
| C90.31 | Solitary plasmacytoma in remission |
| C90.32 | Solitary plasmacytoma in relapse |
| C91.00 | Acute lymphoblastic leukemia not having achieved remission |
| C91.01 | Acute lymphoblastic leukemia, in remission |
| C91.02 | Acute lymphoblastic leukemia, in relapse |
| C91.10 | Chronic lymphocytic leukemia of B-cell type not having achieved remission |
| C91.11 | Chronic lymphocytic leukemia of B-cell type in remission |
| C91.12 | Chronic lymphocytic leukemia of B-cell type in relapse |
| C91.30 | Prolymphocytic leukemia of B-cell type not having achieved remission |
| C91.31 | Prolymphocytic leukemia of B-cell type, in remission |
| C91.32 | Prolymphocytic leukemia of B –cell type, in relapse |
| C91.40 | Hairy cell leukemia not having achieved remission |
| C91.41 | Hairy cell leukemia, in remission |
| C91.42 | Hairy cell leukemia, in relapse |
| C91.50 | Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission |
| C91.51 | Adult T-cell lymphoma/leukemia (HTLV-1-associated) in remission |
| C91.52 | Adult T-cell lymphoma/leukemia (HTLV-1-associated) in relapse |
| C91.60 | Prolymphocytic leukemia of T-cell type not having achieved remission |
| C91.61 | Prolymphocytic leukemia of T-cell type, in remission |
| C91.62 | Prolymphocytic leukemia of T –cell type, in relapse |
| C91.90 | Lymphoid leukemia, unspecified not having achieved remission |
| C91.91 | Lymphoid leukemia, unspecified, in remission |
| C91.92 | Lymphoid leukemia, unspecified, in relapse |
| C91.A0 | Mature B-cell leukemia Burkitt-type not having achieved remission |
| C91.A1 | Mature B-cell leukemia Burkitt-type, in remission |
| C91.A2 | Mature B-cell leukemia Burkitt-type, in relapse |
| C91.Z0 | Other lymphoid leukemia not having achieved remission |
| C91.Z1 | Other lymphoid leukemia, in remission |
| C91.Z2 | Other lymphoid leukemia, in relapse |
| C92.00 | Acute myeloblastic leukemia, not having achieved remission |
| C92.01 | Acute myeloblastic leukemia, in remission |
| C92.02 | Acute myeloblastic leukemia, in relapse |
| C92.10 | Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission |
| C92.11 | Chronic myeloid leukemia, BCR/ABL-positive, in remission |
| C92.12 | Chronic myeloid leukemia, BCR/ABL-positive, in relapse |
| C92.20 | Atypical chronic myeloid leukemia, BCR/ABL-negative not having achieved remission |
| C92.21 | Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission |
| C92.22 | Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse |
| C92.30 | Myeloid sarcoma, not having achieved remission |
| C92.31 | Myeloid sarcoma, in remission |
| C92.32 | Myeloid sarcoma, in relapse |
| C92.40 | Acute promyelocytic leukemia, not having achieved remission |
| C92.41 | Acute promyelocytic leukemia, in remission |
| C92.42 | Acute promyelocytic leukemia, in relapse |
| C92.50 | Acute myelomonocytic leukemia, not having achieved remission |
| C92.51 | Acute myelomonocytic in remission |
| C92.52 | Acute myelomonocytic in relapse |
| C92.60 | Acute myeloid leukemia with 11q23 abnormality not having achieved remission |
| C92.61 | Acute myeloid leukemia with 11q23 abnormality in remission |
| C92.62 | Acute myeloid leukemia with 11q23 abnormality in relapse |
| C92.90 | Myeloid leukemia, unspecified, not having achieved remission |
| C92.91 | Myeloid leukemia, unspecified in remission |
| C92.92 | Myeloid leukemia, unspecified in relapse |
| C92.A0 | Acute myeloid leukemia with multilineage dysplasia not having achieved remission |
| C92.A1 | Acute myeloid leukemia with multilineage dysplasia, in remission |
| C92.A2 | Acute myeloid leukemia with multilineage dysplasia, in relapse |
| C92.Z0 | Other myeloid leukemia not having achieved remission |
| C92.Z1 | Other myeloid leukemia, in remission |
| C92.Z2 | Other myeloid leukemia, in relapse |
| C93.00 | Acute monoblastic/monocytic leukemia, not having achieved remission |
| C93.01 | Acute monoblastic/monocytic leukemia, in remission |
| C93.02 | Acute monoblastic/monocytic leukemia, in relapse |
| C93.10 | Chronic myelomonocytic leukemia not having achieved remission |
| C93.11 | Chronic myelomonocytic leukemia, in remission |
| C93.12 | Chronic myelomonocytic leukemia, in relapse |
| C93.30 | Juvenile myelomonocytic leukemia not having achieved remission |
| C93.31 | Juvenile myelomonocytic leukemia, in remission |
| C93.32 | Juvenile myelomonocytic leukemia, in relapse |
| C93.90 | Monocytic leukemia, unspecified, not having achieved remission |
| C93.91 | Monocytic leukemia, unspecified in remission |
| C93.92 | Monocytic leukemia, unspecified in relapse |
| C93.Z0 | Other monocytic leukemia, not having achieved remission |
| C93.Z1 | Other monocytic leukemia in remission |
| C93.Z2 | Other monocytic leukemia in relapse |
| C94.00 | Acute erythroid leukemia, not having achieved remission |
| C94.01 | Acute erythroid leukemia, in remission |
| C94.02 | Acute erythroid leukemia, in relapse |
| C94.20 | Acute megakaryoblastic leukemia not having achieved remission |
| C94.21 | Acute megakaryoblastic leukemia, in remission |
| C94.22 | Acute megakaryoblastic leukemia, in relapse |
| C94.30 | Mast cell leukemia not having achieved remission |
| C94.31 | Mast cell leukemia, in remission |
| C94.32 | Mast cell leukemia, in relapse |
| C94.40 | Acute panmyelosis with myelofibrosis not having achieved remission |
| C94.41 | Acute panmyelosis with myelofibrosis, in remission |
| C94.42 | Acute panmyelosis with myelofibrosis, in relapse |
| C94.6 | Myelodysplastic disease, not classified |
| C94.80 | Other specified leukemias not having achieved remission |
| C94.81 | Other specified leukemias, in remission |
| C94.82 | Other specified leukemias, in relapse |
| C95.00 | Acute leukemia of unspecified cell type not having achieved remission |
| C95.01 | Acute leukemia of unspecified cell type, in remission |
| C95.02 | Acute leukemia of unspecified cell type, in relapse |
| C95.10 | Chronic leukemia of unspecified cell type not having achieved remission |
| C95.11 | Chronic leukemia of unspecified cell type, in remission |
| C95.12 | Chronic leukemia of unspecified cell type, in relapse |
| C95.90 | Leukemia, unspecified not having achieved remission |
| C95.91 | Leukemia, unspecified, in remission |
| C95.92 | Leukemia, unspecified, in relapse |
| C96.0 | Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis |
| C96.20 | Malignant mast cell neoplasm, unspecified |
| C96.21 | Aggressive systemic mastocytosis |
| C96.22 | Mast cell sarcoma |
| C96.29 | Other malignant cell neoplasm |
| C96.4 | Sarcoma of dendritic cells (accessory cells) Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified |
| C96.5 | Multifocal and unisystemic Langerhans-cell histiocytosis |
| C96.6 | Unifocal Langerhans-cell histiocytosis |
| C96.9 | Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified |
| C96.A | Histiocytic sarcoma |
| C96.Z | Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue |
| D45 | POLYCYTHEMIA VERA |
| D46.0 | Refractory anemia without ring sideroblasts, so stated |
| D46.1 | Refractory anemia with ring sideroblasts |
| D46.20 | Refractory anemia with excess of blasts, unspecified |
| D46.21 | Refractory anemia with excess of blasts 1 |
| D46.22 | Refractory anemia with excess of blasts 2 |
| D46.4 | Refractory anemia, unspecified |
| D46.9 | Myelodysplastic syndrome, unspecified |
| D46.B | Refractory cytopenia with multilineage dysplasia and ring sideroblasts |
| D46.C | Myelodysplastic syndrome with isolated del (5q) chromosomal abnormality |
| D46.Z | Other myelodysplastic syndromes |
| D47.02 | Systemic mastocytosis |
| D47.1 | Chronic myeloproliferative disease |
| D47.3 | Essential (hemorrhagic) thrombocythemia |
| D47.4 | Osteomyelofibrosis |
| D47.9 | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified |
| D47.Z1 | Post-transplant lymphoproliferative disorder (PTLD) |
| D47.Z9 | Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
| D49.6 | Neoplasm of unspecified behavior of brain |
| D49.7 | Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system |
This value set excludes codes based on the following rules:
http://snomed.info/sct where concept is-a 128462008 (Metastatic neoplasm (disease))This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 393573009 (Hypereosinophilic syndrome)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D72.110 | Idiopathic hypereosinophilic syndrome [HES] |
| D72.111 | Lymphocytic Variant Hypereosinophilic Syndrome [LHES] |
| D72.118 | Other hypereosinophilic syndrome |
| D72.119 | Hypereosinophilic syndrome [HES], unspecified |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 109355002 (Carcinoma in situ (disorder))http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D00 | CARCINOMA IN SITU OF ORAL CAVITY, ESOPHAGUS AND STOMACH |
| D00.0 | Carcinoma in situ of lip, oral cavity and pharynx |
| D00.00 | Carcinoma in situ of oral cavity, unspecified site |
| D00.01 | Carcinoma in situ of labial mucosa and vermilion border |
| D00.02 | Carcinoma in situ of buccal mucosa |
| D00.03 | Carcinoma in situ of gingiva and edentulous alveolar ridge |
| D00.04 | Carcinoma in situ of soft palate |
| D00.05 | Carcinoma in situ of hard palate |
| D00.06 | Carcinoma in situ of floor of mouth |
| D00.07 | Carcinoma in situ of tongue |
| D00.08 | Carcinoma in situ of pharynx |
| D00.1 | Carcinoma in situ of esophagus |
| D00.2 | Carcinoma in situ of stomach |
| D01 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED DIGESTIVE ORGANS |
| D01.0 | Carcinoma in situ of colon |
| D01.1 | Carcinoma in situ of rectosigmoid junction |
| D01.2 | Carcinoma in situ of rectum |
| D01.3 | Carcinoma in situ of anus and anal canal |
| D01.4 | Carcinoma in situ of other and unspecified parts of intestine |
| D01.40 | Carcinoma in situ of unspecified part of intestine |
| D01.49 | Carcinoma in situ of other parts of intestine |
| D01.5 | Carcinoma in situ of liver, gallbladder and bile ducts |
| D01.7 | Carcinoma in situ of other specified digestive organs |
| D01.9 | Carcinoma in situ of digestive organ, unspecified |
| D02 | CARCINOMA IN SITU OF MIDDLE EAR AND RESPIRATORY SYSTEM |
| D02.0 | Carcinoma in situ of larynx |
| D02.1 | Carcinoma in situ of trachea |
| D02.2 | Carcinoma in situ of bronchus and lung |
| D02.20 | Carcinoma in situ of unspecified bronchus and lung |
| D02.21 | Carcinoma in situ of right bronchus and lung |
| D02.22 | Carcinoma in situ of left bronchus and lung |
| D02.3 | Carcinoma in situ of other parts of respiratory system |
| D02.4 | Carcinoma in situ of respiratory system, unspecified |
| D05 | CARCINOMA IN SITU OF BREAST |
| D05.0 | Lobular carcinoma in situ of breast |
| D05.00 | Lobular carcinoma in situ of unspecified breast |
| D05.01 | Lobular carcinoma in situ of right breast |
| D05.02 | Lobular carcinoma in situ of left breast |
| D05.1 | Intraductal carcinoma in situ of breast |
| D05.10 | Intraductal carcinoma in situ of unspecified breast |
| D05.11 | Intraductal carcinoma in situ of right breast |
| D05.12 | Intraductal carcinoma in situ of left breast |
| D05.8 | Other specified type of carcinoma in situ of breast |
| D05.80 | Other specified type of carcinoma in situ of unspecified breast |
| D05.81 | Other specified type of carcinoma in situ of right breast |
| D05.82 | Other specified type of carcinoma in situ of left breast |
| D05.9 | Unspecified type of carcinoma in situ of breast |
| D05.90 | Unspecified type of carcinoma in situ of unspecified breast |
| D05.91 | Unspecified type of carcinoma in situ of right breast |
| D05.92 | Unspecified type of carcinoma in situ of left breast |
| D07 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED GENITAL ORGANS |
| D07.0 | Carcinoma in situ of endometrium |
| D07.1 | Carcinoma in situ of vulva |
| D07.2 | Carcinoma in situ of vagina |
| D07.3 | Carcinoma in situ of other and unspecified female genital organs |
| D07.30 | Carcinoma in situ of unspecified female genital organs |
| D07.39 | Carcinoma in situ of other female genital organs |
| D07.4 | Carcinoma in situ of penis |
| D07.6 | Carcinoma in situ of other and unspecified male genital organs |
| D07.60 | Carcinoma in situ of unspecified male genital organs |
| D07.61 | Carcinoma in situ of scrotum |
| D07.69 | Carcinoma in situ of other male genital organs |
| D09 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED SITES |
| D09.0 | Carcinoma in situ of bladder |
| D09.1 | Carcinoma in situ of other and unspecified urinary organs |
| D09.10 | Carcinoma in situ of unspecified urinary organ |
| D09.19 | Carcinoma in situ of other urinary organs |
| D09.2 | Carcinoma in situ of eye |
| D09.20 | Carcinoma in situ of unspecified eye |
| D09.21 | Carcinoma in situ of right eye |
| D09.22 | Carcinoma in situ of left eye |
| D09.3 | Carcinoma in situ of thyroid and other endocrine glands |
| D09.8 | Carcinoma in situ of other specified sites |
| D09.9 | Carcinoma in situ, unspecified |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 189758001 (Melanoma in situ)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D03 | Melanoma in situ of skin |
| D03.0 | Melanoma in situ of lip |
| D03.1 | Melanoma in situ of eyelid, including canthus |
| D03.10 | Melanoma in situ of unspecified eyelid, including canthus |
| D03.11 | Melanoma in situ of right eyelid, including canthus |
| D03.111 | Melanoma in situ of right upper eyelid, including canthus |
| D03.112 | Melanoma in situ of right lower eyelid, including canthus |
| D03.12 | Melanoma in situ of left eyelid, including canthus |
| D03.121 | Melanoma in situ of left upper eyelid, including canthus |
| D03.122 | Melanoma in situ of left lower eyelid, including canthus |
| D03.2 | Melanoma in situ of ear and external auricular canal |
| D03.20 | Melanoma in situ of unspecified ear and external auricular canal |
| D03.21 | Melanoma in situ of right ear and external auricular canal |
| D03.22 | Melanoma in situ of left ear and external auricular canal |
| D03.3 | Melanoma in situ of other and unspecified parts of face |
| D03.30 | Melanoma in situ of unspecified part of face |
| D03.39 | Melanoma in situ of other parts of face |
| D03.4 | Melanoma in situ of scalp and neck |
| D03.5 | Melanoma in situ of trunk |
| D03.51 | Melanoma in situ of anal skin |
| D03.52 | Melanoma in situ of breast (skin) (soft tissue) |
| D03.59 | Melanoma in situ of other part of trunk |
| D03.6 | Melanoma in situ of upper limb, including shoulder |
| D03.60 | Melanoma in situ of unspecified upper limb, including shoulder |
| D03.61 | Melanoma in situ of right upper limb, including shoulder |
| D03.62 | Melanoma in situ of left upper limb, including shoulder |
| D03.7 | Melanoma in situ of lower limb, including hip |
| D03.70 | Melanoma in situ of unspecified lower limb, including hip |
| D03.71 | Melanoma in situ of right lower limb, including hip |
| D03.72 | Melanoma in situ of left lower limb, including hip |
| D03.8 | Melanoma in situ of other sites |
| D03.9 | Melanoma in situ, unspecified |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 93468003 (Hemangioma of intracranial structure)http://snomed.info/sct where concept is-a 109913001 (Benign neoplasm of meninges)http://snomed.info/sct where concept is-a 92030004 (Benign neoplasm of brain)http://snomed.info/sct where concept is-a 92048008 (Benign neoplasm of central nervous system)http://snomed.info/sct where concept is-a 92296004 (Benign neoplasm of pituitary gland)http://snomed.info/sct where concept is-a 92294001 (Benign neoplasm of pineal gland)http://snomed.info/sct where concept is-a 94963005 (Neoplasm of uncertain behavior of nervous system)http://snomed.info/sct where concept is-a 94767002 (Neoplasm of uncertain behavior of brain)http://snomed.info/sct where concept is-a 95002008 (Neoplasm of uncertain behavior of pineal gland)http://snomed.info/sct where concept is-a 95004009 (Neoplasm of uncertain behavior of pituitary gland)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D18.02 | Hemangioma of intracranial structures |
| D32 | BENIGN NEOPLASM OF MENINGES |
| D32.0 | Benign neoplasm of cerebral meninges |
| D32.1 | Benign neoplasm of spinal meninges |
| D32.9 | Benign neoplasm of meninges, unspecified |
| D33 | BENIGN NEOPLASM OF BRAIN AND OTHER PARTS OF CENTRAL NERVOUS SYSTEM |
| D33.0 | Benign neoplasm of brain, supratentorial |
| D33.1 | Benign neoplasm of brain, infratentorial |
| D33.2 | Benign neoplasm of brain, unspecified |
| D33.3 | Benign neoplasm of cranial nerves |
| D33.4 | Benign neoplasm of spinal cord |
| D33.7 | Benign neoplasm of other specified parts of central nervous system |
| D33.9 | Benign neoplasm of central nervous system, unspecified |
| D35.2 | Benign neoplasm of pituitary gland |
| D35.3 | Benign neoplasm of craniopharyngeal duct |
| D35.4 | Benign neoplasm of pineal gland |
| D42.0 | Neoplasm of uncertain behavior of cerebral meninges |
| D42.1 | Neoplasm of uncertain behavior of spinal meninges |
| D42.9 | Neoplasm of uncertain behavior of meninges, unspecified |
| D43.0 | Neoplasm of uncertain behavior of brain, supratentorial |
| D43.1 | Neoplasm of uncertain behavior of brain, infratentorial |
| D43.2 | Neoplasm of uncertain behavior of brain, unspecified |
| D43.3 | Neoplasm of uncertain behavior of cranial nerves |
| D43.4 | Neoplasm of uncertain behavior of spinal cord |
| D43.8 | Neoplasm of uncertain behavior of other specified parts of central nervous system |
| D43.9 | Neoplasm of uncertain behavior of central nervous system, unspecified |
| D44.3 | Neoplasm of uncertain behavior of pituitary gland |
| D44.4 | Neoplasm of uncertain behavior of craniopharyngeal duct |
| D44.5 | Neoplasm of uncertain behavior of pineal gland |
This value set includes codes based on the following rules:
http://snomed.info/sct| Code | Display |
| 126361000119107 | Cytological evidence of malignancy on anal Papanicolaou smear (finding) |
| 126371000119101 | Cytological evidence of malignancy on vaginal Papanicolaou smear (finding) |
http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| R85.614 | Cytologic evidence of malignancy on smear of anus |
| R87.624 | Cytologic evidence of malignancy on smear of vagina |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 128462008 (Metastatic neoplasm (disease))http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| C77 | SECONDARY AND UNSPECIFIED MALIGNANT NEOPLASM OF LYMPH NODES |
| C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck |
| C77.1 | Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes |
| C77.2 | Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes |
| C77.3 | Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes |
| C77.4 | Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes |
| C77.5 | Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes |
| C77.8 | Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions |
| C77.9 | Secondary and unspecified malignant neoplasm of lymph node, unspecified |
| C78 | SECONDARY MALIGNANT NEOPLASM OF RESPIRATORY AND DIGESTIVE ORGANS |
| C78.0 | Secondary malignant neoplasm of lung |
| C78.00 | Secondary malignant neoplasm of unspecified lung |
| C78.01 | Secondary malignant neoplasm of right lung |
| C78.02 | Secondary malignant neoplasm of left lung |
| C78.1 | Secondary malignant neoplasm of mediastinum |
| C78.2 | Secondary malignant neoplasm of pleura |
| C78.3 | Secondary malignant neoplasm of other and unspecified respiratory organs |
| C78.30 | Secondary malignant neoplasm of unspecified respiratory organ |
| C78.39 | Secondary malignant neoplasm of other respiratory organs |
| C78.4 | Secondary malignant neoplasm of small intestine |
| C78.5 | Secondary malignant neoplasm of large intestine and rectum |
| C78.6 | Secondary malignant neoplasm of retroperitoneum and peritoneum |
| C78.7 | Secondary malignant neoplasm of liver and intrahepatic bile duct |
| C78.8 | Secondary malignant neoplasm of other and unspecified digestive organs |
| C78.80 | Secondary malignant neoplasm of unspecified digestive organ |
| C78.89 | Secondary malignant neoplasm of other digestive organs |
| C79 | SECONDARY MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED SITES |
| C79.0 | Secondary malignant neoplasm of kidney and renal pelvis |
| C79.00 | Secondary malignant neoplasm of unspecified kidney and renal pelvis |
| C79.01 | Secondary malignant neoplasm of right kidney and renal pelvis |
| C79.02 | Secondary malignant neoplasm of left kidney and renal pelvis |
| C79.1 | Secondary malignant neoplasm of bladder and other urinary organs |
| C79.10 | Secondary malignant neoplasm of unspecified urinary organs |
| C79.11 | Secondary malignant neoplasm of bladder |
| C79.19 | Secondary malignant neoplasm of other urinary organs |
| C79.2 | Secondary malignant neoplasm of skin |
| C79.3 | Secondary malignant neoplasm of brain cerebral meninges |
| C79.31 | Secondary malignant neoplasm of brain |
| C79.32 | Secondary malignant neoplasm of cerebral meninges |
| C79.4 | Secondary malignant neoplasm of other and unspecified of nervous system |
| C79.40 | Secondary malignant neoplasm of unspecified part of nervous system |
| C79.49 | Secondary malignant neoplasm of other parts of nervous system |
| C79.5 | Secondary malignant neoplasm of bone and bone marrow |
| C79.51 | Secondary malignant neoplasm of bone |
| C79.52 | Secondary malignant neoplasm of bone marrow |
| C79.6 | Secondary malignant neoplasm of ovary |
| C79.60 | Secondary malignant neoplasm of unspecified ovary |
| C79.61 | Secondary malignant neoplasm of right ovary |
| C79.62 | Secondary malignant neoplasm of left ovary |
| C79.7 | Secondary malignant neoplasm of adrenal gland |
| C79.70 | Secondary malignant neoplasm of unspecified adrenal gland |
| C79.71 | Secondary malignant neoplasm of right adrenal gland |
| C79.72 | Secondary malignant neoplasm of left adrenal gland |
| C79.8 | Secondary malignant neoplasm of other specified sites |
| C79.81 | Secondary malignant neoplasm of breast |
| C79.82 | Secondary malignant neoplasm of genital organs |
| C79.89 | Secondary malignant neoplasm of other specified sites |
| C79.9 | Secondary malignant neoplasm of unspecified site |
| C7B | SECONDARY NEUROENDOCRINE TUMORS |
| C7B.0 | Secondary carcinoid tumors |
| C7B.00 | Secondary carcinoid tumors, unspecified site |
| C7B.01 | Secondary carcinoid tumors of distant lymph nodes |
| C7B.02 | Secondary carcinoid tumors of liver |
| C7B.03 | Secondary carcinoid tumors of bone |
| C7B.04 | Secondary carcinoid tumors of peritoneum |
| C7B.09 | Secondary carcinoid tumors of other sites |
| C7B.1 | Secondary merkel cell carcinoma |
| C7B.8 | Other secondary neuroendocrine tumors |
This value set includes codes based on the following rules:
http://terminology.hl7.org/CodeSystem/icd-o-3http://snomed.info/sct where concept is-a 367651003 (Malignant Neoplasm (Morphology))http://snomed.info/sct where concept is-a 399919001 (Carcinoma in situ - category (morphologic abnormality))http://snomed.info/sct where concept is-a 399983006 (In situ adenomatous neoplasm - category (morphologic abnormality))http://snomed.info/sct| Code | Display |
| 399878004 | Malignant neoplasm with pilar differentiation (morphologic abnormality) |
| 253035009 | In situ melanocytic morphology (morphologic abnormality) |
This value set excludes codes based on the following rules:
http://snomed.info/sct where concept is-a 450893003 (Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia (morphologic abnormality))http://snomed.info/sct where concept is-a 128640002 (Prostatic intraepithelial neoplasia, grade III)http://snomed.info/sct where concept is-a 450890000 (Glandular intraepithelial neoplasia, low grade)http://snomed.info/sct where concept is-a 703548001 (Atypical hyperplasia of the endometrium)This value set includes codes based on the following rules:
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 363346000 (Malignant tumor)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| C00.0 | Malignant neoplasm of external upper lip |
| C00.1 | Malignant neoplasm of external lower lip |
| C00.2 | Malignant neoplasm of external lip, unspecified |
| C00.3 | Malignant neoplasm of upper lip, inner aspect |
| C00.4 | Malignant neoplasm of lower lip, inner aspect |
| C00.5 | Malignant neoplasm of lip, unspecified, inner aspect |
| C00.6 | Malignant neoplasm of commissure of lip, unspecified |
| C00.8 | Malignant neoplasm of overlapping sites of lip |
| C00.9 | Malignant neoplasm of lip, unspecified |
| C01 | MALIGNANT NEOPLASM OF BASE OF TONGUE |
| C02.0 | Malignant neoplasm of dorsal surface of tongue |
| C02.1 | Malignant neoplasm of border of tongue |
| C02.2 | Malignant neoplasm of ventral surface of tongue |
| C02.3 | Malignant neoplasm of anterior two-thirds of tongue, part unspecified |
| C02.4 | Malignant neoplasm of lingual tonsil |
| C02.8 | Malignant neoplasm of overlapping sites of tongue |
| C02.9 | Malignant neoplasm of tongue, unspecified |
| C03.0 | Malignant neoplasm of upper gum |
| C03.1 | Malignant neoplasm of lower gum |
| C03.9 | Malignant neoplasm of gum, unspecified |
| C04.0 | Malignant neoplasm of anterior floor of mouth |
| C04.1 | Malignant neoplasm of lateral floor of mouth |
| C04.8 | Malignant neoplasm of overlapping sites of floor of mouth |
| C04.9 | Malignant neoplasm of floor of mouth, unspecified |
| C05.0 | Malignant neoplasm of hard palate |
| C05.1 | Malignant neoplasm of soft palate |
| C05.2 | Malignant neoplasm of uvula |
| C05.8 | Malignant neoplasm of overlapping sites of palate |
| C05.9 | Malignant neoplasm of palate, unspecified |
| C06.0 | Malignant neoplasm of cheek mucosa |
| C06.1 | Malignant neoplasm of vestibule of mouth |
| C06.2 | Malignant neoplasm of retromolar area |
| C06.80 | Malignant neoplasm of overlapping sites of unspecified parts of mouth |
| C06.89 | Malignant neoplasm of overlapping sites of other parts of mouth |
| C06.9 | Malignant neoplasm of mouth, unspecified |
| C07 | MALIGNANT NEOPLASM OF PAROTID GLAND |
| C08.0 | Malignant neoplasm of submandibular gland |
| C08.1 | Malignant neoplasm of sublingual gland |
| C08.9 | Malignant neoplasm of major salivary gland, unspecified |
| C09.0 | Malignant neoplasm of tonsillar fossa |
| C09.1 | Malignant neoplasm of tonsillar pillar (anterior) (posterior) |
| C09.8 | Malignant neoplasm of overlapping sites of tonsil |
| C09.9 | Malignant neoplasm of tonsil, unspecified |
| C10.0 | Malignant neoplasm of vallecula |
| C10.1 | Malignant neoplasm of anterior surface of epiglottis |
| C10.2 | Malignant neoplasm of lateral wall of oropharynx |
| C10.3 | Malignant neoplasm of posterior wall of oropharynx |
| C10.4 | Malignant neoplasm of branchial cleft |
| C10.8 | Malignant neoplasm of overlapping sites of oropharynx |
| C10.9 | Malignant neoplasm of oropharynx, unspecified |
| C11.0 | Malignant neoplasm of superior wall of nasopharynx |
| C11.1 | Malignant neoplasm of posterior wall of nasopharynx |
| C11.2 | Malignant neoplasm of lateral wall of nasopharynx |
| C11.3 | Malignant neoplasm of anterior wall of nasopharynx |
| C11.8 | Malignant neoplasm of overlapping sites of nasopharynx |
| C11.9 | Malignant neoplasm of nasopharynx, unspecified |
| C12 | MALIGNANT NEOPLASM OF PYRIFORM SINUS |
| C13.0 | Malignant neoplasm of postcricoid region |
| C13.1 | Malignant neoplasm aryepiglottic fold, hypopharyngeal aspect |
| C13.2 | Malignant neoplasm of posterior wall of hypopharynx |
| C13.8 | Malignant neoplasm of overlapping sites of hypopharynx |
| C13.9 | Malignant neoplasm of hypopharynx, unspecified |
| C14.0 | Malignant neoplasm of pharynx, unspecified |
| C14.2 | Malignant neoplasm of Waldeyer's ring |
| C14.8 | Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx |
| C15.3 | Malignant neoplasm of upper third of esophagus |
| C15.4 | Malignant neoplasm of middle third of esophagus |
| C15.5 | Malignant neoplasm of lower third of esophagus |
| C15.8 | Malignant neoplasm of overlapping sites esophagus |
| C15.9 | Malignant neoplasm of esophagus, unspecified |
| C16.0 | Malignant neoplasm of cardia |
| C16.1 | Malignant neoplasm of fundus of stomach |
| C16.2 | Malignant neoplasm of body of stomach |
| C16.3 | Malignant neoplasm of pyloric antrum |
| C16.4 | Malignant neoplasm of pylorus |
| C16.5 | Malignant neoplasm of lesser curvature of stomach, unspecified |
| C16.6 | Malignant neoplasm of greater curvature of stomach, unspecified |
| C16.8 | Malignant neoplasm of overlapping sites of stomach |
| C16.9 | Malignant neoplasm of stomach, unspecified |
| C17.0 | Malignant neoplasm of duodenum |
| C17.1 | Malignant neoplasm of jejunum |
| C17.2 | Malignant neoplasm of ileum |
| C17.3 | Meckel's diverticulum, malignant |
| C17.8 | Malignant neoplasm of overlapping sites of small intestine |
| C17.9 | Malignant neoplasm of small intestine, unspecified |
| C18.0 | Malignant neoplasm of cecum |
| C18.1 | Malignant neoplasm of appendix |
| C18.2 | Malignant neoplasm of ascending colon |
| C18.3 | Malignant neoplasm of hepatic flexure |
| C18.4 | Malignant neoplasm of transverse colon |
| C18.5 | Malignant neoplasm of splenic flexure |
| C18.6 | Malignant neoplasm of descending colon |
| C18.7 | Malignant neoplasm of sigmoid colon |
| C18.8 | Malignant neoplasm of overlapping sites of colon |
| C18.9 | Malignant neoplasm of colon, unspecified |
| C19 | MALIGNANT NEOPLASM OF RECTOSIGMOID JUNCTION |
| C20 | MALIGNANT NEOPLASM OF RECTUM |
| C21.0 | Malignant neoplasm of anus, unspecified |
| C21.1 | Malignant neoplasm of anal canal |
| C21.2 | Malignant neoplasm of cloacogenic zone |
| C21.8 | Malignant neoplasm of overlapping sites of rectum, anus and anal canal |
| C22.0 | Liver cell carcinoma |
| C22.1 | Intrahepatic bile duct carcinoma |
| C22.2 | Hepatoblastoma |
| C22.3 | Angiosarcoma of liver |
| C22.4 | Other sarcomas of liver |
| C22.7 | Other specified carcinomas of liver |
| C22.8 | Malignant neoplasm of liver, primary, unspecified as to type |
| C22.9 | Malignant neoplasm of liver, not specified as primary or secondary |
| C23 | MALIGNANT NEOPLASM OF GALLBLADDER |
| C24.0 | Malignant neoplasm of extrahepatic bile duct |
| C24.1 | Malignant neoplasm of Ampulla of Vater |
| C24.8 | Malignant neoplasm of overlapping sites of biliary tract |
| C24.9 | Malignant neoplasm of biliary tract, unspecified |
| C25.0 | Malignant neoplasm of head of pancreas |
| C25.1 | Malignant neoplasm of body of pancreas |
| C25.2 | Malignant neoplasm of tail of pancreas |
| C25.3 | Malignant neoplasm of pancreatic duct |
| C25.4 | Malignant neoplasm of endocrine pancreas |
| C25.7 | Malignant neoplasm of other parts of pancreas |
| C25.8 | Malignant neoplasm of overlapping sites of pancreas |
| C25.9 | Malignant neoplasm of pancreas, unspecified |
| C26.0 | Malignant neoplasm of intestinal tract, part unspecified |
| C26.1 | Malignant neoplasm of spleen |
| C26.9 | Malignant neoplasm of ill-defined sites within the digestive system |
| C30.0 | Malignant neoplasm of nasal cavity |
| C30.1 | Malignant neoplasm of middle ear |
| C31.0 | Malignant neoplasm of maxillary sinus |
| C31.1 | Malignant neoplasm of ethmoidal sinus |
| C31.2 | Malignant neoplasm of frontal sinus |
| C31.3 | Malignant neoplasm of sphenoid sinus |
| C31.8 | Malignant neoplasm of overlapping sites of accessory sinuses |
| C31.9 | Malignant neoplasm of accessory sinus, unspecified |
| C32.0 | Malignant neoplasm of glottis |
| C32.1 | Malignant neoplasm of supraglottis |
| C32.2 | Malignant neoplasm of subglottis |
| C32.3 | Malignant neoplasm of laryngeal cartilage |
| C32.8 | Malignant neoplasm of overlapping sites of larynx |
| C32.9 | Malignant neoplasm of larynx, unspecified |
| C33 | MALIGNANT NEOPLASM OF TRACHEA |
| C34.00 | Malignant neoplasm of unspecified main bronchus |
| C34.01 | Malignant neoplasm of right main bronchus |
| C34.02 | Malignant neoplasm of left main bronchus |
| C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
| C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
| C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
| C37 | MALIGNANT NEOPLASM OF THYMUS |
| C38.0 | Malignant neoplasm of heart |
| C38.1 | Malignant neoplasm of anterior mediastinum |
| C38.2 | Malignant neoplasm of posterior mediastinum |
| C38.3 | Malignant neoplasm of mediastinum, part unspecified |
| C38.4 | Malignant neoplasm of pleura |
| C38.8 | Malignant neoplasm of overlapping sites of heart, mediastinum and pleura |
| C39.0 | Malignant neoplasm of upper respiratory tract, part unspecified |
| C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
| C40.00 | Malignant neoplasm of scapula and long bones of unspecified upper limb |
| C40.01 | Malignant neoplasm of scapula and long bones of right upper limb |
| C40.02 | Malignant neoplasm of scapula and long bones of left upper limb |
| C40.10 | Malignant neoplasm of short bones of unspecified upper limb |
| C40.11 | Malignant neoplasm of short bones of right upper limb |
| C40.12 | Malignant neoplasm of short bones of left upper limb |
| C40.20 | Malignant neoplasm of long bones of unspecified lower limb |
| C40.21 | Malignant neoplasm of long bones of right lower limb |
| C40.22 | Malignant neoplasm of long bones of left lower limb |
| C40.30 | Malignant neoplasm of short bones of unspecified lower limb |
| C40.31 | Malignant neoplasm of short bones of right lower limb |
| C40.32 | Malignant neoplasm of short bones of left lower limb |
| C40.80 | Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb |
| C40.81 | Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb |
| C40.82 | Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb |
| C40.90 | Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb |
| C40.91 | Malignant neoplasm of unspecified bones and articular cartilage of right limb |
| C40.92 | Malignant neoplasm of unspecified bones and articular cartilage of left limb |
| C41.0 | Malignant neoplasm of bones of skull and face |
| C41.1 | Malignant neoplasm of mandible |
| C41.2 | Malignant neoplasm of vertebral column |
| C41.3 | Malignant neoplasm of ribs, sternum and clavicle |
| C41.4 | Malignant neoplasm of pelvic bones, sacrum and coccyx |
| C41.9 | Malignant neoplasm of unspecified bones and articular cartilage of limb |
| C43.0 | Malignant melanoma of lip |
| C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
| C43.111 | Malignant melanoma of right upper eyelid, including canthus |
| C43.112 | Malignant melanoma of right lower eyelid, including canthus |
| C43.121 | Malignant melanoma of left upper eyelid, including canthus |
| C43.122 | Malignant melanoma of left lower eyelid, including canthus |
| C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
| C43.21 | Malignant melanoma of right ear and external auricular canal |
| C43.22 | Malignant melanoma of left ear and external auricular canal |
| C43.30 | Malignant melanoma of unspecified part of face |
| C43.31 | Malignant melanoma of nose |
| C43.39 | Malignant melanoma of other parts of face |
| C43.4 | Malignant melanoma of scalp and neck |
| C43.51 | Malignant melanoma of anal skin |
| C43.52 | Malignant melanoma of skin of breast |
| C43.59 | Malignant melanoma of other part of trunk |
| C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
| C43.61 | Malignant melanoma of right upper limb, including shoulder |
| C43.62 | Malignant melanoma of left upper limb, including shoulder |
| C43.70 | Malignant melanoma of unspecified lower limb, including hip |
| C43.71 | Malignant melanoma of right lower limb, including hip |
| C43.72 | Malignant melanoma of left lower limb, including hip |
| C43.8 | Malignant melanoma of overlapping sites of skin |
| C43.9 | Malignant melanoma of skin, unspecified |
| C44.131 | Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus |
| C44.1321 | Sebaceous cell carcinoma of skin of right upper eyelid, including canthus |
| C44.1322 | Sebaceous cell carcinoma of skin of right lower eyelid, including canthus |
| C44.1391 | Sebaceous cell carcinoma of skin of left upper eyelid, including canthus |
| C44.1392 | Sebaceous cell carcinoma of skin of left lower eyelid, including canthus |
| C44.90 | Unspecified malignant neoplasm of skin, unspecified |
| C44.99 | Other specified malignant neoplasm of skin, unspecified |
| C45.0 | Mesothelioma of pleura |
| C45.1 | Mesothelioma of peritoneum |
| C45.2 | Mesothelioma of pericardium |
| C45.7 | Mesothelioma of other sites |
| C45.9 | Mesothelioma, unspecified |
| C46.0 | Kaposi's sarcoma of skin |
| C46.1 | Kaposi's sarcoma of soft tissue |
| C46.2 | Kaposi's sarcoma of palate |
| C46.3 | Kaposi's sarcoma of lymph nodes |
| C46.4 | Kaposi’s sarcoma of gastrointestinal sites |
| C46.50 | Kaposi's sarcoma of unspecified lung |
| C46.51 | Kaposi's sarcoma of right lung |
| C46.52 | Kaposi's sarcoma of left lung |
| C46.7 | Kaposi's sarcoma of other sites |
| C46.9 | Kaposi's sarcoma, unspecified |
| C47.0 | Malignant neoplasm of peripheral nerves of head, face and neck |
| C47.1 | Malignant neoplasm of peripheral nerves of upper limb, including shoulder |
| C47.10 | Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder |
| C47.11 | Malignant neoplasm of peripheral nerves of right upper limb, including shoulder |
| C47.12 | Malignant neoplasm of peripheral nerves of left upper limb, including shoulder |
| C47.20 | Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip |
| C47.21 | Malignant neoplasm of peripheral nerves of right lower limb, including hip |
| C47.22 | Malignant neoplasm of peripheral nerves of left lower limb, including hip |
| C47.3 | Malignant neoplasm of peripheral nerves of thorax |
| C47.4 | Malignant neoplasm of peripheral nerves of abdomen |
| C47.5 | Malignant neoplasm of peripheral nerves of pelvis |
| C47.6 | Malignant neoplasm of peripheral nerves of trunk, unspecified |
| C47.8 | Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system |
| C47.9 | Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified |
| C48.0 | Malignant neoplasm of retroperitoneum |
| C48.1 | Malignant neoplasm of specified parts of peritoneum |
| C48.2 | Malignant neoplasm of peritoneum, unspecified |
| C48.8 | Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum |
| C49.0 | Malignant neoplasm of connective and soft tissue of head, face and neck |
| C49.10 | Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder |
| C49.11 | Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder |
| C49.12 | Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder |
| C49.20 | Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip |
| C49.21 | Malignant neoplasm of connective and soft tissue of right lower limb, including hip |
| C49.22 | Malignant neoplasm of connective and soft tissue of left lower limb, including hip |
| C49.3 | Malignant neoplasm of connective and soft tissue of thorax |
| C49.4 | Malignant neoplasm of connective and soft tissue of abdomen |
| C49.5 | Malignant neoplasm of connective and soft tissue of pelvis |
| C49.6 | Malignant neoplasm of connective and soft tissue of trunk, unspecified |
| C49.8 | Malignant neoplasm of overlapping sites of connective and soft tissue |
| C49.9 | Malignant neoplasm of connective and soft tissue, unspecified |
| C49.A0 | Gastrointestinal stromal tumor, unspecified site |
| C49.A1 | Gastrointestinal stromal tumor of esophagus |
| C49.A2 | Gastrointestinal stromal tumor of stomach |
| C49.A3 | Gastrointestinal stromal tumor of small intestine |
| C49.A4 | Gastrointestinal stromal tumor of large intestine |
| C49.A5 | Gastrointestinal stromal tumor of rectum |
| C49.A9 | Gastrointestinal stromal tumor of other site |
| C4A.0 | Merkel cell carcinoma of lip |
| C4A.10 | Merkel cell carcinoma of unspecified eyelid, including canthus |
| C4A.111 | Merkel cell carcinoma of right upper eyelid, including canthus |
| C4A.112 | Merkel cell carcinoma of right lower eyelid, including canthus |
| C4A.121 | Merkel cell carcinoma of left upper eyelid, including canthus |
| C4A.122 | Merkel cell carcinoma of left lower eyelid, including canthus |
| C4A.20 | Merkel cell carcinoma of unspecified ear and external auricular canal |
| C4A.21 | Merkel cell carcinoma of right ear and external auricular canal |
| C4A.22 | Merkel cell carcinoma of left ear and external auricular canal |
| C4A.30 | Merkel cell carcinoma of unspecified part of face |
| C4A.31 | Merkel cell carcinoma of nose |
| C4A.39 | Merkel cell carcinoma of other parts of face |
| C4A.4 | Merkel cell carcinoma of scalp and neck |
| C4A.51 | Merkel cell carcinoma of anal skin |
| C4A.52 | Merkel cell carcinoma of skin of breast |
| C4A.59 | Merkel cell carcinoma of other part of trunk |
| C4A.60 | Merkel cell carcinoma of unspecified upper limb, including shoulder |
| C4A.61 | Merkel cell carcinoma of right upper limb, including shoulder |
| C4A.62 | Merkel cell carcinoma of left upper limb, including shoulder |
| C4A.70 | Merkel cell carcinoma of unspecified lower limb, including hip |
| C4A.71 | Merkel cell carcinoma of right lower limb, including hip |
| C4A.72 | Merkel cell carcinoma of left lower limb, including hip |
| C4A.8 | Merkel cell carcinoma of overlapping sites |
| C4A.9 | Merkel cell carcinoma, unspecified |
| C50.011 | Malignant neoplasm of nipple and areola, right female breast |
| C50.012 | Malignant neoplasm of nipple and areola, left female breast |
| C50.019 | Malignant neoplasm of nipple and areola, unspecified female breast |
| C50.021 | Malignant neoplasm of nipple and areola, right male breast |
| C50.022 | Malignant neoplasm of nipple and areola, left male breast |
| C50.029 | Malignant neoplasm of nipple and areola, unspecified male breast |
| C50.111 | Malignant neoplasm of central portion of right female breast |
| C50.112 | Malignant neoplasm of central portion of left female breast |
| C50.119 | Malignant neoplasm of central portion of unspecified female breast |
| C50.121 | Malignant neoplasm of central portion of right male breast |
| C50.122 | Malignant neoplasm of central portion of left male breast |
| C50.129 | Malignant neoplasm of central portion of unspecified male breast |
| C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
| C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
| C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
| C50.221 | Malignant neoplasm of upper-inner quadrant of right male breast |
| C50.222 | Malignant neoplasm of upper-inner quadrant of left male breast |
| C50.229 | Malignant neoplasm of upper-inner quadrant of unspecified male breast |
| C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
| C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
| C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
| C50.321 | Malignant neoplasm of lower-inner quadrant of right male breast |
| C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast |
| C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast |
| C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
| C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
| C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
| C50.421 | Malignant neoplasm of upper-outer quadrant of right male breast |
| C50.422 | Malignant neoplasm of upper-outer quadrant of left male breast |
| C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast |
| C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
| C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
| C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
| C50.521 | Malignant neoplasm of lower-outer quadrant of right male breast |
| C50.522 | Malignant neoplasm of lower-outer quadrant of left male breast |
| C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast |
| C50.611 | Malignant neoplasm of axillary tail of right female breast |
| C50.612 | Malignant neoplasm of axillary tail of left female breast |
| C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
| C50.621 | Malignant neoplasm of axillary tail of right male breast |
| C50.622 | Malignant neoplasm of axillary tail of left male breast |
| C50.629 | Malignant neoplasm of axillary tail of unspecified male breast |
| C50.811 | Malignant neoplasm of overlapping sites of right female breast |
| C50.812 | Malignant neoplasm of overlapping sites of left female breast |
| C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
| C50.821 | Malignant neoplasm of overlapping sites of right male breast |
| C50.822 | Malignant neoplasm of overlapping sites of left male breast |
| C50.829 | Malignant neoplasm of overlapping sites of unspecified male breast |
| C50.911 | Malignant neoplasm of unspecified site of right female breast |
| C50.912 | Malignant neoplasm of unspecified site of left female breast |
| C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
| C50.921 | Malignant neoplasm of unspecified site of right male breast |
| C50.922 | Malignant neoplasm of unspecified site of left male breast |
| C50.929 | Malignant neoplasm of unspecified site of unspecified male breast |
| C51.0 | Malignant neoplasm of labium majus |
| C51.1 | Malignant neoplasm of labium minus |
| C51.2 | Malignant neoplasm of clitoris |
| C51.8 | Malignant neoplasm of other specified female genital organs |
| C51.9 | Malignant neoplasm of vulva, unspecified |
| C52 | MALIGNANT NEOPLASM OF VAGINA |
| C53.0 | Malignant neoplasm of endocervix |
| C53.1 | Malignant neoplasm of exocervix |
| C53.8 | Malignant neoplasm of overlapping sites of cervix uteri |
| C53.9 | Malignant neoplasm of cervix uteri, unspecified |
| C54.0 | Malignant neoplasm of isthmus uteri |
| C54.1 | Malignant neoplasm of endometrium |
| C54.2 | Malignant neoplasm of myometrium |
| C54.3 | Malignant neoplasm of fundus uteri |
| C54.8 | Malignant neoplasm of overlapping sites of corpus uteri |
| C54.9 | Malignant neoplasm of corpus uteri, unspecified |
| C55 | MALIGNANT NEOPLASM OF UTERUS, PART UNSPECIFIED |
| C56.1 | Malignant neoplasm of right ovary |
| C56.2 | Malignant neoplasm of left ovary |
| C56.9 | Malignant neoplasm of unspecified ovary |
| C57.00 | Malignant neoplasm of unspecified fallopian tube |
| C57.01 | Malignant neoplasm of right fallopian tube |
| C57.02 | Malignant neoplasm of left fallopian tube |
| C57.10 | Malignant neoplasm of unspecified broad ligament |
| C57.11 | Malignant neoplasm of right broad ligament |
| C57.12 | Malignant neoplasm of left broad ligament |
| C57.20 | Malignant neoplasm of unspecified round ligament |
| C57.21 | Malignant neoplasm of right round ligament |
| C57.22 | Malignant neoplasm of left round ligament |
| C57.3 | Malignant neoplasm of parametrium |
| C57.4 | Malignant neoplasm of uterine adnexa, unspecified |
| C57.7 | Malignant neoplasm of overlapping sites of vulva |
| C57.8 | Malignant neoplasm of overlapping sites of female genital organs |
| C57.9 | Malignant neoplasm of female genital organ, unspecified |
| C58 | MALIGNANT NEOPLASM OF PLACENTA |
| C60.0 | Malignant neoplasm of prepuce |
| C60.1 | Malignant neoplasm of glans penis |
| C60.2 | Malignant neoplasm of body of penis |
| C60.8 | Malignant neoplasm of overlapping sites of penis |
| C60.9 | Malignant neoplasm of penis, unspecified |
| C61 | MALIGNANT NEOPLASM OF PROSTATE |
| C62.00 | Malignant neoplasm of unspecified undescended testis |
| C62.01 | Malignant neoplasm of undescended right testis |
| C62.02 | Malignant neoplasm of undescended left testis |
| C62.10 | Malignant neoplasm of unspecified descended testis |
| C62.11 | Malignant neoplasm of descended right testis |
| C62.12 | Malignant neoplasm of descended left testis |
| C62.90 | Malignant neoplasm of unspecified testis, unspecified whether descended or undescended |
| C62.91 | Malignant neoplasm of right testis, unspecified whether descended or undescended |
| C62.92 | Malignant neoplasm of left testis, unspecified whether descended or undescended |
| C63.00 | Malignant neoplasm of unspecified epididymis |
| C63.01 | Malignant neoplasm of right epididymis |
| C63.02 | Malignant neoplasm of left epididymis |
| C63.10 | Malignant neoplasm of unspecified spermatic cord |
| C63.11 | Malignant neoplasm of right spermatic cord |
| C63.12 | Malignant neoplasm of left spermatic cord |
| C63.2 | Malignant neoplasm of scrotum |
| C63.7 | Malignant neoplasm of other specified male genital organs |
| C63.8 | Malignant neoplasm of overlapping sites of male genital organs |
| C63.9 | Malignant neoplasm of male genital organ, unspecified |
| C64.1 | Malignant neoplasm of right kidney, except renal pelvis |
| C64.2 | Malignant neoplasm of left kidney, except renal pelvis |
| C64.9 | Malignant neoplasm of unspecified kidney, except renal pelvis |
| C65.1 | Malignant neoplasm of right renal pelvis |
| C65.2 | Malignant neoplasm of left renal pelvis |
| C65.9 | Malignant neoplasm of unspecified renal pelvis |
| C66.1 | Malignant neoplasm of right ureter |
| C66.2 | Malignant neoplasm of left ureter |
| C66.9 | Malignant neoplasm of unspecified ureter |
| C67.0 | Malignant neoplasm of trigone of bladder |
| C67.1 | Malignant neoplasm of dome of bladder |
| C67.2 | Malignant neoplasm of lateral wall of bladder |
| C67.3 | Malignant neoplasm of anterior wall of bladder |
| C67.4 | Malignant neoplasm of posterior wall of bladder |
| C67.5 | Malignant neoplasm of bladder neck |
| C67.6 | Malignant neoplasm of ureteric orifice |
| C67.7 | Malignant neoplasm of urachus |
| C67.8 | Malignant neoplasm of overlapping sites of bladder |
| C67.9 | Malignant neoplasm of bladder, unspecified |
| C68.0 | Malignant neoplasm of urethra |
| C68.1 | Malignant neoplasm of paraurethral glands |
| C68.8 | Malignant neoplasm of overlapping sites of urinary organs |
| C68.9 | Malignant neoplasm of urinary organ, unspecified |
| C69.00 | Malignant neoplasm of unspecified conjunctiva |
| C69.01 | Malignant neoplasm of right conjunctiva |
| C69.02 | Malignant neoplasm of left conjunctiva |
| C69.10 | Malignant neoplasm of unspecified cornea |
| C69.11 | Malignant neoplasm of right cornea |
| C69.12 | Malignant neoplasm of left cornea |
| C69.20 | Malignant neoplasm of unspecified retina |
| C69.21 | Malignant neoplasm of right retina |
| C69.22 | Malignant neoplasm of left retina |
| C69.30 | Malignant neoplasm of unspecified choroid |
| C69.31 | Malignant neoplasm of right choroid |
| C69.32 | Malignant neoplasm of left choroid |
| C69.40 | Malignant neoplasm of unspecified ciliary body |
| C69.41 | Malignant neoplasm of right ciliary body |
| C69.42 | Malignant neoplasm of left ciliary body |
| C69.50 | Malignant neoplasm of unspecified lacrimal gland and duct |
| C69.51 | Malignant neoplasm of right lacrimal gland and duct |
| C69.52 | Malignant neoplasm of left lacrimal gland and duct |
| C69.60 | Malignant neoplasm of unspecified orbit |
| C69.61 | Malignant neoplasm of right orbit |
| C69.62 | Malignant neoplasm of left orbit |
| C69.80 | Malignant neoplasm of overlapping sites of unspecified eye and adnexa |
| C69.81 | Malignant neoplasm of overlapping sites of right eye and adnexa |
| C69.82 | Malignant neoplasm of overlapping sites of left eye and adnexa |
| C69.90 | Malignant neoplasm of unspecified site of unspecified eye |
| C69.91 | Malignant neoplasm of unspecified site of right eye |
| C69.92 | Malignant neoplasm of unspecified site of left eye |
| C70.0 | Malignant neoplasm of cerebral meninges |
| C70.1 | Malignant neoplasm of spinal meninges |
| C70.9 | Malignant neoplasm of meninges, unspecified |
| C71.0 | Malignant neoplasm of cerebrum, except lobes and ventricles |
| C71.1 | Malignant neoplasm of frontal lobe |
| C71.2 | Malignant neoplasm of temporal lobe |
| C71.3 | Malignant neoplasm of parietal lobe |
| C71.4 | Malignant neoplasm of occipital lobe |
| C71.5 | Malignant neoplasm of cerebral ventricle |
| C71.6 | Malignant neoplasm of cerebellum |
| C71.7 | Malignant neoplasm of brain stem |
| C71.8 | Malignant neoplasm of overlapping sites of brain |
| C71.9 | Malignant neoplasm of brain, unspecified |
| C72.0 | Malignant neoplasm of spinal cord |
| C72.1 | Malignant neoplasm of cauda equina |
| C72.20 | Malignant neoplasm of unspecified olfactory nerve |
| C72.21 | Malignant neoplasm of right olfactory nerve |
| C72.22 | Malignant neoplasm of left olfactory nerve |
| C72.30 | Malignant neoplasm of unspecified optic nerve |
| C72.31 | Malignant neoplasm of right optic nerve |
| C72.32 | Malignant neoplasm of left optic nerve |
| C72.40 | Malignant neoplasm of unspecified acoustic nerve |
| C72.41 | Malignant neoplasm of right acoustic nerve |
| C72.42 | Malignant neoplasm of left acoustic nerve |
| C72.50 | Malignant neoplasm of unspecified cranial nerve |
| C72.59 | Malignant neoplasm of other cranial nerves |
| C72.9 | Malignant neoplasm of central nervous system, unspecified |
| C73 | MALIGNANT NEOPLASM OF THYROID GLAND |
| C74.00 | Malignant neoplasm of cortex of unspecified adrenal gland |
| C74.01 | Malignant neoplasm of cortex of right adrenal gland |
| C74.02 | Malignant neoplasm of cortex of left adrenal gland |
| C74.10 | Malignant neoplasm of medulla of unspecified adrenal gland |
| C74.11 | Malignant neoplasm of medulla of right adrenal gland |
| C74.12 | Malignant neoplasm of medulla of left adrenal gland |
| C74.90 | Malignant neoplasm of unspecified part of unspecified adrenal gland |
| C74.91 | Malignant neoplasm of unspecified part of right adrenal gland |
| C74.92 | Malignant neoplasm of unspecified part of left adrenal gland |
| C75.0 | Malignant neoplasm of parathyroid gland |
| C75.1 | Malignant neoplasm of pituitary gland |
| C75.2 | Malignant neoplasm of craniopharyngeal duct |
| C75.3 | Malignant neoplasm of pineal gland |
| C75.4 | Malignant neoplasm of carotid body |
| C75.5 | Malignant neoplasm of aortic body and other paraganglia |
| C75.8 | Malignant neoplasm with pluriglanduar involvement, unspecified |
| C75.9 | Malignant neoplasm of endocrine gland, unspecified |
| C76.0 | Malignant neoplasm of head, face and neck |
| C76.1 | Malignant neoplasm of thorax |
| C76.2 | Malignant neoplasm of abdomen |
| C76.3 | Malignant neoplasm pelvis |
| C76.40 | Malignant neoplasm of unspecified upper limb |
| C76.41 | Malignant neoplasm of right upper limb |
| C76.42 | Malignant neoplasm of left upper limb |
| C76.50 | Malignant neoplasm of unspecified lower limb |
| C76.51 | Malignant neoplasm of right lower limb |
| C76.52 | Malignant neoplasm of left lower limb |
| C76.8 | Malignant neoplasm of overlapping sites of other and ill-defined sites |
| C7A.00 | Malignant carcinoid tumor of unspecified site |
| C7A.010 | Malignant carcinoid tumor of the duodenum |
| C7A.011 | Malignant carcinoid tumor of the jejunum |
| C7A.012 | Malignant carcinoid tumor of the ileum |
| C7A.019 | Malignant carcinoid tumor of the small intestine, unspecified portion |
| C7A.020 | Malignant carcinoid tumor of the appendix |
| C7A.021 | Malignant carcinoid tumor of the cecum |
| C7A.022 | Malignant carcinoid tumor of the ascending colon |
| C7A.023 | Malignant carcinoid tumor of the transverse colon |
| C7A.024 | Malignant carcinoid tumor of the descending colon |
| C7A.025 | Malignant carcinoid tumor of the sigmoid colon |
| C7A.026 | Malignant carcinoid tumor of the rectum |
| C7A.029 | Malignant carcinoid tumor of the large intestine, unspecified portion |
| C7A.090 | Malignant carcinoid tumor of the bronchus and lung |
| C7A.091 | Malignant carcinoid tumor of thymus |
| C7A.092 | Malignant carcinoid tumor of the stomach |
| C7A.093 | Malignant carcinoid tumor of the kidney |
| C7A.094 | Malignant carcinoid tumors of the foregut NOS |
| C7A.095 | Malignant carcinoid tumors of the midgut NOS |
| C7A.096 | Malignant carcinoid tumors of the hindgut NOS |
| C7A.098 | Malignant carcinoid tumors of other sites |
| C7A.1 | Malignant poorly differentiated neuroendocrine tumors |
| C7A.8 | Other malignant neuroendocrine tumors |
| C80.0 | Disseminated malignant neoplasm, unspecified |
| C80.1 | Malignant (primary) neoplasm, unspecified |
| C80.2 | Malignant neoplasm associated with transplanted organ |
| C81.00 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site |
| C81.01 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.02 | Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.03 | Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.04 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.05 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.06 | Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.07 | Nodular lymphocyte predominant Hodgkin lymphoma, spleen |
| C81.08 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.09 | Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites |
| C81.10 | Nodular sclerosis classical Hodgkin lymphoma, unspecified site |
| C81.11 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.12 | Nodular sclerosis classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.13 | Nodular sclerosis classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.14 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.15 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.16 | Nodular sclerosis classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.17 | Nodular sclerosis classical Hodgkin lymphoma, spleen |
| C81.18 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.19 | Nodular sclerosis classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.20 | Mixed cellularity classical Hodgkin lymphoma, unspecified site |
| C81.21 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.22 | Mixed cellularity classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.23 | Mixed cellularity classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.24 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.25 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.26 | Mixed cellularity classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.27 | Mixed cellularity classical Hodgkin lymphoma, spleen |
| C81.28 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.29 | Mixed cellularity classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.30 | Lymphocyte depleted classical Hodgkin lymphoma, unspecified site |
| C81.31 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.32 | Lymphocyte depleted classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.33 | Lymphocyte depleted classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.34 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.35 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.36 | Lymphocyte depleted classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.37 | Lymphocyte depleted classical Hodgkin lymphoma, spleen |
| C81.38 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.39 | Lymphocyte depleted classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.40 | Lymphocyte-rich classical Hodgkin lymphoma, unspecified site |
| C81.41 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.42 | Lymphocyte-rich classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.43 | Lymphocyte-rich classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.44 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.45 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.46 | Lymphocyte-rich classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.47 | Lymphocyte-rich classical Hodgkin lymphoma, spleen |
| C81.48 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.49 | Lymphocyte-rich classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.70 | Other classical Hodgkin lymphoma, unspecified site |
| C81.71 | Other classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.72 | Other classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.73 | Other classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.74 | Other classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.75 | Other classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.76 | Other classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.77 | Other classical Hodgkin lymphoma, spleen |
| C81.78 | Other classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.79 | Other classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.90 | Hodgkin lymphoma, unspecified, unspecified site |
| C81.91 | Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
| C81.92 | Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
| C81.93 | Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
| C81.94 | Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C81.95 | Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C81.96 | Hodgkin lymphoma, unspecified, intrapelvic lymph nodes |
| C81.97 | Hodgkin lymphoma, unspecified, spleen |
| C81.98 | Hodgkin lymphoma, unspecified, lymph nodes of multiple sites |
| C81.99 | Hodgkin lymphoma, unspecified, extranodal and solid organ sites |
| C82.00 | Follicular lymphoma grade I, unspecified site |
| C82.01 | Follicular lymphoma grade I, lymph nodes of head, face, and neck |
| C82.02 | Follicular lymphoma grade I, intrathoracic lymph nodes |
| C82.03 | Follicular lymphoma grade I, intra-abdominal lymph nodes |
| C82.04 | Follicular lymphoma grade I, lymph nodes of axilla and upper limb |
| C82.05 | Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb |
| C82.06 | Follicular lymphoma grade I, intrapelvic lymph nodes |
| C82.07 | Follicular lymphoma grade I, spleen |
| C82.08 | Follicular lymphoma grade I, lymph nodes of multiple sites |
| C82.09 | Follicular lymphoma grade I, extranodal and solid organ sites |
| C82.10 | Follicular lymphoma grade II, unspecified site |
| C82.11 | Follicular lymphoma grade II, lymph nodes of head, face, and neck |
| C82.12 | Follicular lymphoma grade II, intrathoracic lymph nodes |
| C82.13 | Follicular lymphoma grade II, intra-abdominal lymph nodes |
| C82.14 | Follicular lymphoma grade II, lymph nodes of axilla and upper limb |
| C82.15 | Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb |
| C82.16 | Follicular lymphoma grade II, intrapelvic lymph nodes |
| C82.17 | Follicular lymphoma grade II, spleen |
| C82.18 | Follicular lymphoma grade II, lymph nodes of multiple sites |
| C82.19 | Follicular lymphoma grade II, extranodal and solid organ sites |
| C82.20 | Follicular lymphoma grade III, unspecified, unspecified site |
| C82.21 | Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck |
| C82.22 | Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes |
| C82.23 | Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes |
| C82.24 | Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb |
| C82.25 | Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb |
| C82.26 | Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes |
| C82.27 | Follicular lymphoma grade III, unspecified, spleen |
| C82.28 | Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites |
| C82.29 | Follicular lymphoma grade III, unspecified, extranodal and solid organ sites |
| C82.30 | Follicular lymphoma grade IIIa, unspecified site |
| C82.31 | Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck |
| C82.32 | Follicular lymphoma grade IIIa, intrathoracic lymph nodes |
| C82.33 | Follicular lymphoma grade IIIa, intra-abdominal lymph nodes |
| C82.34 | Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb |
| C82.35 | Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb |
| C82.36 | Follicular lymphoma grade IIIa, intrapelvic lymph nodes |
| C82.37 | Follicular lymphoma grade IIIa, spleen |
| C82.38 | Follicular lymphoma grade IIIa, lymph nodes of multiple sites |
| C82.39 | Follicular lymphoma grade IIIa, extranodal and solid organ sites |
| C82.40 | Follicular lymphoma grade IIIb, unspecified site |
| C82.41 | Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck |
| C82.42 | Follicular lymphoma grade IIIb, intrathoracic lymph nodes |
| C82.43 | Follicular lymphoma grade IIIb, intra-abdominal lymph nodes |
| C82.44 | Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb |
| C82.45 | Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb |
| C82.46 | Follicular lymphoma grade IIIb, intrapelvic lymph nodes |
| C82.47 | Follicular lymphoma grade IIIb, spleen |
| C82.48 | Follicular lymphoma grade IIIb, lymph nodes of multiple sites |
| C82.49 | Follicular lymphoma grade IIIb, extranodal and solid organ sites |
| C82.50 | Diffuse follicle center lymphoma, unspecified site |
| C82.51 | Diffuse follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.52 | Diffuse follicle center lymphoma, intrathoracic lymph nodes |
| C82.53 | Diffuse follicle center lymphoma, intra-abdominal lymph nodes |
| C82.54 | Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.55 | Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.56 | Diffuse follicle center lymphoma, intrapelvic lymph nodes |
| C82.57 | Diffuse follicle center lymphoma, spleen |
| C82.58 | Diffuse follicle center lymphoma, lymph nodes of multiple sites |
| C82.59 | Diffuse follicle center lymphoma, extranodal and solid organ sites |
| C82.60 | Cutaneous follicle center lymphoma, unspecified site |
| C82.61 | Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.62 | Cutaneous follicle center lymphoma, intrathoracic lymph nodes |
| C82.63 | Cutaneous follicle center lymphoma, intra-abdominal lymph nodes |
| C82.64 | Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.65 | Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.66 | Cutaneous follicle center lymphoma, intrapelvic lymph nodes |
| C82.67 | Cutaneous follicle center lymphoma, spleen |
| C82.68 | Cutaneous follicle center lymphoma, lymph nodes of multiple sites |
| C82.69 | Cutaneous follicle center lymphoma, extranodal and solid organ sites |
| C82.80 | Other types of follicular lymphoma, unspecified site |
| C82.81 | Other types of follicular lymphoma, lymph nodes of head, face, and neck |
| C82.82 | Other types of follicular lymphoma, intrathoracic lymph nodes |
| C82.83 | Other types of follicular lymphoma, intra-abdominal lymph nodes |
| C82.84 | Other types of follicular lymphoma, lymph nodes of axilla and upper limb |
| C82.85 | Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C82.86 | Other types of follicular lymphoma, intrapelvic lymph nodes |
| C82.87 | Other types of follicular lymphoma, spleen |
| C82.88 | Other types of follicular lymphoma, lymph nodes of multiple sites |
| C82.89 | Other types of follicular lymphoma, extranodal and solid organ sites |
| C82.90 | Follicular lymphoma, unspecified, unspecified site |
| C82.91 | Follicular lymphoma, unspecified, lymph nodes of head, face, and neck |
| C82.92 | Follicular lymphoma, unspecified, intrathoracic lymph nodes |
| C82.93 | Follicular lymphoma, unspecified, intra-abdominal lymph nodes |
| C82.94 | Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C82.95 | Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C82.96 | Follicular lymphoma, unspecified, intrapelvic lymph nodes |
| C82.97 | Follicular lymphoma, unspecified, spleen |
| C82.98 | Follicular lymphoma, unspecified, lymph nodes of multiple sites |
| C82.99 | Follicular lymphoma, unspecified, extranodal and solid organ sites |
| C83.00 | Small cell B-cell lymphoma, unspecified site |
| C83.01 | Small cell B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.02 | Small cell B-cell lymphoma, intrathoracic lymph nodes |
| C83.03 | Small cell B-cell lymphoma, intra-abdominal lymph nodes |
| C83.04 | Small cell B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.05 | Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.06 | Small cell B-cell lymphoma, intrapelvic lymph nodes |
| C83.07 | Small cell B-cell lymphoma, spleen |
| C83.08 | Small cell B-cell lymphoma, lymph nodes of multiple sites |
| C83.09 | Small cell B-cell lymphoma, extranodal and solid organ sites |
| C83.10 | Mantle cell lymphoma, unspecified site |
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C83.12 | Mantle cell lymphoma, intrathoracic lymph nodes |
| C83.13 | Mantle cell lymphoma, intra-abdominal lymph nodes |
| C83.14 | Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C83.15 | Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.16 | Mantle cell lymphoma, intrapelvic lymph nodes |
| C83.17 | Mantle cell lymphoma, spleen |
| C83.18 | Mantle cell lymphoma, lymph nodes of multiple sites |
| C83.19 | Mantle cell lymphoma, extranodal and solid organ sites |
| C83.30 | Diffuse large B-cell lymphoma, unspecified site |
| C83.31 | Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.32 | Diffuse large B-cell lymphoma, intrathoracic lymph nodes |
| C83.33 | Diffuse large B-cell lymphoma, intra-abdominal lymph nodes |
| C83.34 | Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.35 | Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.36 | Diffuse large B-cell lymphoma, intrapelvic lymph nodes |
| C83.37 | Diffuse large B-cell lymphoma, spleen |
| C83.38 | Diffuse large B-cell lymphoma, lymph nodes of multiple sites |
| C83.39 | Diffuse large B-cell lymphoma, extranodal and solid organ sites |
| C83.50 | Lymphoblastic (diffuse) lymphoma, unspecified site |
| C83.51 | Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck |
| C83.52 | Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes |
| C83.53 | Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes |
| C83.54 | Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb |
| C83.55 | Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb |
| C83.56 | Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes |
| C83.57 | Lymphoblastic (diffuse) lymphoma, spleen |
| C83.58 | Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites |
| C83.59 | Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites |
| C83.70 | Burkitt lymphoma, unspecified site |
| C83.71 | Burkitt lymphoma, lymph nodes of head, face, and neck |
| C83.72 | Burkitt lymphoma, intrathoracic lymph nodes |
| C83.73 | Burkitt lymphoma, intra-abdominal lymph nodes |
| C83.74 | Burkitt lymphoma, lymph nodes of axilla and upper limb |
| C83.75 | Burkitt lymphoma, lymph nodes of inguinal region and lower limb |
| C83.76 | Burkitt lymphoma, intrapelvic lymph nodes |
| C83.77 | Burkitt lymphoma, spleen |
| C83.78 | Burkitt lymphoma, lymph nodes of multiple sites |
| C83.79 | Burkitt lymphoma, extranodal and solid organ sites |
| C83.80 | Other non-follicular lymphoma, unspecified site |
| C83.81 | Other non-follicular lymphoma, lymph nodes of head, face, and neck |
| C83.82 | Other non-follicular lymphoma, intrathoracic lymph nodes |
| C83.83 | Other non-follicular lymphoma, intra-abdominal lymph nodes |
| C83.84 | Other non-follicular lymphoma, lymph nodes of axilla and upper limb |
| C83.85 | Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C83.86 | Other non-follicular lymphoma, intrapelvic lymph nodes |
| C83.87 | Other non-follicular lymphoma, spleen |
| C83.88 | Other non-follicular lymphoma, lymph nodes of multiple sites |
| C83.89 | Other non-follicular lymphoma, extranodal and solid organ sites |
| C83.90 | Non-follicular (diffuse) lymphoma, unspecified, unspecified site |
| C83.91 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck |
| C83.92 | Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes |
| C83.93 | Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes |
| C83.94 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C83.95 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C83.96 | Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes |
| C83.97 | Non-follicular (diffuse) lymphoma, unspecified, spleen |
| C83.98 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites |
| C83.99 | Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites |
| C84.00 | Mycosis fungoides, unspecified site |
| C84.01 | Mycosis fungoides, lymph nodes of head, face, and neck |
| C84.02 | Mycosis fungoides, intrathoracic lymph nodes |
| C84.03 | Mycosis fungoides, intra-abdominal lymph nodes |
| C84.04 | Mycosis fungoides, lymph nodes of axilla and upper limb |
| C84.05 | Mycosis fungoides, lymph nodes of inguinal region and lower limb |
| C84.06 | Mycosis fungoides, intrapelvic lymph nodes |
| C84.07 | Mycosis fungoides, spleen |
| C84.08 | Mycosis fungoides, lymph nodes of multiple sites |
| C84.09 | Mycosis fungoides, extranodal and solid organ sites |
| C84.10 | Sezary disease, unspecified site |
| C84.11 | Sezary disease, lymph nodes of head, face, and neck |
| C84.12 | Sezary disease, intrathoracic lymph nodes |
| C84.13 | Sezary disease, intra-abdominal lymph nodes |
| C84.14 | Sezary disease, lymph nodes of axilla and upper limb |
| C84.15 | Sezary disease, lymph nodes of inguinal region and lower limb |
| C84.16 | Sezary disease, intrapelvic lymph nodes |
| C84.17 | Sezary disease, spleen |
| C84.18 | Sezary disease, lymph nodes of multiple sites |
| C84.19 | Sezary disease, extranodal and solid organ sites |
| C84.40 | Peripheral T-cell lymphoma, not classified, unspecified site |
| C84.41 | Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck |
| C84.42 | Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes |
| C84.43 | Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes |
| C84.44 | Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb |
| C84.45 | Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb |
| C84.46 | Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes |
| C84.47 | Peripheral T-cell lymphoma, not classified, spleen |
| C84.48 | Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites |
| C84.49 | Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites |
| C84.60 | Anaplastic large cell lymphoma, ALK-positive, unspecified site |
| C84.61 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck |
| C84.62 | Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes |
| C84.63 | Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes |
| C84.64 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb |
| C84.65 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb |
| C84.66 | Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes |
| C84.67 | Anaplastic large cell lymphoma, ALK-positive, spleen |
| C84.68 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites |
| C84.69 | Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites |
| C84.70 | Anaplastic large cell lymphoma, ALK-negative, unspecified site |
| C84.71 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck |
| C84.72 | Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes |
| C84.73 | Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes |
| C84.74 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb |
| C84.75 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb |
| C84.76 | Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes |
| C84.77 | Anaplastic large cell lymphoma, ALK-negative, spleen |
| C84.78 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites |
| C84.79 | Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites |
| C84.90 | Mature T/NK-cell lymphomas, unspecified, unspecified site |
| C84.91 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck |
| C84.92 | Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes |
| C84.93 | Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes |
| C84.94 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb |
| C84.95 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb |
| C84.96 | Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes |
| C84.97 | Mature T/NK-cell lymphomas, unspecified, spleen |
| C84.98 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites |
| C84.99 | Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites |
| C84.A0 | Cutaneous T-cell lymphoma, unspecified, unspecified site |
| C84.A1 | Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck |
| C84.A2 | Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes |
| C84.A3 | Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes |
| C84.A4 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C84.A5 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C84.A6 | Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes |
| C84.A7 | Cutaneous T-cell lymphoma, unspecified, spleen |
| C84.A8 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites |
| C84.A9 | Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites |
| C84.Z0 | Other mature T/NK-cell lymphomas, unspecified site |
| C84.Z1 | Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck |
| C84.Z2 | Other mature T/NK-cell lymphomas, intrathoracic lymph nodes |
| C84.Z3 | Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes |
| C84.Z4 | Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb |
| C84.Z5 | Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb |
| C84.Z6 | Other mature T/NK-cell lymphomas, intrapelvic lymph nodes |
| C84.Z7 | Other mature T/NK-cell lymphomas, spleen |
| C84.Z8 | Other mature T/NK-cell lymphomas, lymph nodes of multiple sites |
| C84.Z9 | Other mature T/NK-cell lymphomas, extranodal and solid organ sites |
| C85.10 | Unspecified B-cell lymphoma, unspecified site |
| C85.11 | Unspecified B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.12 | Unspecified B-cell lymphoma, intrathoracic lymph nodes |
| C85.13 | Unspecified B-cell lymphoma, intra-abdominal lymph nodes |
| C85.14 | Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.15 | Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.16 | Unspecified B-cell lymphoma, intrapelvic lymph nodes |
| C85.17 | Unspecified B-cell lymphoma, spleen |
| C85.18 | Unspecified B-cell lymphoma, lymph nodes of multiple sites |
| C85.19 | Unspecified B-cell lymphoma, extranodal and solid organ sites |
| C85.20 | Mediastinal (thymic) large B-cell lymphoma, unspecified site |
| C85.21 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.22 | Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes |
| C85.23 | Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes |
| C85.24 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.25 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.26 | Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes |
| C85.27 | Mediastinal (thymic) large B-cell lymphoma, spleen |
| C85.28 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites |
| C85.29 | Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites |
| C85.80 | Other specified types of non-Hodgkin lymphoma, unspecified site |
| C85.81 | Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C85.82 | Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes |
| C85.83 | Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes |
| C85.84 | Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C85.85 | Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C85.86 | Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.87 | Other specified types of non-Hodgkin lymphoma, spleen |
| C85.88 | Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites |
| C85.89 | Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites |
| C85.90 | Non-Hodgkin lymphoma, unspecified site |
| C85.91 | Non-Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C85.92 | Non-Hodgkin lymphoma, intrathoracic lymph nodes |
| C85.93 | Non-Hodgkin lymphoma, intra-abdominal lymph nodes |
| C85.94 | Non-Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C85.95 | Non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C85.96 | Non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.97 | Non-Hodgkin lymphoma, spleen |
| C85.98 | Non-Hodgkin lymphoma, lymph nodes of multiple sites |
| C85.99 | Non-Hodgkin lymphoma, extranodal and solid organ sites |
| C86.0 | Extranodal NK/T-cell lymphoma, nasal type |
| C86.1 | Hepatosplenic T-cell lymphoma |
| C86.2 | Enteropathy-type (intestinal) T-cell lymphoma |
| C86.3 | Subcutaneous panniculitis-like T-cell lymphoma |
| C86.4 | Blastic NK-cell lymphoma |
| C86.5 | Angioimmunoblastic T-cell lymphoma |
| C86.6 | Primary cutaneous CD30-positive T-cell proliferation |
| C88.0 | Waldenstrom's macroglobulinemia |
| C88.2 | Heavy chain disease |
| C88.3 | Immunoproliferative small intestinal diseases |
| C88.4 | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] |
| C88.8 | Other malignant immunoproliferative diseases |
| C88.9 | Malignant immunoproliferative disease, unspecified |
| C90.00 | Multiple myeloma not having achieved remission |
| C90.01 | Multiple myeloma in remission |
| C90.02 | Multiple myeloma in relapse |
| C90.10 | Plasma cell leukemia not having achieved remission |
| C90.11 | Plasma cell leukemia in remission |
| C90.12 | Plasma cell leukemia in relapse |
| C90.20 | Extramedullary plasmacytoma not having achieved remission |
| C90.21 | Extramedullary plasmacytoma in remission |
| C90.22 | Extramedullary plasmacytoma in relapse |
| C90.30 | Solitary plasmacytoma not having achieved remission |
| C90.31 | Solitary plasmacytoma in remission |
| C90.32 | Solitary plasmacytoma in relapse |
| C91.00 | Acute lymphoblastic leukemia not having achieved remission |
| C91.01 | Acute lymphoblastic leukemia, in remission |
| C91.02 | Acute lymphoblastic leukemia, in relapse |
| C91.10 | Chronic lymphocytic leukemia of B-cell type not having achieved remission |
| C91.11 | Chronic lymphocytic leukemia of B-cell type in remission |
| C91.12 | Chronic lymphocytic leukemia of B-cell type in relapse |
| C91.30 | Prolymphocytic leukemia of B-cell type not having achieved remission |
| C91.31 | Prolymphocytic leukemia of B-cell type, in remission |
| C91.32 | Prolymphocytic leukemia of B –cell type, in relapse |
| C91.40 | Hairy cell leukemia not having achieved remission |
| C91.41 | Hairy cell leukemia, in remission |
| C91.42 | Hairy cell leukemia, in relapse |
| C91.50 | Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission |
| C91.51 | Adult T-cell lymphoma/leukemia (HTLV-1-associated) in remission |
| C91.52 | Adult T-cell lymphoma/leukemia (HTLV-1-associated) in relapse |
| C91.60 | Prolymphocytic leukemia of T-cell type not having achieved remission |
| C91.61 | Prolymphocytic leukemia of T-cell type, in remission |
| C91.62 | Prolymphocytic leukemia of T –cell type, in relapse |
| C91.90 | Lymphoid leukemia, unspecified not having achieved remission |
| C91.91 | Lymphoid leukemia, unspecified, in remission |
| C91.92 | Lymphoid leukemia, unspecified, in relapse |
| C91.A0 | Mature B-cell leukemia Burkitt-type not having achieved remission |
| C91.A1 | Mature B-cell leukemia Burkitt-type, in remission |
| C91.A2 | Mature B-cell leukemia Burkitt-type, in relapse |
| C91.Z0 | Other lymphoid leukemia not having achieved remission |
| C91.Z1 | Other lymphoid leukemia, in remission |
| C91.Z2 | Other lymphoid leukemia, in relapse |
| C92.00 | Acute myeloblastic leukemia, not having achieved remission |
| C92.01 | Acute myeloblastic leukemia, in remission |
| C92.02 | Acute myeloblastic leukemia, in relapse |
| C92.10 | Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission |
| C92.11 | Chronic myeloid leukemia, BCR/ABL-positive, in remission |
| C92.12 | Chronic myeloid leukemia, BCR/ABL-positive, in relapse |
| C92.20 | Atypical chronic myeloid leukemia, BCR/ABL-negative not having achieved remission |
| C92.21 | Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission |
| C92.22 | Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse |
| C92.30 | Myeloid sarcoma, not having achieved remission |
| C92.31 | Myeloid sarcoma, in remission |
| C92.32 | Myeloid sarcoma, in relapse |
| C92.40 | Acute promyelocytic leukemia, not having achieved remission |
| C92.41 | Acute promyelocytic leukemia, in remission |
| C92.42 | Acute promyelocytic leukemia, in relapse |
| C92.50 | Acute myelomonocytic leukemia, not having achieved remission |
| C92.51 | Acute myelomonocytic in remission |
| C92.52 | Acute myelomonocytic in relapse |
| C92.60 | Acute myeloid leukemia with 11q23 abnormality not having achieved remission |
| C92.61 | Acute myeloid leukemia with 11q23 abnormality in remission |
| C92.62 | Acute myeloid leukemia with 11q23 abnormality in relapse |
| C92.90 | Myeloid leukemia, unspecified, not having achieved remission |
| C92.91 | Myeloid leukemia, unspecified in remission |
| C92.92 | Myeloid leukemia, unspecified in relapse |
| C92.A0 | Acute myeloid leukemia with multilineage dysplasia not having achieved remission |
| C92.A1 | Acute myeloid leukemia with multilineage dysplasia, in remission |
| C92.A2 | Acute myeloid leukemia with multilineage dysplasia, in relapse |
| C92.Z0 | Other myeloid leukemia not having achieved remission |
| C92.Z1 | Other myeloid leukemia, in remission |
| C92.Z2 | Other myeloid leukemia, in relapse |
| C93.00 | Acute monoblastic/monocytic leukemia, not having achieved remission |
| C93.01 | Acute monoblastic/monocytic leukemia, in remission |
| C93.02 | Acute monoblastic/monocytic leukemia, in relapse |
| C93.10 | Chronic myelomonocytic leukemia not having achieved remission |
| C93.11 | Chronic myelomonocytic leukemia, in remission |
| C93.12 | Chronic myelomonocytic leukemia, in relapse |
| C93.30 | Juvenile myelomonocytic leukemia not having achieved remission |
| C93.31 | Juvenile myelomonocytic leukemia, in remission |
| C93.32 | Juvenile myelomonocytic leukemia, in relapse |
| C93.90 | Monocytic leukemia, unspecified, not having achieved remission |
| C93.91 | Monocytic leukemia, unspecified in remission |
| C93.92 | Monocytic leukemia, unspecified in relapse |
| C93.Z0 | Other monocytic leukemia, not having achieved remission |
| C93.Z1 | Other monocytic leukemia in remission |
| C93.Z2 | Other monocytic leukemia in relapse |
| C94.00 | Acute erythroid leukemia, not having achieved remission |
| C94.01 | Acute erythroid leukemia, in remission |
| C94.02 | Acute erythroid leukemia, in relapse |
| C94.20 | Acute megakaryoblastic leukemia not having achieved remission |
| C94.21 | Acute megakaryoblastic leukemia, in remission |
| C94.22 | Acute megakaryoblastic leukemia, in relapse |
| C94.30 | Mast cell leukemia not having achieved remission |
| C94.31 | Mast cell leukemia, in remission |
| C94.32 | Mast cell leukemia, in relapse |
| C94.40 | Acute panmyelosis with myelofibrosis not having achieved remission |
| C94.41 | Acute panmyelosis with myelofibrosis, in remission |
| C94.42 | Acute panmyelosis with myelofibrosis, in relapse |
| C94.6 | Myelodysplastic disease, not classified |
| C94.80 | Other specified leukemias not having achieved remission |
| C94.81 | Other specified leukemias, in remission |
| C94.82 | Other specified leukemias, in relapse |
| C95.00 | Acute leukemia of unspecified cell type not having achieved remission |
| C95.01 | Acute leukemia of unspecified cell type, in remission |
| C95.02 | Acute leukemia of unspecified cell type, in relapse |
| C95.10 | Chronic leukemia of unspecified cell type not having achieved remission |
| C95.11 | Chronic leukemia of unspecified cell type, in remission |
| C95.12 | Chronic leukemia of unspecified cell type, in relapse |
| C95.90 | Leukemia, unspecified not having achieved remission |
| C95.91 | Leukemia, unspecified, in remission |
| C95.92 | Leukemia, unspecified, in relapse |
| C96.0 | Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis |
| C96.20 | Malignant mast cell neoplasm, unspecified |
| C96.21 | Aggressive systemic mastocytosis |
| C96.22 | Mast cell sarcoma |
| C96.29 | Other malignant cell neoplasm |
| C96.4 | Sarcoma of dendritic cells (accessory cells) Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified |
| C96.5 | Multifocal and unisystemic Langerhans-cell histiocytosis |
| C96.6 | Unifocal Langerhans-cell histiocytosis |
| C96.9 | Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified |
| C96.A | Histiocytic sarcoma |
| C96.Z | Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue |
| D45 | POLYCYTHEMIA VERA |
| D46.0 | Refractory anemia without ring sideroblasts, so stated |
| D46.1 | Refractory anemia with ring sideroblasts |
| D46.20 | Refractory anemia with excess of blasts, unspecified |
| D46.21 | Refractory anemia with excess of blasts 1 |
| D46.22 | Refractory anemia with excess of blasts 2 |
| D46.4 | Refractory anemia, unspecified |
| D46.9 | Myelodysplastic syndrome, unspecified |
| D46.B | Refractory cytopenia with multilineage dysplasia and ring sideroblasts |
| D46.C | Myelodysplastic syndrome with isolated del (5q) chromosomal abnormality |
| D46.Z | Other myelodysplastic syndromes |
| D47.02 | Systemic mastocytosis |
| D47.1 | Chronic myeloproliferative disease |
| D47.3 | Essential (hemorrhagic) thrombocythemia |
| D47.4 | Osteomyelofibrosis |
| D47.9 | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified |
| D47.Z1 | Post-transplant lymphoproliferative disorder (PTLD) |
| D47.Z9 | Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
| D49.6 | Neoplasm of unspecified behavior of brain |
| D49.7 | Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system |
This value set excludes codes based on the following rules:
http://snomed.info/sct where concept is-a 128462008 (Metastatic neoplasm (disease))This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 393573009 (Hypereosinophilic syndrome)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D72.110 | Idiopathic hypereosinophilic syndrome [HES] |
| D72.111 | Lymphocytic Variant Hypereosinophilic Syndrome [LHES] |
| D72.118 | Other hypereosinophilic syndrome |
| D72.119 | Hypereosinophilic syndrome [HES], unspecified |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 109355002 (Carcinoma in situ (disorder))http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D00 | CARCINOMA IN SITU OF ORAL CAVITY, ESOPHAGUS AND STOMACH |
| D00.0 | Carcinoma in situ of lip, oral cavity and pharynx |
| D00.00 | Carcinoma in situ of oral cavity, unspecified site |
| D00.01 | Carcinoma in situ of labial mucosa and vermilion border |
| D00.02 | Carcinoma in situ of buccal mucosa |
| D00.03 | Carcinoma in situ of gingiva and edentulous alveolar ridge |
| D00.04 | Carcinoma in situ of soft palate |
| D00.05 | Carcinoma in situ of hard palate |
| D00.06 | Carcinoma in situ of floor of mouth |
| D00.07 | Carcinoma in situ of tongue |
| D00.08 | Carcinoma in situ of pharynx |
| D00.1 | Carcinoma in situ of esophagus |
| D00.2 | Carcinoma in situ of stomach |
| D01 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED DIGESTIVE ORGANS |
| D01.0 | Carcinoma in situ of colon |
| D01.1 | Carcinoma in situ of rectosigmoid junction |
| D01.2 | Carcinoma in situ of rectum |
| D01.3 | Carcinoma in situ of anus and anal canal |
| D01.4 | Carcinoma in situ of other and unspecified parts of intestine |
| D01.40 | Carcinoma in situ of unspecified part of intestine |
| D01.49 | Carcinoma in situ of other parts of intestine |
| D01.5 | Carcinoma in situ of liver, gallbladder and bile ducts |
| D01.7 | Carcinoma in situ of other specified digestive organs |
| D01.9 | Carcinoma in situ of digestive organ, unspecified |
| D02 | CARCINOMA IN SITU OF MIDDLE EAR AND RESPIRATORY SYSTEM |
| D02.0 | Carcinoma in situ of larynx |
| D02.1 | Carcinoma in situ of trachea |
| D02.2 | Carcinoma in situ of bronchus and lung |
| D02.20 | Carcinoma in situ of unspecified bronchus and lung |
| D02.21 | Carcinoma in situ of right bronchus and lung |
| D02.22 | Carcinoma in situ of left bronchus and lung |
| D02.3 | Carcinoma in situ of other parts of respiratory system |
| D02.4 | Carcinoma in situ of respiratory system, unspecified |
| D05 | CARCINOMA IN SITU OF BREAST |
| D05.0 | Lobular carcinoma in situ of breast |
| D05.00 | Lobular carcinoma in situ of unspecified breast |
| D05.01 | Lobular carcinoma in situ of right breast |
| D05.02 | Lobular carcinoma in situ of left breast |
| D05.1 | Intraductal carcinoma in situ of breast |
| D05.10 | Intraductal carcinoma in situ of unspecified breast |
| D05.11 | Intraductal carcinoma in situ of right breast |
| D05.12 | Intraductal carcinoma in situ of left breast |
| D05.8 | Other specified type of carcinoma in situ of breast |
| D05.80 | Other specified type of carcinoma in situ of unspecified breast |
| D05.81 | Other specified type of carcinoma in situ of right breast |
| D05.82 | Other specified type of carcinoma in situ of left breast |
| D05.9 | Unspecified type of carcinoma in situ of breast |
| D05.90 | Unspecified type of carcinoma in situ of unspecified breast |
| D05.91 | Unspecified type of carcinoma in situ of right breast |
| D05.92 | Unspecified type of carcinoma in situ of left breast |
| D07 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED GENITAL ORGANS |
| D07.0 | Carcinoma in situ of endometrium |
| D07.1 | Carcinoma in situ of vulva |
| D07.2 | Carcinoma in situ of vagina |
| D07.3 | Carcinoma in situ of other and unspecified female genital organs |
| D07.30 | Carcinoma in situ of unspecified female genital organs |
| D07.39 | Carcinoma in situ of other female genital organs |
| D07.4 | Carcinoma in situ of penis |
| D07.6 | Carcinoma in situ of other and unspecified male genital organs |
| D07.60 | Carcinoma in situ of unspecified male genital organs |
| D07.61 | Carcinoma in situ of scrotum |
| D07.69 | Carcinoma in situ of other male genital organs |
| D09 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED SITES |
| D09.0 | Carcinoma in situ of bladder |
| D09.1 | Carcinoma in situ of other and unspecified urinary organs |
| D09.10 | Carcinoma in situ of unspecified urinary organ |
| D09.19 | Carcinoma in situ of other urinary organs |
| D09.2 | Carcinoma in situ of eye |
| D09.20 | Carcinoma in situ of unspecified eye |
| D09.21 | Carcinoma in situ of right eye |
| D09.22 | Carcinoma in situ of left eye |
| D09.3 | Carcinoma in situ of thyroid and other endocrine glands |
| D09.8 | Carcinoma in situ of other specified sites |
| D09.9 | Carcinoma in situ, unspecified |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 189758001 (Melanoma in situ)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D03 | Melanoma in situ of skin |
| D03.0 | Melanoma in situ of lip |
| D03.1 | Melanoma in situ of eyelid, including canthus |
| D03.10 | Melanoma in situ of unspecified eyelid, including canthus |
| D03.11 | Melanoma in situ of right eyelid, including canthus |
| D03.111 | Melanoma in situ of right upper eyelid, including canthus |
| D03.112 | Melanoma in situ of right lower eyelid, including canthus |
| D03.12 | Melanoma in situ of left eyelid, including canthus |
| D03.121 | Melanoma in situ of left upper eyelid, including canthus |
| D03.122 | Melanoma in situ of left lower eyelid, including canthus |
| D03.2 | Melanoma in situ of ear and external auricular canal |
| D03.20 | Melanoma in situ of unspecified ear and external auricular canal |
| D03.21 | Melanoma in situ of right ear and external auricular canal |
| D03.22 | Melanoma in situ of left ear and external auricular canal |
| D03.3 | Melanoma in situ of other and unspecified parts of face |
| D03.30 | Melanoma in situ of unspecified part of face |
| D03.39 | Melanoma in situ of other parts of face |
| D03.4 | Melanoma in situ of scalp and neck |
| D03.5 | Melanoma in situ of trunk |
| D03.51 | Melanoma in situ of anal skin |
| D03.52 | Melanoma in situ of breast (skin) (soft tissue) |
| D03.59 | Melanoma in situ of other part of trunk |
| D03.6 | Melanoma in situ of upper limb, including shoulder |
| D03.60 | Melanoma in situ of unspecified upper limb, including shoulder |
| D03.61 | Melanoma in situ of right upper limb, including shoulder |
| D03.62 | Melanoma in situ of left upper limb, including shoulder |
| D03.7 | Melanoma in situ of lower limb, including hip |
| D03.70 | Melanoma in situ of unspecified lower limb, including hip |
| D03.71 | Melanoma in situ of right lower limb, including hip |
| D03.72 | Melanoma in situ of left lower limb, including hip |
| D03.8 | Melanoma in situ of other sites |
| D03.9 | Melanoma in situ, unspecified |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 93468003 (Hemangioma of intracranial structure)http://snomed.info/sct where concept is-a 109913001 (Benign neoplasm of meninges)http://snomed.info/sct where concept is-a 92030004 (Benign neoplasm of brain)http://snomed.info/sct where concept is-a 92048008 (Benign neoplasm of central nervous system)http://snomed.info/sct where concept is-a 92296004 (Benign neoplasm of pituitary gland)http://snomed.info/sct where concept is-a 92294001 (Benign neoplasm of pineal gland)http://snomed.info/sct where concept is-a 94963005 (Neoplasm of uncertain behavior of nervous system)http://snomed.info/sct where concept is-a 94767002 (Neoplasm of uncertain behavior of brain)http://snomed.info/sct where concept is-a 95002008 (Neoplasm of uncertain behavior of pineal gland)http://snomed.info/sct where concept is-a 95004009 (Neoplasm of uncertain behavior of pituitary gland)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D18.02 | Hemangioma of intracranial structures |
| D32 | BENIGN NEOPLASM OF MENINGES |
| D32.0 | Benign neoplasm of cerebral meninges |
| D32.1 | Benign neoplasm of spinal meninges |
| D32.9 | Benign neoplasm of meninges, unspecified |
| D33 | BENIGN NEOPLASM OF BRAIN AND OTHER PARTS OF CENTRAL NERVOUS SYSTEM |
| D33.0 | Benign neoplasm of brain, supratentorial |
| D33.1 | Benign neoplasm of brain, infratentorial |
| D33.2 | Benign neoplasm of brain, unspecified |
| D33.3 | Benign neoplasm of cranial nerves |
| D33.4 | Benign neoplasm of spinal cord |
| D33.7 | Benign neoplasm of other specified parts of central nervous system |
| D33.9 | Benign neoplasm of central nervous system, unspecified |
| D35.2 | Benign neoplasm of pituitary gland |
| D35.3 | Benign neoplasm of craniopharyngeal duct |
| D35.4 | Benign neoplasm of pineal gland |
| D42.0 | Neoplasm of uncertain behavior of cerebral meninges |
| D42.1 | Neoplasm of uncertain behavior of spinal meninges |
| D42.9 | Neoplasm of uncertain behavior of meninges, unspecified |
| D43.0 | Neoplasm of uncertain behavior of brain, supratentorial |
| D43.1 | Neoplasm of uncertain behavior of brain, infratentorial |
| D43.2 | Neoplasm of uncertain behavior of brain, unspecified |
| D43.3 | Neoplasm of uncertain behavior of cranial nerves |
| D43.4 | Neoplasm of uncertain behavior of spinal cord |
| D43.8 | Neoplasm of uncertain behavior of other specified parts of central nervous system |
| D43.9 | Neoplasm of uncertain behavior of central nervous system, unspecified |
| D44.3 | Neoplasm of uncertain behavior of pituitary gland |
| D44.4 | Neoplasm of uncertain behavior of craniopharyngeal duct |
| D44.5 | Neoplasm of uncertain behavior of pineal gland |
This value set includes codes based on the following rules:
http://snomed.info/sct| Code | Display |
| 126361000119107 | Cytological evidence of malignancy on anal Papanicolaou smear (finding) |
| 126371000119101 | Cytological evidence of malignancy on vaginal Papanicolaou smear (finding) |
http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| R85.614 | Cytologic evidence of malignancy on smear of anus |
| R87.624 | Cytologic evidence of malignancy on smear of vagina |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 128462008 (Metastatic neoplasm (disease))http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| C77 | SECONDARY AND UNSPECIFIED MALIGNANT NEOPLASM OF LYMPH NODES |
| C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck |
| C77.1 | Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes |
| C77.2 | Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes |
| C77.3 | Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes |
| C77.4 | Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes |
| C77.5 | Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes |
| C77.8 | Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions |
| C77.9 | Secondary and unspecified malignant neoplasm of lymph node, unspecified |
| C78 | SECONDARY MALIGNANT NEOPLASM OF RESPIRATORY AND DIGESTIVE ORGANS |
| C78.0 | Secondary malignant neoplasm of lung |
| C78.00 | Secondary malignant neoplasm of unspecified lung |
| C78.01 | Secondary malignant neoplasm of right lung |
| C78.02 | Secondary malignant neoplasm of left lung |
| C78.1 | Secondary malignant neoplasm of mediastinum |
| C78.2 | Secondary malignant neoplasm of pleura |
| C78.3 | Secondary malignant neoplasm of other and unspecified respiratory organs |
| C78.30 | Secondary malignant neoplasm of unspecified respiratory organ |
| C78.39 | Secondary malignant neoplasm of other respiratory organs |
| C78.4 | Secondary malignant neoplasm of small intestine |
| C78.5 | Secondary malignant neoplasm of large intestine and rectum |
| C78.6 | Secondary malignant neoplasm of retroperitoneum and peritoneum |
| C78.7 | Secondary malignant neoplasm of liver and intrahepatic bile duct |
| C78.8 | Secondary malignant neoplasm of other and unspecified digestive organs |
| C78.80 | Secondary malignant neoplasm of unspecified digestive organ |
| C78.89 | Secondary malignant neoplasm of other digestive organs |
| C79 | SECONDARY MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED SITES |
| C79.0 | Secondary malignant neoplasm of kidney and renal pelvis |
| C79.00 | Secondary malignant neoplasm of unspecified kidney and renal pelvis |
| C79.01 | Secondary malignant neoplasm of right kidney and renal pelvis |
| C79.02 | Secondary malignant neoplasm of left kidney and renal pelvis |
| C79.1 | Secondary malignant neoplasm of bladder and other urinary organs |
| C79.10 | Secondary malignant neoplasm of unspecified urinary organs |
| C79.11 | Secondary malignant neoplasm of bladder |
| C79.19 | Secondary malignant neoplasm of other urinary organs |
| C79.2 | Secondary malignant neoplasm of skin |
| C79.3 | Secondary malignant neoplasm of brain cerebral meninges |
| C79.31 | Secondary malignant neoplasm of brain |
| C79.32 | Secondary malignant neoplasm of cerebral meninges |
| C79.4 | Secondary malignant neoplasm of other and unspecified of nervous system |
| C79.40 | Secondary malignant neoplasm of unspecified part of nervous system |
| C79.49 | Secondary malignant neoplasm of other parts of nervous system |
| C79.5 | Secondary malignant neoplasm of bone and bone marrow |
| C79.51 | Secondary malignant neoplasm of bone |
| C79.52 | Secondary malignant neoplasm of bone marrow |
| C79.6 | Secondary malignant neoplasm of ovary |
| C79.60 | Secondary malignant neoplasm of unspecified ovary |
| C79.61 | Secondary malignant neoplasm of right ovary |
| C79.62 | Secondary malignant neoplasm of left ovary |
| C79.7 | Secondary malignant neoplasm of adrenal gland |
| C79.70 | Secondary malignant neoplasm of unspecified adrenal gland |
| C79.71 | Secondary malignant neoplasm of right adrenal gland |
| C79.72 | Secondary malignant neoplasm of left adrenal gland |
| C79.8 | Secondary malignant neoplasm of other specified sites |
| C79.81 | Secondary malignant neoplasm of breast |
| C79.82 | Secondary malignant neoplasm of genital organs |
| C79.89 | Secondary malignant neoplasm of other specified sites |
| C79.9 | Secondary malignant neoplasm of unspecified site |
| C7B | SECONDARY NEUROENDOCRINE TUMORS |
| C7B.0 | Secondary carcinoid tumors |
| C7B.00 | Secondary carcinoid tumors, unspecified site |
| C7B.01 | Secondary carcinoid tumors of distant lymph nodes |
| C7B.02 | Secondary carcinoid tumors of liver |
| C7B.03 | Secondary carcinoid tumors of bone |
| C7B.04 | Secondary carcinoid tumors of peritoneum |
| C7B.09 | Secondary carcinoid tumors of other sites |
| C7B.1 | Secondary merkel cell carcinoma |
| C7B.8 | Other secondary neuroendocrine tumors |
This value set includes codes based on the following rules:
http://terminology.hl7.org/CodeSystem/icd-o-3http://snomed.info/sct where concept is-a 367651003 (Malignant Neoplasm (Morphology))http://snomed.info/sct where concept is-a 399919001 (Carcinoma in situ - category (morphologic abnormality))http://snomed.info/sct where concept is-a 399983006 (In situ adenomatous neoplasm - category (morphologic abnormality))http://snomed.info/sct| Code | Display |
| 399878004 | Malignant neoplasm with pilar differentiation (morphologic abnormality) |
| 253035009 | In situ melanocytic morphology (morphologic abnormality) |
This value set excludes codes based on the following rules:
http://snomed.info/sct where concept is-a 450893003 (Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia (morphologic abnormality))http://snomed.info/sct where concept is-a 128640002 (Prostatic intraepithelial neoplasia, grade III)http://snomed.info/sct where concept is-a 450890000 (Glandular intraepithelial neoplasia, low grade)http://snomed.info/sct where concept is-a 703548001 (Atypical hyperplasia of the endometrium)http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 1011 | lymphocyte immune globulin, anti-thymocyte globulin |
| 107047 | rabbit anti-human T-lymphocyte globulin 25 MG Injection |
| 107050 | rabbit anti-human T-lymphocyte globulin 25 MG Injection [Thymoglobulin] |
| 11065 | ursodiol |
| 1164265 | alemtuzumab Injectable Product |
| 1165939 | ATGAM Injectable Product |
| 117055 | alemtuzumab |
| 1172298 | Campath Injectable Product |
| 1177887 | Thymoglobulin Injectable Product |
| 1204 | ATGAM |
| 1311089 | defibrotide |
| 1594657 | alemtuzumab 10 MG/ML |
| 1594658 | 1.2 ML alemtuzumab 10 MG/ML Injection |
| 1594659 | Lemtrada |
| 1594660 | alemtuzumab 10 MG/ML [Lemtrada] |
| 1594662 | Lemtrada Injectable Product |
| 1594663 | 1.2 ML alemtuzumab 10 MG/ML Injection [Lemtrada] |
| 1656628 | alemtuzumab 30 MG/ML |
| 1656629 | alemtuzumab Injection |
| 1656631 | alemtuzumab 30 MG/ML [Campath] |
| 1656632 | alemtuzumab Injection [Campath] |
| 1656637 | alemtuzumab Injection [Lemtrada] |
| 1746523 | defibrotide sodium |
| 1746524 | defibrotide sodium 80 MG/ML |
| 1746525 | defibrotide Injectable Product |
| 1746526 | defibrotide Injection |
| 1746527 | 2.5 ML defibrotide sodium 80 MG/ML Injection |
| 1746528 | Defitelio |
| 1746529 | defibrotide sodium 80 MG/ML [Defitelio] |
| 1746530 | defibrotide Injection [Defitelio] |
| 1746531 | Defitelio Injectable Product |
| 1746532 | 2.5 ML defibrotide sodium 80 MG/ML Injection [Defitelio] |
| 1788946 | defibrotide, bovine lung |
| 197906 | 5 ML lymphocyte immune globulin, anti-thymocyte globulin, equine 50 MG/ML Injection |
| 206289 | 5 ML lymphocyte immune globulin, anti-thymocyte globulin, equine 50 MG/ML Injection [ATGAM] |
| 225741 | Thymoglobulin |
| 2282514 | lymphocyte immune globulin, anti-thymocyte globulin, equine 50 MG/ML |
| 2282515 | lymphocyte immune globulin, anti-thymocyte globulin Injectable Product |
| 2282516 | lymphocyte immune globulin, anti-thymocyte globulin Injection |
| 2282518 | lymphocyte immune globulin, anti-thymocyte globulin, equine 50 MG/ML [ATGAM] |
| 2282519 | lymphocyte immune globulin, anti-thymocyte globulin Injection [ATGAM] |
| 2282525 | rabbit anti-human T-lymphocyte globulin 25 MG |
| 2282527 | rabbit anti-human T-lymphocyte globulin 25 MG [Thymoglobulin] |
| 2282528 | lymphocyte immune globulin, anti-thymocyte globulin Injection [Thymoglobulin] |
| 2376942 | ursodiol 400 MG Oral Capsule |
| 2477892 | ursodiol 200 MG [Reltone] |
| 2477896 | ursodiol 200 MG Oral Capsule [Reltone] |
| 2477897 | ursodiol 400 MG [Reltone] |
| 2477898 | ursodiol 400 MG Oral Capsule [Reltone] |
| 284679 | Campath |
| 360513 | ursodiol 250 MG |
| 412174 | ursodiol 200 MG Oral Capsule |
| 452499 | ursodiol 200 MG |
| 452500 | ursodiol 400 MG |
| 828265 | 1 ML alemtuzumab 30 MG/ML Injection |
| 828267 | 1 ML alemtuzumab 30 MG/ML Injection [Campath] |
| 858328 | ursodiol 300 MG |
| 858329 | ursodiol 300 MG Oral Tablet |
| 858330 | ursodiol 150 MG |
| 858332 | ursodiol 50 MG/ML |
| 858333 | ursodiol 50 MG/ML Oral Suspension |
| 858335 | ursodiol 150 MG Oral Tablet |
| 858732 | ursodiol 500 MG |
| 858733 | ursodiol 500 MG Oral Tablet |
| 858734 | ursodiol 500 MG [Urso Forte] |
| 858735 | ursodiol 500 MG Oral Tablet [Urso Forte] |
| 858744 | ursodiol 250 MG Oral Capsule |
| 858745 | ursodiol 250 MG [Urso] |
| 858747 | ursodiol 300 MG Oral Capsule |
| 858748 | ursodiol 300 MG [Actigall] |
| 858749 | ursodiol 300 MG Oral Capsule [Actigall] |
| 858751 | ursodiol 250 MG Oral Tablet |
| 858752 | ursodiol 250 MG Oral Tablet [Urso] |
| 91601 | lymphocyte immune globulin, anti-thymocyte globulin, equine |
| 973 | antilymphocyte immunoglobulin |
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 105585 | methotrexate 2.5 MG Oral Tablet |
| 105586 | methotrexate 10 MG Oral Tablet |
| 105589 | methotrexate 100 MG/ML Injectable Solution |
| 108513 | tacrolimus 1 MG Oral Capsule [Prograf] |
| 108514 | tacrolimus 5 MG Oral Capsule [Prograf] |
| 108515 | 1 ML tacrolimus 5 MG/ML Injection [Prograf] |
| 1093172 | cyclosporine 0.002 MG/MG |
| 1093173 | cyclosporine Ophthalmic Ointment |
| 1093174 | cyclosporine 0.002 MG/MG Ophthalmic Ointment |
| 1093175 | Optimmune |
| 1093176 | cyclosporine 0.002 MG/MG [Optimmune] |
| 1093177 | cyclosporine Ophthalmic Ointment [Optimmune] |
| 1093178 | cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune] |
| 1145927 | abatacept 125 MG/ML |
| 1145928 | abatacept Prefilled Syringe |
| 1145929 | 1 ML abatacept 125 MG/ML Prefilled Syringe |
| 1145930 | abatacept 125 MG/ML [Orencia] |
| 1145931 | abatacept Prefilled Syringe [Orencia] |
| 1145932 | 1 ML abatacept 125 MG/ML Prefilled Syringe [Orencia] |
| 1151834 | daclizumab Injectable Product |
| 1156181 | cyclophosphamide Injectable Product |
| 1156182 | cyclophosphamide Oral Product |
| 1156183 | cyclophosphamide Pill |
| 1156186 | cyclosporine Injectable Product |
| 1156187 | cyclosporine Ophthalmic Product |
| 1156188 | cyclosporine Oral Liquid Product |
| 1156189 | cyclosporine Oral Product |
| 1156190 | cyclosporine Pill |
| 1157869 | mycophenolate mofetil Injectable Product |
| 1157870 | mycophenolate mofetil Oral Liquid Product |
| 1157871 | mycophenolate mofetil Oral Product |
| 1157872 | mycophenolate mofetil Pill |
| 1158757 | sirolimus Oral Liquid Product |
| 1158758 | sirolimus Oral Product |
| 1158759 | sirolimus Pill |
| 1161488 | temsirolimus Injectable Product |
| 1162235 | methotrexate Injectable Product |
| 1162236 | methotrexate Oral Product |
| 1162237 | methotrexate Pill |
| 1162729 | tocilizumab Injectable Product |
| 1163066 | abatacept Injectable Product |
| 1163075 | bortezomib Injectable Product |
| 1163655 | tacrolimus Injectable Product |
| 1164202 | tacrolimus Oral Product |
| 1164203 | tacrolimus Pill |
| 1164204 | tacrolimus Topical Product |
| 1165075 | maraviroc Oral Product |
| 1165076 | maraviroc Pill |
| 1166213 | Cellcept Injectable Product |
| 1166214 | Cellcept Oral Liquid Product |
| 1166215 | Cellcept Oral Product |
| 1166216 | Cellcept Pill |
| 1169167 | Actemra Injectable Product |
| 1169824 | Gengraf Oral Liquid Product |
| 1169825 | Gengraf Oral Product |
| 1169826 | Gengraf Pill |
| 1172882 | Atopica Oral Product |
| 1172883 | Atopica Pill |
| 1177701 | Rapamune Oral Liquid Product |
| 1177702 | Rapamune Oral Product |
| 1177703 | Rapamune Pill |
| 1178366 | Selzentry Oral Product |
| 1178367 | Selzentry Pill |
| 1179677 | Trexall Oral Product |
| 1179678 | Trexall Pill |
| 1180662 | Prograf Injectable Product |
| 1180663 | Prograf Oral Product |
| 1180664 | Prograf Pill |
| 1181672 | Neoral Oral Liquid Product |
| 1181673 | Neoral Oral Product |
| 1181674 | Neoral Pill |
| 1182342 | Optimmune Ophthalmic Product |
| 1182458 | Protopic Topical Product |
| 1182527 | Restasis Ophthalmic Product |
| 1183963 | Orencia Injectable Product |
| 1185408 | Sandimmune Injectable Product |
| 1185409 | Sandimmune Oral Liquid Product |
| 1185410 | Sandimmune Oral Product |
| 1185411 | Sandimmune Pill |
| 1187756 | Velcade Injectable Product |
| 1193325 | ruxolitinib phosphate |
| 1193326 | ruxolitinib |
| 1193327 | ruxolitinib 10 MG |
| 1193328 | ruxolitinib Oral Product |
| 1193329 | ruxolitinib Pill |
| 1193330 | ruxolitinib Oral Tablet |
| 1193331 | ruxolitinib 10 MG Oral Tablet |
| 1193332 | Jakafi |
| 1193333 | ruxolitinib 10 MG [Jakafi] |
| 1193334 | ruxolitinib Oral Tablet [Jakafi] |
| 1193335 | Jakafi Oral Product |
| 1193336 | Jakafi Pill |
| 1193337 | ruxolitinib 10 MG Oral Tablet [Jakafi] |
| 1193338 | ruxolitinib 5 MG |
| 1193339 | ruxolitinib 5 MG Oral Tablet |
| 1193340 | ruxolitinib 5 MG [Jakafi] |
| 1193341 | ruxolitinib 5 MG Oral Tablet [Jakafi] |
| 1193342 | ruxolitinib 15 MG |
| 1193343 | ruxolitinib 15 MG Oral Tablet |
| 1193344 | ruxolitinib 15 MG [Jakafi] |
| 1193345 | ruxolitinib 15 MG Oral Tablet [Jakafi] |
| 1193346 | ruxolitinib 20 MG |
| 1193347 | ruxolitinib 20 MG Oral Tablet |
| 1193348 | ruxolitinib 20 MG [Jakafi] |
| 1193349 | ruxolitinib 20 MG Oral Tablet [Jakafi] |
| 1193350 | ruxolitinib 25 MG |
| 1193351 | ruxolitinib 25 MG Oral Tablet |
| 1193352 | ruxolitinib 25 MG [Jakafi] |
| 1193353 | ruxolitinib 25 MG Oral Tablet [Jakafi] |
| 1233905 | cyclosporine, modified 100 MG/ML [Atopica] |
| 1233906 | cyclosporine Oral Solution [Atopica] |
| 1233907 | Atopica Oral Liquid Product |
| 1233908 | cyclosporine, modified 100 MG/ML Oral Solution [Atopica] |
| 1431970 | tacrolimus Extended Release Oral Capsule |
| 1431971 | 24 HR tacrolimus 0.5 MG Extended Release Oral Capsule |
| 1431972 | Astagraf |
| 1431973 | tacrolimus 0.5 MG [Astagraf] |
| 1431974 | tacrolimus Extended Release Oral Capsule [Astagraf] |
| 1431975 | Astagraf Oral Product |
| 1431976 | Astagraf Pill |
| 1431977 | 24 HR tacrolimus 0.5 MG Extended Release Oral Capsule [Astagraf] |
| 1431980 | 24 HR tacrolimus 1 MG Extended Release Oral Capsule |
| 1431981 | tacrolimus 1 MG [Astagraf] |
| 1431982 | 24 HR tacrolimus 1 MG Extended Release Oral Capsule [Astagraf] |
| 1431985 | 24 HR tacrolimus 5 MG Extended Release Oral Capsule |
| 1431986 | tacrolimus 5 MG [Astagraf] |
| 1431987 | 24 HR tacrolimus 5 MG Extended Release Oral Capsule [Astagraf] |
| 1437967 | cyclophosphamide Oral Capsule |
| 1437968 | cyclophosphamide 25 MG Oral Capsule |
| 1437969 | cyclophosphamide 50 MG Oral Capsule |
| 1441402 | 0.4 ML methotrexate 25 MG/ML Auto-Injector |
| 1441403 | Otrexup |
| 1441404 | methotrexate 25 MG/ML [Otrexup] |
| 1441406 | Otrexup Injectable Product |
| 1441407 | 0.4 ML methotrexate 25 MG/ML Auto-Injector [Otrexup] |
| 1441410 | methotrexate 37.5 MG/ML |
| 1441411 | 0.4 ML methotrexate 37.5 MG/ML Auto-Injector |
| 1441412 | methotrexate 37.5 MG/ML [Otrexup] |
| 1441413 | 0.4 ML methotrexate 37.5 MG/ML Auto-Injector [Otrexup] |
| 1441416 | 0.4 ML methotrexate 50 MG/ML Auto-Injector |
| 1441417 | methotrexate 50 MG/ML [Otrexup] |
| 1441418 | 0.4 ML methotrexate 50 MG/ML Auto-Injector [Otrexup] |
| 1441421 | methotrexate 62.5 MG/ML |
| 1441422 | 0.4 ML methotrexate 62.5 MG/ML Auto-Injector |
| 1441423 | methotrexate 62.5 MG/ML [Otrexup] |
| 1441424 | 0.4 ML methotrexate 62.5 MG/ML Auto-Injector [Otrexup] |
| 1441525 | tocilizumab 180 MG/ML |
| 1441526 | tocilizumab Prefilled Syringe |
| 1441527 | 0.9 ML tocilizumab 180 MG/ML Prefilled Syringe |
| 1441528 | tocilizumab 180 MG/ML [Actemra] |
| 1441529 | tocilizumab Prefilled Syringe [Actemra] |
| 1441530 | 0.9 ML tocilizumab 180 MG/ML Prefilled Syringe [Actemra] |
| 152633 | Cellcept |
| 1544378 | 0.2 ML methotrexate 50 MG/ML Auto-Injector |
| 1544379 | Rasuvo |
| 1544380 | methotrexate 50 MG/ML [Rasuvo] |
| 1544382 | Rasuvo Injectable Product |
| 1544383 | 0.2 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] |
| 1544385 | 0.25 ML methotrexate 50 MG/ML Auto-Injector |
| 1544386 | 0.25 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] |
| 1544387 | 0.3 ML methotrexate 50 MG/ML Auto-Injector |
| 1544388 | 0.3 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] |
| 1544389 | 0.35 ML methotrexate 50 MG/ML Auto-Injector |
| 1544390 | 0.35 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] |
| 1544394 | 0.4 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] |
| 1544395 | 0.45 ML methotrexate 50 MG/ML Auto-Injector |
| 1544396 | 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] |
| 1544397 | 0.5 ML methotrexate 50 MG/ML Auto-Injector |
| 1544398 | 0.5 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] |
| 1544401 | 0.6 ML methotrexate 50 MG/ML Auto-Injector |
| 1544402 | 0.6 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] |
| 1544403 | 0.15 ML methotrexate 50 MG/ML Auto-Injector |
| 1544404 | 0.15 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] |
| 1545988 | cyclophosphamide anhydrous |
| 1655203 | methotrexate Auto-Injector |
| 1655205 | methotrexate Auto-Injector [Otrexup] |
| 1655252 | methotrexate Auto-Injector [Rasuvo] |
| 1655955 | methotrexate Injection |
| 1655956 | 40 ML methotrexate 25 MG/ML Injection |
| 1655959 | 10 ML methotrexate 25 MG/ML Injection |
| 1655960 | 2 ML methotrexate 25 MG/ML Injection |
| 1655967 | 4 ML methotrexate 25 MG/ML Injection |
| 1655968 | 8 ML methotrexate 25 MG/ML Injection |
| 1656681 | methotrexate 1000 MG |
| 1657973 | tocilizumab Injection |
| 1657974 | 4 ML tocilizumab 20 MG/ML Injection |
| 1657975 | tocilizumab Injection [Actemra] |
| 1657976 | 4 ML tocilizumab 20 MG/ML Injection [Actemra] |
| 1657979 | 10 ML tocilizumab 20 MG/ML Injection |
| 1657980 | 10 ML tocilizumab 20 MG/ML Injection [Actemra] |
| 1657981 | 20 ML tocilizumab 20 MG/ML Injection |
| 1657982 | 20 ML tocilizumab 20 MG/ML Injection [Actemra] |
| 1659771 | abatacept 250 MG |
| 1659772 | abatacept Injection |
| 1659774 | abatacept 250 MG [Orencia] |
| 1659775 | abatacept Injection [Orencia] |
| 1664432 | tacrolimus 4 MG |
| 1664433 | tacrolimus Extended Release Oral Tablet |
| 1664434 | 24 HR tacrolimus 4 MG Extended Release Oral Tablet |
| 1664435 | Envarsus |
| 1664436 | tacrolimus 4 MG [Envarsus] |
| 1664437 | tacrolimus Extended Release Oral Tablet [Envarsus] |
| 1664438 | Envarsus Oral Product |
| 1664439 | Envarsus Pill |
| 1664440 | 24 HR tacrolimus 4 MG Extended Release Oral Tablet [Envarsus] |
| 1664455 | tacrolimus 0.75 MG |
| 1664456 | 24 HR tacrolimus 0.75 MG Extended Release Oral Tablet |
| 1664457 | tacrolimus 0.75 MG [Envarsus] |
| 1664458 | 24 HR tacrolimus 0.75 MG Extended Release Oral Tablet [Envarsus] |
| 1664461 | 24 HR tacrolimus 1 MG Extended Release Oral Tablet |
| 1664462 | tacrolimus 1 MG [Envarsus] |
| 1664463 | 24 HR tacrolimus 1 MG Extended Release Oral Tablet [Envarsus] |
| 1724304 | temsirolimus Injection |
| 1724306 | temsirolimus Injection [Torisel] |
| 1726176 | mycophenolate mofetil Injection |
| 1726179 | mycophenolate mofetil Injection [Cellcept] |
| 1732364 | cyclosporine Injection |
| 1732366 | cyclosporine Injection [Sandimmune] |
| 1734915 | cyclophosphamide 500 MG |
| 1734916 | cyclophosphamide Injection |
| 1734917 | cyclophosphamide 500 MG Injection |
| 1734918 | cyclophosphamide 1000 MG |
| 1734919 | cyclophosphamide 1000 MG Injection |
| 1734920 | cyclophosphamide 2000 MG |
| 1734921 | cyclophosphamide 2000 MG Injection |
| 1738334 | tacrolimus Injection |
| 1738336 | tacrolimus Injection [Prograf] |
| 1747178 | methotrexate 31.3 MG/ML |
| 1747179 | 0.4 ML methotrexate 31.3 MG/ML Auto-Injector |
| 1747180 | methotrexate 31.3 MG/ML [Otrexup] |
| 1747181 | 0.4 ML methotrexate 31.3 MG/ML Auto-Injector [Otrexup] |
| 1747184 | methotrexate 43.8 MG/ML |
| 1747185 | 0.4 ML methotrexate 43.8 MG/ML Auto-Injector |
| 1747186 | methotrexate 43.8 MG/ML [Otrexup] |
| 1747187 | 0.4 ML methotrexate 43.8 MG/ML Auto-Injector [Otrexup] |
| 1747191 | methotrexate 56.3 MG/ML |
| 1747192 | 0.4 ML methotrexate 56.3 MG/ML Auto-Injector |
| 1747193 | methotrexate 56.3 MG/ML [Otrexup] |
| 1747194 | 0.4 ML methotrexate 56.3 MG/ML Auto-Injector [Otrexup] |
| 1799227 | abatacept Auto-Injector |
| 1799228 | 1 ML abatacept 125 MG/ML Auto-Injector |
| 1799229 | abatacept Auto-Injector [Orencia] |
| 1799230 | 1 ML abatacept 125 MG/ML Auto-Injector [Orencia] |
| 1804993 | bortezomib 3.5 MG |
| 1804994 | bortezomib Injection |
| 1804996 | bortezomib 3.5 MG [Velcade] |
| 1804997 | bortezomib Injection [Velcade] |
| 1857910 | maraviroc 25 MG |
| 1857911 | maraviroc 25 MG Oral Tablet |
| 1857912 | maraviroc 25 MG [Selzentry] |
| 1857913 | maraviroc 25 MG Oral Tablet [Selzentry] |
| 1857914 | maraviroc 75 MG |
| 1857915 | maraviroc 75 MG Oral Tablet |
| 1857916 | maraviroc 75 MG [Selzentry] |
| 1857917 | maraviroc 75 MG Oral Tablet [Selzentry] |
| 1857918 | maraviroc 20 MG/ML |
| 1857919 | maraviroc Oral Liquid Product |
| 1857920 | maraviroc Oral Solution |
| 1857921 | maraviroc 20 MG/ML Oral Solution |
| 1857922 | maraviroc 20 MG/ML [Selzentry] |
| 1857923 | maraviroc Oral Solution [Selzentry] |
| 1857924 | Selzentry Oral Liquid Product |
| 1857925 | maraviroc 20 MG/ML Oral Solution [Selzentry] |
| 190353 | daclizumab |
| 1921590 | methotrexate Oral Liquid Product |
| 1921591 | methotrexate Oral Solution |
| 1921592 | methotrexate 2.5 MG/ML Oral Solution |
| 1921593 | Xatmep |
| 1921594 | methotrexate 2.5 MG/ML [Xatmep] |
| 1921595 | methotrexate Oral Solution [Xatmep] |
| 1921596 | Xatmep Oral Liquid Product |
| 1921597 | Xatmep Oral Product |
| 1921598 | methotrexate 2.5 MG/ML Oral Solution [Xatmep] |
| 1925254 | 0.4 ML abatacept 125 MG/ML Prefilled Syringe |
| 1925255 | 0.4 ML abatacept 125 MG/ML Prefilled Syringe [Orencia] |
| 1925256 | 0.7 ML abatacept 125 MG/ML Prefilled Syringe |
| 1925257 | 0.7 ML abatacept 125 MG/ML Prefilled Syringe [Orencia] |
| 1946772 | methotrexate 25 MG/ML Injectable Solution |
| 196463 | Prograf |
| 197549 | cyclophosphamide 25 MG Oral Tablet |
| 197550 | cyclophosphamide 50 MG Oral Tablet |
| 197552 | cyclosporine 100 MG Oral Capsule [Sandimmune] |
| 197553 | cyclosporine 25 MG Oral Capsule |
| 198377 | tacrolimus 1 MG Oral Capsule |
| 198378 | tacrolimus 5 MG Oral Capsule |
| 198379 | 1 ML tacrolimus 5 MG/ML Injection |
| 199058 | mycophenolate mofetil 250 MG Oral Capsule |
| 200060 | mycophenolate mofetil 500 MG Oral Tablet |
| 202816 | Sandimmune |
| 202817 | Neoral |
| 205168 | cyclosporine 50 MG Oral Capsule |
| 205175 | 5 ML cyclosporine 50 MG/ML Injection |
| 2052503 | tacrolimus 0.2 MG |
| 2052603 | tacrolimus Granule Product |
| 2052604 | tacrolimus Granules for Oral Suspension |
| 2052605 | tacrolimus 0.2 MG Granules for Oral Suspension |
| 2052606 | tacrolimus 0.2 MG [Prograf] |
| 2052607 | tacrolimus Granules for Oral Suspension [Prograf] |
| 2052608 | Prograf Granule Product |
| 2052609 | tacrolimus 0.2 MG Granules for Oral Suspension [Prograf] |
| 2052703 | tacrolimus 1 MG Granules for Oral Suspension |
| 2052704 | tacrolimus 1 MG Granules for Oral Suspension [Prograf] |
| 2055019 | cyclosporine 0.9 MG/ML |
| 2055020 | cyclosporine Ophthalmic Solution |
| 2055021 | cyclosporine 0.9 MG/ML Ophthalmic Solution |
| 2055022 | Cequa |
| 2055023 | cyclosporine 0.9 MG/ML [Cequa] |
| 2055024 | cyclosporine Ophthalmic Solution [Cequa] |
| 2055025 | Cequa Ophthalmic Product |
| 2055026 | cyclosporine 0.9 MG/ML Ophthalmic Solution [Cequa] |
| 2106072 | tocilizumab Auto-Injector |
| 2106073 | 0.9 ML tocilizumab 180 MG/ML Auto-Injector |
| 2106074 | tocilizumab Auto-Injector [Actemra] |
| 2106075 | 0.9 ML tocilizumab 180 MG/ML Auto-Injector [Actemra] |
| 212810 | cyclosporine 25 MG Oral Capsule [Sandimmune] |
| 212844 | 5 ML cyclosporine 50 MG/ML Injection [Sandimmune] |
| 212957 | cyclosporine 100 MG/ML Oral Solution [Sandimmune] |
| 213394 | mycophenolate mofetil 500 MG Injection [Cellcept] |
| 221085 | cyclophosphamide lyophilized |
| 235991 | anhydrous tacrolimus |
| 236077 | cyclosporine, modified |
| 237112 | mycophenolate mofetil hydrochloride |
| 2377332 | methotrexate Prefilled Syringe |
| 2377333 | 0.4 ML methotrexate 25 MG/ML Prefilled Syringe |
| 2377334 | Reditrex |
| 2377335 | methotrexate 25 MG/ML [Reditrex] |
| 2377336 | methotrexate Prefilled Syringe [Reditrex] |
| 2377337 | Reditrex Injectable Product |
| 2377338 | 0.4 ML methotrexate 25 MG/ML Prefilled Syringe [Reditrex] |
| 2377341 | 0.5 ML methotrexate 25 MG/ML Prefilled Syringe |
| 2377342 | 0.5 ML methotrexate 25 MG/ML Prefilled Syringe [Reditrex] |
| 2377343 | 0.6 ML methotrexate 25 MG/ML Prefilled Syringe |
| 2377344 | 0.6 ML methotrexate 25 MG/ML Prefilled Syringe [Reditrex] |
| 2377345 | 0.7 ML methotrexate 25 MG/ML Prefilled Syringe |
| 2377346 | 0.7 ML methotrexate 25 MG/ML Prefilled Syringe [Reditrex] |
| 2377347 | 0.8 ML methotrexate 25 MG/ML Prefilled Syringe |
| 2377348 | 0.8 ML methotrexate 25 MG/ML Prefilled Syringe [Reditrex] |
| 2377349 | 0.9 ML methotrexate 25 MG/ML Prefilled Syringe |
| 2377350 | 0.9 ML methotrexate 25 MG/ML Prefilled Syringe [Reditrex] |
| 2377351 | 1 ML methotrexate 25 MG/ML Prefilled Syringe |
| 2377352 | 1 ML methotrexate 25 MG/ML Prefilled Syringe [Reditrex] |
| 2377353 | 0.3 ML methotrexate 25 MG/ML Prefilled Syringe |
| 2377354 | 0.3 ML methotrexate 25 MG/ML Prefilled Syringe [Reditrex] |
| 2386858 | cyclophosphamide 200 MG/ML |
| 2386859 | cyclophosphamide 200 MG/ML Injectable Solution |
| 241834 | cyclosporine, modified 100 MG Oral Capsule |
| 2470532 | Cyclavance |
| 2470533 | cyclosporine, modified 100 MG/ML [Cyclavance] |
| 2470534 | cyclosporine Oral Solution [Cyclavance] |
| 2470535 | Cyclavance Oral Liquid Product |
| 2470536 | Cyclavance Oral Product |
| 2470537 | cyclosporine, modified 100 MG/ML Oral Solution [Cyclavance] |
| 2568661 | 5 ML cyclophosphamide 200 MG/ML Injection |
| 2568663 | 2.5 ML cyclophosphamide 200 MG/ML Injection |
| 2570749 | ruxolitinib 15 MG/ML |
| 2570750 | ruxolitinib Topical Product |
| 2570751 | ruxolitinib Topical Cream |
| 2570752 | ruxolitinib 15 MG/ML Topical Cream |
| 2570753 | Opzelura |
| 2570754 | ruxolitinib 15 MG/ML [Opzelura] |
| 2570755 | Opzelura Topical Product |
| 2570756 | ruxolitinib Topical Cream [Opzelura] |
| 2570757 | ruxolitinib 15 MG/ML Topical Cream [Opzelura] |
| 2572292 | 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension |
| 2572293 | 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis] |
| 258355 | Rapamune |
| 2586860 | sirolimus 100 MG |
| 2586861 | sirolimus Injectable Product |
| 2586862 | sirolimus Injection |
| 2586863 | sirolimus 100 MG Injection |
| 2586864 | Fyarro |
| 2586865 | sirolimus 100 MG [Fyarro] |
| 2586866 | Fyarro Injectable Product |
| 2586867 | sirolimus Injection [Fyarro] |
| 2586868 | sirolimus 100 MG Injection [Fyarro] |
| 2590607 | cyclosporine 1 MG/ML |
| 2590608 | cyclosporine 1 MG/ML Ophthalmic Suspension |
| 2590609 | Verkazia |
| 2590610 | cyclosporine 1 MG/ML [Verkazia] |
| 2590611 | Verkazia Ophthalmic Product |
| 2590612 | cyclosporine Ophthalmic Suspension [Verkazia] |
| 2590613 | cyclosporine 1 MG/ML Ophthalmic Suspension [Verkazia] |
| 2596861 | sirolimus 0.002 MG/MG |
| 2596862 | sirolimus Topical Product |
| 2596863 | sirolimus Topical Gel |
| 2596864 | sirolimus 0.002 MG/MG Topical Gel |
| 2596865 | Hyftor |
| 2596866 | sirolimus 0.002 MG/MG [Hyftor] |
| 2596867 | Hyftor Topical Product |
| 2596868 | sirolimus Topical Gel [Hyftor] |
| 2596869 | sirolimus 0.002 MG/MG Topical Gel [Hyftor] |
| 2601541 | bortezomib 1 MG |
| 2601542 | bortezomib 1 MG Injection |
| 2601543 | bortezomib 2.5 MG |
| 2601544 | bortezomib 2.5 MG Injection |
| 261134 | tacrolimus 0.5 MG Oral Capsule [Prograf] |
| 261530 | Gengraf |
| 283510 | methotrexate 15 MG Oral Tablet |
| 283511 | methotrexate 5 MG Oral Tablet |
| 283671 | methotrexate 7.5 MG Oral Tablet |
| 284520 | tacrolimus 0.001 MG/MG Topical Ointment [Protopic] |
| 284521 | tacrolimus 0.0003 MG/MG Topical Ointment [Protopic] |
| 284592 | methotrexate 5 MG Oral Tablet [Trexall] |
| 284593 | methotrexate 10 MG Oral Tablet [Trexall] |
| 284594 | methotrexate 7.5 MG Oral Tablet [Trexall] |
| 284595 | methotrexate 15 MG Oral Tablet [Trexall] |
| 284848 | Protopic |
| 284900 | Trexall |
| 287734 | methotrexate sodium |
| 3002 | cyclophosphamide |
| 3008 | cyclosporine |
| 309632 | cyclosporine 100 MG/ML Oral Solution |
| 311625 | methotrexate 1000 MG Injection |
| 311880 | mycophenolate mofetil 200 MG/ML Oral Suspension |
| 311881 | mycophenolate mofetil 500 MG Injection |
| 313189 | tacrolimus 0.0003 MG/MG Topical Ointment |
| 313190 | tacrolimus 0.5 MG Oral Capsule |
| 314230 | sirolimus 1 MG/ML Oral Solution |
| 314266 | tacrolimus 0.001 MG/MG Topical Ointment |
| 315148 | methotrexate 2.5 MG/ML Injectable Solution |
| 315746 | cyclophosphamide 25 MG |
| 315747 | cyclophosphamide 50 MG |
| 315749 | cyclosporine 100 MG |
| 315750 | cyclosporine 100 MG/ML |
| 315751 | cyclosporine 25 MG |
| 315752 | cyclosporine 50 MG |
| 315753 | cyclosporine 50 MG/ML |
| 316316 | mycophenolate mofetil 250 MG |
| 316317 | mycophenolate mofetil 500 MG |
| 316758 | tacrolimus 1 MG |
| 316759 | tacrolimus 5 MG |
| 317510 | tacrolimus 5 MG/ML |
| 328160 | cyclosporine 100 MG Oral Capsule |
| 328404 | methotrexate 50 MG/ML |
| 328406 | methotrexate 25 MG/ML |
| 328407 | methotrexate 2.5 MG |
| 330028 | methotrexate 2.5 MG/ML |
| 330404 | tacrolimus 0.5 MG |
| 331549 | tacrolimus 0.001 MG/MG |
| 331550 | tacrolimus 0.0003 MG/MG |
| 331568 | methotrexate 10 MG |
| 331569 | methotrexate 15 MG |
| 331587 | mycophenolate mofetil 200 MG/ML |
| 332454 | methotrexate 5 MG |
| 332455 | methotrexate 7.5 MG |
| 333296 | sirolimus 1 MG/ML |
| 334294 | cyclosporine, modified 100 MG |
| 349208 | sirolimus 1 MG Oral Tablet |
| 350512 | sirolimus 1 MG |
| 351291 | cyclosporine 0.5 MG/ML Ophthalmic Suspension |
| 351901 | sirolimus 1 MG/ML Oral Solution [Rapamune] |
| 351989 | sirolimus 1 MG Oral Tablet [Rapamune] |
| 352951 | Restasis |
| 35302 | sirolimus |
| 353400 | cyclosporine 0.5 MG/ML |
| 356733 | Velcade |
| 358258 | bortezomib |
| 360110 | sirolimus 2 MG Oral Tablet |
| 360318 | sirolimus 2 MG |
| 360547 | methotrexate 100 MG/ML |
| 363914 | cyclosporine Oral Solution [Gengraf] |
| 363942 | cyclosporine Oral Solution [Neoral] |
| 364904 | sirolimus Oral Solution [Rapamune] |
| 366173 | cyclosporine Oral Capsule [Gengraf] |
| 366273 | tacrolimus Oral Capsule [Prograf] |
| 366479 | cyclosporine Oral Capsule [Neoral] |
| 366488 | cyclosporine Oral Capsule [Sandimmune] |
| 367339 | tacrolimus Topical Ointment [Protopic] |
| 368138 | methotrexate Oral Tablet [Trexall] |
| 368672 | sirolimus Oral Tablet [Rapamune] |
| 371664 | cyclophosphamide Oral Tablet |
| 371666 | cyclosporine Oral Capsule |
| 371667 | cyclosporine Oral Solution |
| 372835 | methotrexate Injectable Solution |
| 372836 | methotrexate Oral Tablet |
| 374015 | tacrolimus Oral Capsule |
| 374667 | mycophenolate mofetil Oral Tablet |
| 374670 | mycophenolate mofetil Oral Suspension |
| 375278 | sirolimus Oral Solution |
| 376666 | cyclophosphamide Injectable Solution |
| 378277 | sirolimus Oral Tablet |
| 378766 | cyclosporine Ophthalmic Suspension |
| 379060 | mycophenolate mofetil Oral Capsule |
| 379082 | tacrolimus Topical Ointment |
| 402092 | cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis] |
| 402243 | bortezomib 3.5 MG Injection |
| 402244 | bortezomib 3.5 MG Injection [Velcade] |
| 402330 | cyclosporine Ophthalmic Suspension [Restasis] |
| 404432 | sirolimus 2 MG Oral Tablet [Rapamune] |
| 42316 | tacrolimus |
| 484288 | tacrolimus monohydrate |
| 484788 | cyclosporine microemulsion |
| 486331 | cyclosporine 100 MG/ML [Sandimmune] |
| 539497 | Atopica |
| 539499 | cyclosporine Oral Capsule [Atopica] |
| 564557 | tacrolimus 1 MG [Prograf] |
| 564558 | tacrolimus 5 MG [Prograf] |
| 564559 | tacrolimus 5 MG/ML [Prograf] |
| 565430 | cyclosporine 100 MG [Sandimmune] |
| 572889 | cyclosporine 25 MG [Sandimmune] |
| 572915 | cyclosporine 50 MG/ML [Sandimmune] |
| 574378 | tacrolimus 0.5 MG [Prograf] |
| 574948 | tacrolimus 0.001 MG/MG [Protopic] |
| 574949 | tacrolimus 0.0003 MG/MG [Protopic] |
| 575019 | methotrexate 5 MG [Trexall] |
| 575020 | methotrexate 10 MG [Trexall] |
| 575021 | methotrexate 7.5 MG [Trexall] |
| 575022 | methotrexate 15 MG [Trexall] |
| 575659 | sirolimus 1 MG/ML [Rapamune] |
| 575733 | sirolimus 1 MG [Rapamune] |
| 576100 | cyclosporine 0.5 MG/ML [Restasis] |
| 576390 | sirolimus 2 MG [Rapamune] |
| 612865 | tocilizumab |
| 614391 | abatacept |
| 616011 | Orencia |
| 616015 | abatacept 250 MG Injection |
| 616018 | abatacept 250 MG Injection [Orencia] |
| 616433 | mycophenolate mofetil 500 MG [Cellcept] |
| 616434 | mycophenolate mofetil Oral Tablet [Cellcept] |
| 616435 | mycophenolate mofetil 500 MG Oral Tablet [Cellcept] |
| 616442 | mycophenolate mofetil 200 MG/ML [Cellcept] |
| 616443 | mycophenolate mofetil Oral Suspension [Cellcept] |
| 616444 | mycophenolate mofetil 200 MG/ML Oral Suspension [Cellcept] |
| 616445 | mycophenolate mofetil 250 MG [Cellcept] |
| 616446 | mycophenolate mofetil Oral Capsule [Cellcept] |
| 616447 | mycophenolate mofetil 250 MG Oral Capsule [Cellcept] |
| 620216 | maraviroc |
| 657797 | temsirolimus |
| 68149 | mycophenolate mofetil |
| 6851 | methotrexate |
| 690313 | cyclophosphamide / mannitol |
| 722287 | temsirolimus 25 MG/ML |
| 722289 | 1.2 ML temsirolimus 25 MG/ML Injection |
| 725106 | temsirolimus 25 MG/ML [Torisel] |
| 725108 | 1.2 ML temsirolimus 25 MG/ML Injection [Torisel] |
| 728221 | maraviroc 150 MG |
| 728222 | maraviroc Oral Tablet |
| 728223 | maraviroc 150 MG Oral Tablet |
| 728224 | maraviroc 300 MG |
| 728225 | maraviroc 300 MG Oral Tablet |
| 728648 | Selzentry |
| 729199 | maraviroc 150 MG [Selzentry] |
| 729200 | maraviroc Oral Tablet [Selzentry] |
| 729201 | maraviroc 150 MG Oral Tablet [Selzentry] |
| 729202 | maraviroc 300 MG [Selzentry] |
| 729203 | maraviroc 300 MG Oral Tablet [Selzentry] |
| 835787 | cyclosporine, modified 100 MG [Gengraf] |
| 835835 | cyclosporine, modified 100 MG Oral Capsule [Gengraf] |
| 835885 | cyclosporine, modified 100 MG/ML |
| 835886 | cyclosporine, modified 100 MG/ML Oral Solution |
| 835887 | cyclosporine, modified 100 MG/ML [Gengraf] |
| 835892 | cyclosporine, modified 100 MG/ML Oral Solution [Gengraf] |
| 835893 | cyclosporine, modified 25 MG |
| 835894 | cyclosporine, modified 25 MG Oral Capsule |
| 835895 | cyclosporine, modified 25 MG [Gengraf] |
| 835896 | cyclosporine, modified 25 MG Oral Capsule [Gengraf] |
| 835897 | cyclosporine, modified 100 MG/ML [Neoral] |
| 835899 | cyclosporine, modified 100 MG/ML Oral Solution [Neoral] |
| 835900 | cyclosporine, modified 100 MG [Neoral] |
| 835901 | cyclosporine, modified 25 MG [Neoral] |
| 835909 | cyclosporine, modified 25 MG Oral Capsule [Neoral] |
| 835911 | cyclosporine, modified 100 MG Oral Capsule [Neoral] |
| 835916 | cyclosporine, modified 100 MG [Atopica] |
| 835917 | cyclosporine, modified 100 MG Oral Capsule [Atopica] |
| 835918 | cyclosporine, modified 10 MG |
| 835919 | cyclosporine, modified 10 MG Oral Capsule |
| 835920 | cyclosporine, modified 10 MG [Atopica] |
| 835921 | cyclosporine, modified 10 MG Oral Capsule [Atopica] |
| 835922 | cyclosporine, modified 25 MG [Atopica] |
| 835923 | cyclosporine, modified 25 MG Oral Capsule [Atopica] |
| 835924 | cyclosporine, modified 50 MG |
| 835925 | cyclosporine, modified 50 MG Oral Capsule |
| 835926 | cyclosporine, modified 50 MG [Atopica] |
| 835927 | cyclosporine, modified 50 MG Oral Capsule [Atopica] |
| 895758 | tocilizumab 20 MG/ML |
| 895761 | Actemra |
| 895762 | tocilizumab 20 MG/ML [Actemra] |
| 905157 | sirolimus 0.5 MG |
| 905158 | sirolimus 0.5 MG Oral Tablet |
| 905159 | sirolimus 0.5 MG [Rapamune] |
| 905160 | sirolimus 0.5 MG Oral Tablet [Rapamune] |
| 94035 | cyclosporine Oral Solution [Sandimmune] |
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 1157967 | rituximab Injectable Product |
| 1159651 | filgrastim Injectable Product |
| 1159878 | plerixafor Injectable Product |
| 1161380 | pegfilgrastim Injectable Product |
| 1162571 | lenograstim Injectable Product |
| 1182279 | Neulasta Injectable Product |
| 1182281 | Neupogen Injectable Product |
| 1183314 | Mozobil Injectable Product |
| 1185345 | Rituxan Injectable Product |
| 121191 | rituximab |
| 1433764 | tbo-filgrastim |
| 1433765 | tbo-filgrastim 0.6 MG/ML |
| 1433768 | 0.5 ML tbo-filgrastim 0.6 MG/ML Prefilled Syringe |
| 1433771 | 0.8 ML tbo-filgrastim 0.6 MG/ML Prefilled Syringe |
| 1440046 | lipegfilgrastim |
| 1442677 | Granix |
| 1442678 | tbo-filgrastim 0.6 MG/ML [Granix] |
| 1442679 | filgrastim Prefilled Syringe [Granix] |
| 1442680 | Granix Injectable Product |
| 1442681 | 0.5 ML tbo-filgrastim 0.6 MG/ML Prefilled Syringe [Granix] |
| 1442683 | 0.8 ML tbo-filgrastim 0.6 MG/ML Prefilled Syringe [Granix] |
| 1605064 | filgrastim-sndz |
| 1605065 | filgrastim-sndz 0.6 MG/ML |
| 1605066 | 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe |
| 1605067 | Zarxio |
| 1605068 | filgrastim-sndz 0.6 MG/ML [Zarxio] |
| 1605069 | filgrastim Prefilled Syringe [Zarxio] |
| 1605070 | Zarxio Injectable Product |
| 1605071 | 0.5 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] |
| 1605074 | 0.8 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe |
| 1605075 | 0.8 ML filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] |
| 1649943 | filgrastim Injection |
| 1649944 | 1 ML filgrastim 0.3 MG/ML Injection |
| 1649945 | filgrastim Injection [Neupogen] |
| 1649946 | 1 ML filgrastim 0.3 MG/ML Injection [Neupogen] |
| 1649963 | 1.6 ML filgrastim 0.3 MG/ML Injection |
| 1649964 | 1.6 ML filgrastim 0.3 MG/ML Injection [Neupogen] |
| 1657861 | rituximab Injection |
| 1657862 | 10 ML rituximab 10 MG/ML Injection |
| 1657863 | rituximab Injection [Rituxan] |
| 1657864 | 10 ML rituximab 10 MG/ML Injection [Rituxan] |
| 1657867 | 50 ML rituximab 10 MG/ML Injection |
| 1657868 | 50 ML rituximab 10 MG/ML Injection [Rituxan] |
| 1746487 | pegbovigrastim |
| 1794537 | plerixafor Injection |
| 1794539 | plerixafor Injection [Mozobil] |
| 1927881 | rituximab 120 MG/ML |
| 1927882 | hyaluronidase / rituximab Injectable Product |
| 1927883 | hyaluronidase / rituximab Injection |
| 1927884 | hyaluronidase / rituximab |
| 1927885 | 11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection |
| 1927886 | Rituxan Hycela |
| 1927887 | hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML [Rituxan Hycela] |
| 1927888 | hyaluronidase / rituximab Injection [Rituxan Hycela] |
| 1927889 | Rituxan Hycela Injectable Product |
| 1927890 | 11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] |
| 1927893 | 13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection |
| 1927894 | 13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] |
| 2048018 | pegfilgrastim-jmdb |
| 2048019 | pegfilgrastim-jmdb 10 MG/ML |
| 2048020 | 0.6 ML pegfilgrastim-jmdb 10 MG/ML Prefilled Syringe |
| 2048021 | Fulphila |
| 2048022 | pegfilgrastim-jmdb 10 MG/ML [Fulphila] |
| 2048023 | pegfilgrastim Prefilled Syringe [Fulphila] |
| 2048024 | Fulphila Injectable Product |
| 2048025 | 0.6 ML pegfilgrastim-jmdb 10 MG/ML Prefilled Syringe [Fulphila] |
| 2057198 | filgrastim-aafi |
| 2057199 | filgrastim-aafi 0.6 MG/ML |
| 2057200 | 0.5 ML filgrastim-aafi 0.6 MG/ML Prefilled Syringe |
| 2057201 | Nivestym |
| 2057202 | filgrastim-aafi 0.6 MG/ML [Nivestym] |
| 2057203 | filgrastim Prefilled Syringe [Nivestym] |
| 2057204 | Nivestym Injectable Product |
| 2057205 | 0.5 ML filgrastim-aafi 0.6 MG/ML Prefilled Syringe [Nivestym] |
| 2057208 | filgrastim-aafi 0.3 MG/ML |
| 2057209 | 1 ML filgrastim-aafi 0.3 MG/ML Injection |
| 2057210 | filgrastim-aafi 0.3 MG/ML [Nivestym] |
| 2057211 | filgrastim Injection [Nivestym] |
| 2057212 | 1 ML filgrastim-aafi 0.3 MG/ML Injection [Nivestym] |
| 2057215 | 0.8 ML filgrastim-aafi 0.6 MG/ML Prefilled Syringe |
| 2057216 | 0.8 ML filgrastim-aafi 0.6 MG/ML Prefilled Syringe [Nivestym] |
| 2057218 | 1.6 ML filgrastim-aafi 0.3 MG/ML Injection |
| 2057219 | 1.6 ML filgrastim-aafi 0.3 MG/ML Injection [Nivestym] |
| 2101455 | tbo-filgrastim 0.3 MG/ML |
| 2101456 | 1 ML tbo-filgrastim 0.3 MG/ML Injection |
| 2101457 | tbo-filgrastim 0.3 MG/ML [Granix] |
| 2101458 | filgrastim Injection [Granix] |
| 2101459 | 1 ML tbo-filgrastim 0.3 MG/ML Injection [Granix] |
| 2101464 | 1.6 ML tbo-filgrastim 0.3 MG/ML Injection |
| 2101465 | 1.6 ML tbo-filgrastim 0.3 MG/ML Injection [Granix] |
| 2102692 | pegfilgrastim-cbqv |
| 2102695 | Udenyca |
| 2102697 | pegfilgrastim Prefilled Syringe [Udenyca] |
| 2102698 | Udenyca Injectable Product |
| 2102702 | pegfilgrastim-cbqv 10 MG/ML |
| 2102703 | 0.6 ML pegfilgrastim-cbqv 10 MG/ML Prefilled Syringe |
| 2102704 | pegfilgrastim-cbqv 10 MG/ML [Udenyca] |
| 2102705 | 0.6 ML pegfilgrastim-cbqv 10 MG/ML Prefilled Syringe [Udenyca] |
| 2105824 | rituximab-abbs |
| 2105825 | rituximab-abbs 10 MG/ML |
| 2105826 | 10 ML rituximab-abbs 10 MG/ML Injection |
| 2105827 | Truxima |
| 2105828 | rituximab-abbs 10 MG/ML [Truxima] |
| 2105829 | rituximab Injection [Truxima] |
| 2105830 | Truxima Injectable Product |
| 2105831 | 10 ML rituximab-abbs 10 MG/ML Injection [Truxima] |
| 2105834 | 50 ML rituximab-abbs 10 MG/ML Injection |
| 2105835 | 50 ML rituximab-abbs 10 MG/ML Injection [Truxima] |
| 2260702 | pegfilgrastim-bmez |
| 2260703 | pegfilgrastim-bmez 10 MG/ML |
| 2260704 | 0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syringe |
| 2260705 | Ziextenzo |
| 2260706 | pegfilgrastim-bmez 10 MG/ML [Ziextenzo] |
| 2260707 | pegfilgrastim Prefilled Syringe [Ziextenzo] |
| 2260708 | Ziextenzo Injectable Product |
| 2260709 | 0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syringe [Ziextenzo] |
| 226754 | Rituxan |
| 227304 | Neupogen |
| 2273510 | rituximab-pvvr |
| 2273511 | rituximab-pvvr 10 MG/ML |
| 2273512 | 10 ML rituximab-pvvr 10 MG/ML Injection |
| 2273513 | Ruxience |
| 2273514 | rituximab-pvvr 10 MG/ML [Ruxience] |
| 2273515 | rituximab Injection [Ruxience] |
| 2273516 | Ruxience Injectable Product |
| 2273517 | 10 ML rituximab-pvvr 10 MG/ML Injection [Ruxience] |
| 2273520 | 50 ML rituximab-pvvr 10 MG/ML Injection |
| 2273521 | 50 ML rituximab-pvvr 10 MG/ML Injection [Ruxience] |
| 2469333 | pegfilgrastim-apgf |
| 2469334 | pegfilgrastim-apgf 10 MG/ML |
| 2469335 | 0.6 ML pegfilgrastim-apgf 10 MG/ML Prefilled Syringe |
| 2469336 | Nyvepria |
| 2469337 | pegfilgrastim-apgf 10 MG/ML [Nyvepria] |
| 2469338 | pegfilgrastim Prefilled Syringe [Nyvepria] |
| 2469339 | Nyvepria Injectable Product |
| 2469340 | 0.6 ML pegfilgrastim-apgf 10 MG/ML Prefilled Syringe [Nyvepria] |
| 2472325 | rituximab-arrx |
| 2472326 | rituximab-arrx 10 MG/ML |
| 2472327 | 10 ML rituximab-arrx 10 MG/ML Injection |
| 2472328 | Riabni |
| 2472329 | rituximab-arrx 10 MG/ML [Riabni] |
| 2472330 | rituximab Injection [Riabni] |
| 2472331 | Riabni Injectable Product |
| 2472332 | 10 ML rituximab-arrx 10 MG/ML Injection [Riabni] |
| 2472335 | 50 ML rituximab-arrx 10 MG/ML Injection |
| 2472336 | 50 ML rituximab-arrx 10 MG/ML Injection [Riabni] |
| 2549330 | pegfilgrastim Injection |
| 2549331 | 0.6 ML pegfilgrastim 10 MG/ML Injection |
| 2549332 | pegfilgrastim Injection [Neulasta] |
| 2549333 | 0.6 ML pegfilgrastim 10 MG/ML Injection [Neulasta] |
| 2595942 | filgrastim-ayow |
| 2595943 | filgrastim-ayow 0.6 MG/ML |
| 2595944 | 0.5 ML filgrastim-ayow 0.6 MG/ML Prefilled Syringe |
| 2595946 | Releuko |
| 2595947 | filgrastim-ayow 0.6 MG/ML [Releuko] |
| 2595948 | Releuko Injectable Product |
| 2595949 | filgrastim Prefilled Syringe [Releuko] |
| 2595950 | 0.5 ML filgrastim-ayow 0.6 MG/ML Prefilled Syringe [Releuko] |
| 2595952 | filgrastim-ayow 0.3 MG/ML |
| 2595953 | 1 ML filgrastim-ayow 0.3 MG/ML Injection |
| 2595955 | filgrastim-ayow 0.3 MG/ML [Releuko] |
| 2595956 | filgrastim Injection [Releuko] |
| 2595957 | 1 ML filgrastim-ayow 0.3 MG/ML Injection [Releuko] |
| 2595959 | 1.6 ML filgrastim-ayow 0.3 MG/ML Injection |
| 2595960 | 1.6 ML filgrastim-ayow 0.3 MG/ML Injection [Releuko] |
| 2595961 | 0.8 ML filgrastim-ayow 0.6 MG/ML Prefilled Syringe |
| 2595962 | 0.8 ML filgrastim-ayow 0.6 MG/ML Prefilled Syringe [Releuko] |
| 2602779 | pegfilgrastim-pbbk |
| 2602780 | pegfilgrastim-pbbk 10 MG/ML |
| 2602781 | 0.6 ML pegfilgrastim-pbbk 10 MG/ML Prefilled Syringe |
| 2602783 | Fylnetra |
| 2602784 | pegfilgrastim-pbbk 10 MG/ML [Fylnetra] |
| 2602785 | Fylnetra Injectable Product |
| 2602786 | pegfilgrastim Prefilled Syringe [Fylnetra] |
| 2602787 | 0.6 ML pegfilgrastim-pbbk 10 MG/ML Prefilled Syringe [Fylnetra] |
| 315932 | filgrastim 0.3 MG/ML |
| 316648 | rituximab 10 MG/ML |
| 331527 | filgrastim 0.6 MG/ML |
| 338036 | pegfilgrastim |
| 350977 | pegfilgrastim 10 MG/ML |
| 353501 | Neulasta |
| 567845 | filgrastim 0.3 MG/ML [Neupogen] |
| 573051 | rituximab 10 MG/ML [Rituxan] |
| 574887 | filgrastim 0.6 MG/ML [Neupogen] |
| 575870 | pegfilgrastim 10 MG/ML [Neulasta] |
| 68442 | filgrastim |
| 70167 | lenograstim |
| 727534 | filgrastim Prefilled Syringe |
| 727535 | 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe |
| 727536 | filgrastim Prefilled Syringe [Neupogen] |
| 727537 | 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe [Neupogen] |
| 727538 | pegfilgrastim Prefilled Syringe |
| 727539 | 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe |
| 727541 | pegfilgrastim Prefilled Syringe [Neulasta] |
| 727542 | 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe [Neulasta] |
| 727544 | 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe |
| 727545 | 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe [Neupogen] |
| 733003 | plerixafor |
| 735381 | Mozobil |
| 828698 | plerixafor 20 MG/ML |
| 828700 | 1.2 ML plerixafor 20 MG/ML Injection |
| 828701 | plerixafor 20 MG/ML [Mozobil] |
| 828703 | 1.2 ML plerixafor 20 MG/ML Injection [Mozobil] |
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 10432 | thalidomide |
| 1045401 | dasatinib 140 MG |
| 1045402 | dasatinib 140 MG Oral Tablet |
| 1045403 | dasatinib 140 MG [Sprycel] |
| 1045404 | dasatinib 140 MG Oral Tablet [Sprycel] |
| 1045405 | dasatinib 80 MG |
| 1045406 | dasatinib 80 MG Oral Tablet |
| 1045407 | dasatinib 80 MG [Sprycel] |
| 1045408 | dasatinib 80 MG Oral Tablet [Sprycel] |
| 1147320 | brentuximab vedotin |
| 1147323 | brentuximab vedotin 50 MG Injection |
| 1147324 | Adcetris |
| 1147327 | brentuximab vedotin 50 MG Injection [Adcetris] |
| 1154999 | azacitidine Injectable Product |
| 1157186 | dasatinib Oral Product |
| 1157187 | dasatinib Pill |
| 1157195 | decitabine Injectable Product |
| 1157967 | rituximab Injectable Product |
| 1159691 | sorafenib Oral Product |
| 1159692 | sorafenib Pill |
| 1160679 | imatinib Oral Product |
| 1160680 | imatinib Pill |
| 1160852 | sunitinib Oral Product |
| 1160853 | sunitinib Pill |
| 1162569 | lenalidomide Oral Product |
| 1162570 | lenalidomide Pill |
| 1163075 | bortezomib Injectable Product |
| 1163087 | brentuximab vedotin Injectable Product |
| 1164873 | thalidomide Oral Product |
| 1164874 | thalidomide Pill |
| 1166941 | Dacogen Injectable Product |
| 1170611 | Adcetris Injectable Product |
| 1171230 | Gleevec Oral Product |
| 1171231 | Gleevec Pill |
| 1177781 | Sprycel Oral Product |
| 1177782 | Sprycel Pill |
| 1182522 | Revlimid Oral Product |
| 1182529 | Revlimid Pill |
| 1182862 | Nexavar Oral Product |
| 1182863 | Nexavar Pill |
| 1184929 | Thalomid Oral Product |
| 1184930 | Thalomid Pill |
| 1185345 | Rituxan Injectable Product |
| 1185474 | Sutent Oral Product |
| 1185475 | Sutent Pill |
| 1186581 | Vidaza Injectable Product |
| 1187756 | Velcade Injectable Product |
| 121191 | rituximab |
| 1242230 | lenalidomide 2.5 MG |
| 1242231 | lenalidomide 2.5 MG Oral Capsule |
| 1242232 | lenalidomide 2.5 MG [Revlimid] |
| 1242233 | lenalidomide 2.5 MG Oral Capsule [Revlimid] |
| 1251 | azacitidine |
| 1302966 | carfilzomib |
| 1302968 | carfilzomib Injectable Product |
| 1302971 | Kyprolis |
| 1302974 | Kyprolis Injectable Product |
| 1307619 | bosutinib |
| 1307620 | bosutinib 100 MG |
| 1307621 | bosutinib Oral Product |
| 1307622 | bosutinib Pill |
| 1307623 | bosutinib Oral Tablet |
| 1307624 | bosutinib 100 MG Oral Tablet |
| 1307625 | Bosulif |
| 1307626 | bosutinib 100 MG [Bosulif] |
| 1307627 | bosutinib Oral Tablet [Bosulif] |
| 1307628 | Bosulif Oral Product |
| 1307629 | Bosulif Pill |
| 1307630 | bosutinib 100 MG Oral Tablet [Bosulif] |
| 1307632 | bosutinib 500 MG |
| 1307633 | bosutinib 500 MG Oral Tablet |
| 1307634 | bosutinib 500 MG [Bosulif] |
| 1307635 | bosutinib 500 MG Oral Tablet [Bosulif] |
| 1314319 | bosutinib monohydrate |
| 1428946 | lenalidomide 20 MG |
| 1428947 | lenalidomide 20 MG Oral Capsule |
| 1429366 | lenalidomide 20 MG [Revlimid] |
| 1429367 | lenalidomide 20 MG Oral Capsule [Revlimid] |
| 1442690 | obinutuzumab 25 MG/ML |
| 1442691 | obinutuzumab Injectable Product |
| 1442693 | 40 ML obinutuzumab 25 MG/ML Injection |
| 1442694 | Gazyva |
| 1442695 | obinutuzumab 25 MG/ML [Gazyva] |
| 1442697 | Gazyva Injectable Product |
| 1442698 | 40 ML obinutuzumab 25 MG/ML Injection [Gazyva] |
| 1442981 | ibrutinib |
| 1442982 | ibrutinib 140 MG |
| 1442983 | ibrutinib Oral Product |
| 1442984 | ibrutinib Pill |
| 1442985 | ibrutinib Oral Capsule |
| 1442986 | ibrutinib 140 MG Oral Capsule |
| 1442987 | Imbruvica |
| 1442988 | ibrutinib 140 MG [Imbruvica] |
| 1442989 | ibrutinib Oral Capsule [Imbruvica] |
| 1442990 | Imbruvica Oral Product |
| 1442991 | Imbruvica Pill |
| 1442992 | ibrutinib 140 MG Oral Capsule [Imbruvica] |
| 1541889 | sunitinib 37.5 MG |
| 1541890 | sunitinib 37.5 MG Oral Capsule |
| 1541927 | sunitinib 37.5 MG [Sutent] |
| 1541928 | sunitinib 37.5 MG Oral Capsule [Sutent] |
| 1546019 | dasatinib anhydrous |
| 15657 | decitabine |
| 1597258 | blinatumomab |
| 1597260 | blinatumomab Injectable Product |
| 1597262 | blinatumomab 0.035 MG Injection |
| 1597263 | Blincyto |
| 1597266 | Blincyto Injectable Product |
| 1597267 | blinatumomab 0.035 MG Injection [Blincyto] |
| 1651249 | blinatumomab 0.035 MG |
| 1651250 | blinatumomab Injection |
| 1651252 | blinatumomab 0.035 MG [Blincyto] |
| 1651253 | blinatumomab Injection [Blincyto] |
| 1655961 | brentuximab vedotin 50 MG |
| 1655962 | brentuximab vedotin Injection |
| 1655964 | brentuximab vedotin 50 MG [Adcetris] |
| 1655965 | brentuximab vedotin Injection [Adcetris] |
| 1656294 | obinutuzumab Injection |
| 1656296 | obinutuzumab Injection [Gazyva] |
| 1657861 | rituximab Injection |
| 1657862 | 10 ML rituximab 10 MG/ML Injection |
| 1657863 | rituximab Injection [Rituxan] |
| 1657864 | 10 ML rituximab 10 MG/ML Injection [Rituxan] |
| 1657867 | 50 ML rituximab 10 MG/ML Injection |
| 1657868 | 50 ML rituximab 10 MG/ML Injection [Rituxan] |
| 1721947 | daratumumab |
| 1721948 | daratumumab 20 MG/ML |
| 1721949 | daratumumab Injectable Product |
| 1721950 | daratumumab Injection |
| 1721951 | 5 ML daratumumab 20 MG/ML Injection |
| 1721952 | Darzalex |
| 1721953 | daratumumab 20 MG/ML [Darzalex] |
| 1721954 | daratumumab Injection [Darzalex] |
| 1721955 | Darzalex Injectable Product |
| 1721956 | 5 ML daratumumab 20 MG/ML Injection [Darzalex] |
| 1723734 | ixazomib citrate |
| 1723735 | ixazomib |
| 1723753 | ixazomib 2.3 MG |
| 1723754 | ixazomib Oral Product |
| 1723755 | ixazomib Pill |
| 1723756 | ixazomib Oral Capsule |
| 1723757 | ixazomib 2.3 MG Oral Capsule |
| 1723758 | Ninlaro |
| 1723759 | ixazomib 2.3 MG [Ninlaro] |
| 1723760 | ixazomib Oral Capsule [Ninlaro] |
| 1723761 | Ninlaro Oral Product |
| 1723762 | Ninlaro Pill |
| 1723763 | ixazomib 2.3 MG Oral Capsule [Ninlaro] |
| 1723764 | ixazomib 3 MG |
| 1723765 | ixazomib 3 MG Oral Capsule |
| 1723766 | ixazomib 3 MG [Ninlaro] |
| 1723767 | ixazomib 3 MG Oral Capsule [Ninlaro] |
| 1723769 | ixazomib 4 MG |
| 1723770 | ixazomib 4 MG Oral Capsule |
| 1723771 | ixazomib 4 MG [Ninlaro] |
| 1723772 | ixazomib 4 MG Oral Capsule [Ninlaro] |
| 1726104 | elotuzumab |
| 1726107 | elotuzumab 300 MG |
| 1726108 | elotuzumab Injectable Product |
| 1726109 | elotuzumab Injection |
| 1726110 | elotuzumab 300 MG Injection |
| 1726111 | Empliciti |
| 1726112 | elotuzumab 300 MG [Empliciti] |
| 1726113 | elotuzumab Injection [Empliciti] |
| 1726114 | Empliciti Injectable Product |
| 1726115 | elotuzumab 300 MG Injection [Empliciti] |
| 1726116 | elotuzumab 400 MG |
| 1726117 | elotuzumab 400 MG Injection |
| 1726118 | elotuzumab 400 MG [Empliciti] |
| 1726119 | elotuzumab 400 MG Injection [Empliciti] |
| 1726439 | 20 ML daratumumab 20 MG/ML Injection |
| 1726440 | 20 ML daratumumab 20 MG/ML Injection [Darzalex] |
| 1726496 | azacitidine 100 MG |
| 1726497 | azacitidine Injection |
| 1726499 | azacitidine 100 MG [Vidaza] |
| 1726500 | azacitidine Injection [Vidaza] |
| 1804993 | bortezomib 3.5 MG |
| 1804994 | bortezomib Injection |
| 1804996 | bortezomib 3.5 MG [Velcade] |
| 1804997 | bortezomib Injection [Velcade] |
| 1806906 | decitabine 50 MG |
| 1806907 | decitabine Injection |
| 1806909 | decitabine 50 MG [Dacogen] |
| 1806910 | decitabine Injection [Dacogen] |
| 1806932 | carfilzomib 30 MG |
| 1806933 | carfilzomib Injection |
| 1806934 | carfilzomib 30 MG Injection |
| 1806935 | carfilzomib 30 MG [Kyprolis] |
| 1806936 | carfilzomib Injection [Kyprolis] |
| 1806937 | carfilzomib 30 MG Injection [Kyprolis] |
| 1806939 | carfilzomib 60 MG |
| 1806940 | carfilzomib 60 MG Injection |
| 1806941 | carfilzomib 60 MG [Kyprolis] |
| 1806942 | carfilzomib 60 MG Injection [Kyprolis] |
| 1919083 | midostaurin |
| 1919084 | midostaurin 25 MG |
| 1919085 | midostaurin Oral Product |
| 1919086 | midostaurin Pill |
| 1919087 | midostaurin Oral Capsule |
| 1919088 | midostaurin 25 MG Oral Capsule |
| 1919089 | Rydapt |
| 1919090 | midostaurin 25 MG [Rydapt] |
| 1919091 | midostaurin Oral Capsule [Rydapt] |
| 1919092 | Rydapt Oral Product |
| 1919093 | Rydapt Pill |
| 1919094 | midostaurin 25 MG Oral Capsule [Rydapt] |
| 1927881 | rituximab 120 MG/ML |
| 1927882 | hyaluronidase / rituximab Injectable Product |
| 1927883 | hyaluronidase / rituximab Injection |
| 1927884 | hyaluronidase / rituximab |
| 1927885 | 11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection |
| 1927886 | Rituxan Hycela |
| 1927887 | hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML [Rituxan Hycela] |
| 1927888 | hyaluronidase / rituximab Injection [Rituxan Hycela] |
| 1927889 | Rituxan Hycela Injectable Product |
| 1927890 | 11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] |
| 1927893 | 13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection |
| 1927894 | 13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] |
| 1940331 | enasidenib mesylate |
| 1940332 | enasidenib |
| 1940334 | enasidenib Oral Product |
| 1940335 | enasidenib Pill |
| 1940336 | enasidenib Oral Tablet |
| 1940338 | Idhifa |
| 1940340 | enasidenib Oral Tablet [Idhifa] |
| 1940341 | Idhifa Oral Product |
| 1940342 | Idhifa Pill |
| 1940369 | enasidenib 100 MG |
| 1940370 | enasidenib 100 MG Oral Tablet |
| 1940371 | enasidenib 100 MG [Idhifa] |
| 1940372 | enasidenib 100 MG Oral Tablet [Idhifa] |
| 1940373 | enasidenib 50 MG |
| 1940374 | enasidenib 50 MG Oral Tablet |
| 1940375 | enasidenib 50 MG [Idhifa] |
| 1940376 | enasidenib 50 MG Oral Tablet [Idhifa] |
| 1987732 | bosutinib 400 MG Oral Tablet |
| 1987734 | bosutinib 400 MG Oral Tablet [Bosulif] |
| 1988983 | bosutinib 400 MG |
| 1988985 | bosutinib 400 MG [Bosulif] |
| 1994359 | ibrutinib 70 MG |
| 1994360 | ibrutinib 70 MG Oral Capsule |
| 1994361 | ibrutinib 70 MG [Imbruvica] |
| 1994362 | ibrutinib 70 MG Oral Capsule [Imbruvica] |
| 2000016 | ibrutinib Oral Tablet |
| 2000017 | ibrutinib 140 MG Oral Tablet |
| 2000018 | ibrutinib Oral Tablet [Imbruvica] |
| 2000019 | ibrutinib 140 MG Oral Tablet [Imbruvica] |
| 2000020 | ibrutinib 280 MG |
| 2000021 | ibrutinib 280 MG Oral Tablet |
| 2000022 | ibrutinib 280 MG [Imbruvica] |
| 2000023 | ibrutinib 280 MG Oral Tablet [Imbruvica] |
| 2000024 | ibrutinib 420 MG |
| 2000025 | ibrutinib 420 MG Oral Tablet |
| 2000026 | ibrutinib 420 MG [Imbruvica] |
| 2000027 | ibrutinib 420 MG Oral Tablet [Imbruvica] |
| 2000028 | ibrutinib 560 MG |
| 2000029 | ibrutinib 560 MG Oral Tablet |
| 2000030 | ibrutinib 560 MG [Imbruvica] |
| 2000031 | ibrutinib 560 MG Oral Tablet [Imbruvica] |
| 200390 | thalidomide 50 MG Oral Capsule |
| 2046641 | carfilzomib 10 MG |
| 2046642 | carfilzomib 10 MG Injection |
| 2046643 | carfilzomib 10 MG [Kyprolis] |
| 2046644 | carfilzomib 10 MG Injection [Kyprolis] |
| 2049873 | ivosidenib |
| 2049874 | ivosidenib 250 MG |
| 2049875 | ivosidenib Oral Product |
| 2049876 | ivosidenib Pill |
| 2049877 | ivosidenib Oral Tablet |
| 2049878 | ivosidenib 250 MG Oral Tablet |
| 2049879 | Tibsovo |
| 2049880 | ivosidenib 250 MG [Tibsovo] |
| 2049881 | ivosidenib Oral Tablet [Tibsovo] |
| 2049882 | Tibsovo Oral Product |
| 2049883 | Tibsovo Pill |
| 2049884 | ivosidenib 250 MG Oral Tablet [Tibsovo] |
| 2105806 | gilteritinib |
| 2105807 | gilteritinib 40 MG |
| 2105808 | gilteritinib Oral Product |
| 2105809 | gilteritinib Pill |
| 2105810 | gilteritinib Oral Tablet |
| 2105811 | gilteritinib 40 MG Oral Tablet |
| 2105812 | Xospata |
| 2105813 | gilteritinib 40 MG [Xospata] |
| 2105814 | gilteritinib Oral Tablet [Xospata] |
| 2105815 | Xospata Oral Product |
| 2105816 | Xospata Pill |
| 2105817 | gilteritinib 40 MG Oral Tablet [Xospata] |
| 2105823 | gilteritinib fumarate |
| 2105824 | rituximab-abbs |
| 2105825 | rituximab-abbs 10 MG/ML |
| 2105826 | 10 ML rituximab-abbs 10 MG/ML Injection |
| 2105827 | Truxima |
| 2105828 | rituximab-abbs 10 MG/ML [Truxima] |
| 2105829 | rituximab Injection [Truxima] |
| 2105830 | Truxima Injectable Product |
| 2105831 | 10 ML rituximab-abbs 10 MG/ML Injection [Truxima] |
| 2105834 | 50 ML rituximab-abbs 10 MG/ML Injection |
| 2105835 | 50 ML rituximab-abbs 10 MG/ML Injection [Truxima] |
| 213360 | thalidomide 50 MG Oral Capsule [Thalomid] |
| 220239 | Thalomid |
| 226754 | Rituxan |
| 2273510 | rituximab-pvvr |
| 2273511 | rituximab-pvvr 10 MG/ML |
| 2273512 | 10 ML rituximab-pvvr 10 MG/ML Injection |
| 2273513 | Ruxience |
| 2273514 | rituximab-pvvr 10 MG/ML [Ruxience] |
| 2273515 | rituximab Injection [Ruxience] |
| 2273516 | Ruxience Injectable Product |
| 2273517 | 10 ML rituximab-pvvr 10 MG/ML Injection [Ruxience] |
| 2273520 | 50 ML rituximab-pvvr 10 MG/ML Injection |
| 2273521 | 50 ML rituximab-pvvr 10 MG/ML Injection [Ruxience] |
| 2372199 | daratumumab / hyaluronidase |
| 2375130 | daratumumab-fihj |
| 2375131 | daratumumab-fihj 120 MG/ML |
| 2375134 | daratumumab / hyaluronidase Injectable Product |
| 2375135 | daratumumab / hyaluronidase Injection |
| 2375136 | 15 ML daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML Injection |
| 2375137 | Darzalex Faspro |
| 2375138 | daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML [Darzalex Faspro] |
| 2375139 | daratumumab / hyaluronidase Injection [Darzalex Faspro] |
| 2375140 | Darzalex Faspro Injectable Product |
| 2375141 | 15 ML daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML Injection [Darzalex Faspro] |
| 2384452 | decitabine 35 MG |
| 2384453 | cedazuridine / decitabine Oral Product |
| 2384454 | cedazuridine / decitabine Pill |
| 2384455 | cedazuridine / decitabine Oral Tablet |
| 2384456 | cedazuridine / decitabine |
| 2384457 | cedazuridine 100 MG / decitabine 35 MG Oral Tablet |
| 2384458 | {5 (cedazuridine 100 MG / decitabine 35 MG Oral Tablet) } Pack |
| 2384459 | Inqovi |
| 2384460 | cedazuridine 100 MG / decitabine 35 MG [Inqovi] |
| 2384461 | cedazuridine / decitabine Oral Tablet [Inqovi] |
| 2384462 | Inqovi Oral Product |
| 2384463 | Inqovi Pill |
| 2384464 | cedazuridine 100 MG / decitabine 35 MG Oral Tablet [Inqovi] |
| 2384465 | {5 (cedazuridine 100 MG / decitabine 35 MG Oral Tablet [Inqovi]) } Pack [Inqovi 5 Tablet Pack] |
| 2396760 | azacitidine 200 MG |
| 2396761 | azacitidine Oral Product |
| 2396762 | azacitidine Pill |
| 2396763 | azacitidine Oral Tablet |
| 2396764 | azacitidine 200 MG Oral Tablet |
| 2396765 | Onureg |
| 2396766 | azacitidine 200 MG [Onureg] |
| 2396767 | azacitidine Oral Tablet [Onureg] |
| 2396768 | Onureg Oral Product |
| 2396769 | Onureg Pill |
| 2396770 | azacitidine 200 MG Oral Tablet [Onureg] |
| 2396771 | azacitidine 300 MG |
| 2396772 | azacitidine 300 MG Oral Tablet |
| 2396773 | azacitidine 300 MG [Onureg] |
| 2396774 | azacitidine 300 MG Oral Tablet [Onureg] |
| 2472325 | rituximab-arrx |
| 2472326 | rituximab-arrx 10 MG/ML |
| 2472327 | 10 ML rituximab-arrx 10 MG/ML Injection |
| 2472328 | Riabni |
| 2472329 | rituximab-arrx 10 MG/ML [Riabni] |
| 2472330 | rituximab Injection [Riabni] |
| 2472331 | Riabni Injectable Product |
| 2472332 | 10 ML rituximab-arrx 10 MG/ML Injection [Riabni] |
| 2472335 | 50 ML rituximab-arrx 10 MG/ML Injection |
| 2472336 | 50 ML rituximab-arrx 10 MG/ML Injection [Riabni] |
| 2595242 | pacritinib citrate |
| 2595243 | pacritinib |
| 2595244 | pacritinib 100 MG |
| 2595245 | pacritinib Oral Product |
| 2595246 | pacritinib Pill |
| 2595247 | pacritinib Oral Capsule |
| 2595248 | pacritinib 100 MG Oral Capsule |
| 2595249 | Vonjo |
| 2595250 | pacritinib 100 MG [Vonjo] |
| 2595251 | Vonjo Oral Product |
| 2595252 | Vonjo Pill |
| 2595253 | pacritinib Oral Capsule [Vonjo] |
| 2595254 | pacritinib 100 MG Oral Capsule [Vonjo] |
| 2601541 | bortezomib 1 MG |
| 2601542 | bortezomib 1 MG Injection |
| 2601543 | bortezomib 2.5 MG |
| 2601544 | bortezomib 2.5 MG Injection |
| 282386 | Gleevec |
| 282388 | imatinib |
| 284206 | imatinib 100 MG Oral Capsule |
| 316648 | rituximab 10 MG/ML |
| 316784 | thalidomide 50 MG |
| 331600 | imatinib 100 MG |
| 337535 | Revlimid |
| 342369 | lenalidomide |
| 356733 | Velcade |
| 357977 | sunitinib |
| 358258 | bortezomib |
| 360176 | thalidomide 100 MG Oral Capsule |
| 360177 | thalidomide 200 MG Oral Capsule |
| 360321 | thalidomide 100 MG |
| 360322 | thalidomide 200 MG |
| 366451 | thalidomide Oral Capsule [Thalomid] |
| 374072 | thalidomide Oral Capsule |
| 376335 | imatinib Oral Capsule |
| 402243 | bortezomib 3.5 MG Injection |
| 402244 | bortezomib 3.5 MG Injection [Velcade] |
| 403878 | imatinib 100 MG Oral Tablet |
| 403879 | imatinib 400 MG Oral Tablet |
| 404449 | thalidomide 100 MG Oral Capsule [Thalomid] |
| 404450 | thalidomide 200 MG Oral Capsule [Thalomid] |
| 404588 | imatinib 100 MG Oral Tablet [Gleevec] |
| 404589 | imatinib 400 MG Oral Tablet [Gleevec] |
| 406050 | imatinib Oral Tablet |
| 406051 | imatinib 400 MG |
| 406060 | imatinib Oral Tablet [Gleevec] |
| 411240 | imatinib 50 MG Oral Capsule |
| 440549 | imatinib 50 MG |
| 475342 | dasatinib |
| 483431 | imatinib 400 MG Oral Capsule |
| 485246 | azacitidine 100 MG Injection |
| 495881 | sorafenib |
| 545203 | Vidaza |
| 545206 | azacitidine 100 MG Injection [Vidaza] |
| 573051 | rituximab 10 MG/ML [Rituxan] |
| 573254 | thalidomide 50 MG [Thalomid] |
| 575017 | imatinib 100 MG [Gleevec] |
| 576406 | thalidomide 100 MG [Thalomid] |
| 576407 | thalidomide 200 MG [Thalomid] |
| 576514 | imatinib 400 MG [Gleevec] |
| 597744 | sorafenib tosylate |
| 597745 | sorafenib 200 MG |
| 597746 | sorafenib Oral Tablet |
| 597747 | sorafenib 200 MG Oral Tablet |
| 602908 | lenalidomide 10 MG |
| 602909 | lenalidomide Oral Capsule |
| 602910 | lenalidomide 10 MG Oral Capsule |
| 602911 | lenalidomide 5 MG |
| 602912 | lenalidomide 5 MG Oral Capsule |
| 615977 | sorafenib 200 MG [Nexavar] |
| 615978 | sorafenib Oral Tablet [Nexavar] |
| 615979 | sorafenib 200 MG Oral Tablet [Nexavar] |
| 616112 | lenalidomide 10 MG [Revlimid] |
| 616113 | lenalidomide Oral Capsule [Revlimid] |
| 616114 | lenalidomide 10 MG Oral Capsule [Revlimid] |
| 616115 | lenalidomide 5 MG [Revlimid] |
| 616116 | lenalidomide 5 MG Oral Capsule [Revlimid] |
| 616274 | Sutent |
| 616275 | sunitinib malate |
| 616277 | sunitinib 12.5 MG |
| 616278 | sunitinib Oral Capsule |
| 616279 | sunitinib 12.5 MG Oral Capsule |
| 616281 | sunitinib 12.5 MG [Sutent] |
| 616282 | sunitinib Oral Capsule [Sutent] |
| 616283 | sunitinib 12.5 MG Oral Capsule [Sutent] |
| 616284 | sunitinib 25 MG |
| 616285 | sunitinib 25 MG Oral Capsule |
| 616286 | sunitinib 25 MG [Sutent] |
| 616287 | sunitinib 25 MG Oral Capsule [Sutent] |
| 616288 | sunitinib 50 MG |
| 616289 | sunitinib 50 MG Oral Capsule |
| 616291 | sunitinib 50 MG [Sutent] |
| 616292 | sunitinib 50 MG Oral Capsule [Sutent] |
| 619985 | Nexavar |
| 636242 | Dacogen |
| 636631 | decitabine 50 MG Injection |
| 643103 | dasatinib 20 MG |
| 643104 | dasatinib Oral Tablet |
| 643105 | dasatinib 20 MG Oral Tablet |
| 643106 | dasatinib 50 MG |
| 643107 | dasatinib 50 MG Oral Tablet |
| 643108 | dasatinib 70 MG |
| 643109 | dasatinib 70 MG Oral Tablet |
| 643170 | Sprycel |
| 643171 | dasatinib 20 MG [Sprycel] |
| 643172 | dasatinib Oral Tablet [Sprycel] |
| 643173 | dasatinib 20 MG Oral Tablet [Sprycel] |
| 643174 | dasatinib 50 MG [Sprycel] |
| 643175 | dasatinib 50 MG Oral Tablet [Sprycel] |
| 643176 | dasatinib 70 MG [Sprycel] |
| 643177 | dasatinib 70 MG Oral Tablet [Sprycel] |
| 643711 | lenalidomide 15 MG |
| 643712 | lenalidomide 15 MG Oral Capsule |
| 643713 | lenalidomide 15 MG [Revlimid] |
| 643714 | lenalidomide 15 MG Oral Capsule [Revlimid] |
| 643719 | lenalidomide 25 MG |
| 643720 | lenalidomide 25 MG Oral Capsule |
| 643721 | lenalidomide 25 MG [Revlimid] |
| 643722 | lenalidomide 25 MG Oral Capsule [Revlimid] |
| 644989 | decitabine 50 MG Injection [Dacogen] |
| 700415 | thalidomide 150 MG |
| 700416 | thalidomide 150 MG Oral Capsule |
| 700417 | thalidomide 150 MG [Thalomid] |
| 700418 | thalidomide 150 MG Oral Capsule [Thalomid] |
| 799046 | dasatinib 100 MG |
| 799047 | dasatinib 100 MG Oral Tablet |
| 799829 | dasatinib 100 MG [Sprycel] |
| 799830 | dasatinib 100 MG Oral Tablet [Sprycel] |
| 974779 | obinutuzumab |
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 1008080 | aspirin / methylprednisolone |
| 10473 | thiotepa |
| 105551 | busulfan 2 MG Oral Tablet [Myleran] |
| 105552 | carmustine 100 MG Injection [BiCNU] |
| 105562 | melphalan 2 MG Oral Tablet [Alkeran] |
| 105567 | treosulfan 250 MG Oral Capsule |
| 105607 | pentostatin 10 MG Injection [Nipent] |
| 106991 | lidocaine / methylprednisolone |
| 107005 | methylprednisolone / neomycin |
| 1100385 | methylprednisolone acetate 0.01 MG/MG |
| 1100386 | methylprednisolone Topical Gel |
| 1100387 | methylprednisolone acetate 0.01 MG/MG Topical Gel |
| 1100388 | HybriSil |
| 1100389 | methylprednisolone acetate 0.01 MG/MG [HybriSil] |
| 1100390 | methylprednisolone Topical Gel [HybriSil] |
| 1100391 | methylprednisolone acetate 0.01 MG/MG Topical Gel [HybriSil] |
| 1114693 | bendamustine hydrochloride |
| 1148918 | gemcitabine 38 MG/ML |
| 1151374 | busulfan Injectable Product |
| 1151375 | busulfan Oral Product |
| 1151376 | busulfan Pill |
| 1151413 | carmustine Drug Implant Product |
| 1151483 | cytarabine Injectable Product |
| 1151727 | carmustine Injectable Product |
| 1156104 | carboplatin Injectable Product |
| 1156181 | cyclophosphamide Injectable Product |
| 1156182 | cyclophosphamide Oral Product |
| 1156183 | cyclophosphamide Pill |
| 1156288 | ifosfamide Injectable Product |
| 1156487 | thiotepa Injectable Product |
| 1156710 | gemcitabine Injectable Product |
| 1157928 | etoposide Injectable Product |
| 1157929 | etoposide Oral Product |
| 1157930 | etoposide Pill |
| 1157967 | rituximab Injectable Product |
| 1159787 | melphalan Injectable Product |
| 1159788 | melphalan Oral Product |
| 1159789 | melphalan Pill |
| 1160009 | bendamustine Injectable Product |
| 1162765 | treosulfan Injectable Product |
| 1162766 | treosulfan Oral Product |
| 1162767 | treosulfan Pill |
| 1163485 | methylprednisolone / neomycin Topical Product |
| 1163486 | methylprednisolone Injectable Product |
| 1163488 | methylprednisolone Oral Product |
| 1163489 | methylprednisolone Pill |
| 1163491 | methylprednisolone Topical Product |
| 1163761 | clofarabine Injectable Product |
| 1164046 | lidocaine / methylprednisolone Injectable Product |
| 1165043 | fludarabine Injectable Product |
| 1165044 | fludarabine Oral Product |
| 1165045 | fludarabine Pill |
| 1165319 | lomustine Oral Product |
| 1165320 | lomustine Pill |
| 1165408 | pentostatin Injectable Product |
| 1165881 | A-MethaPred Injectable Product |
| 1167136 | Ifex Injectable Product |
| 1168702 | Busulfex Injectable Product |
| 1171232 | Gliadel Drug Implant Product |
| 1172713 | HybriSil Topical Product |
| 1173022 | Clolar Injectable Product |
| 1173110 | Depo-Medrol Injectable Product |
| 1173621 | BiCNU Injectable Product |
| 1176189 | Alkeran Injectable Product |
| 1176190 | Alkeran Oral Product |
| 1176191 | Alkeran Pill |
| 1178005 | Toposar Injectable Product |
| 1179668 | Treanda Injectable Product |
| 1182364 | Paraplatin Injectable Product |
| 1183796 | Medrol Oral Product |
| 1183797 | Medrol Pill |
| 1183920 | Nipent Injectable Product |
| 1184840 | Solu-Medrol Injectable Product |
| 1185345 | Rituxan Injectable Product |
| 1185666 | Myleran Oral Product |
| 1185667 | Myleran Pill |
| 121191 | rituximab |
| 12574 | gemcitabine |
| 134547 | bendamustine |
| 1357886 | methylprednisolone 2000 MG Injection |
| 1357888 | methylprednisolone 2000 MG Injection [Solu-Medrol] |
| 1358496 | methylprednisolone acetate 40 MG/ML |
| 1358497 | lidocaine / methylprednisolone Injectable Suspension |
| 1358498 | lidocaine hydrochloride 10 MG/ML / methylprednisolone acetate 40 MG/ML Injectable Suspension |
| 1358509 | methylprednisolone acetate 20 MG/ML |
| 1358510 | methylprednisolone acetate 20 MG/ML Injectable Suspension |
| 1358511 | methylprednisolone acetate 20 MG/ML [Depo-Medrol] |
| 1358512 | methylprednisolone acetate 20 MG/ML Injectable Suspension [Depo-Medrol] |
| 1358610 | methylprednisolone acetate 40 MG/ML Injectable Suspension |
| 1358611 | methylprednisolone acetate 40 MG/ML [Depo-Medrol] |
| 1358612 | methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol] |
| 1358616 | methylprednisolone acetate 80 MG/ML |
| 1358617 | methylprednisolone acetate 80 MG/ML Injectable Suspension |
| 1358618 | methylprednisolone acetate 80 MG/ML [Depo-Medrol] |
| 1358619 | methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol] |
| 1366537 | Tepadina |
| 1437967 | cyclophosphamide Oral Capsule |
| 1437968 | cyclophosphamide 25 MG Oral Capsule |
| 1437969 | cyclophosphamide 50 MG Oral Capsule |
| 151325 | Alkeran |
| 152115 | Nipent |
| 152200 | Paraplatin |
| 1545771 | Gleostine |
| 1545772 | lomustine 10 MG [Gleostine] |
| 1545773 | lomustine Oral Capsule [Gleostine] |
| 1545774 | Gleostine Oral Product |
| 1545775 | Gleostine Pill |
| 1545776 | lomustine 10 MG Oral Capsule [Gleostine] |
| 1545777 | lomustine 100 MG [Gleostine] |
| 1545778 | lomustine 100 MG Oral Capsule [Gleostine] |
| 1545779 | lomustine 40 MG [Gleostine] |
| 1545780 | lomustine 40 MG Oral Capsule [Gleostine] |
| 1545988 | cyclophosphamide anhydrous |
| 155323 | methylprednisolone acetate |
| 1657861 | rituximab Injection |
| 1657862 | 10 ML rituximab 10 MG/ML Injection |
| 1657863 | rituximab Injection [Rituxan] |
| 1657864 | 10 ML rituximab 10 MG/ML Injection [Rituxan] |
| 1657867 | 50 ML rituximab 10 MG/ML Injection |
| 1657868 | 50 ML rituximab 10 MG/ML Injection [Rituxan] |
| 1660002 | thiotepa 100 MG |
| 1660003 | thiotepa Injection |
| 1660004 | thiotepa 100 MG Injection |
| 1660008 | thiotepa 15 MG |
| 1660009 | thiotepa 15 MG Injection |
| 1718998 | gemcitabine 200 MG |
| 1718999 | gemcitabine Injection |
| 1719000 | gemcitabine 200 MG Injection |
| 1719002 | gemcitabine 1000 MG |
| 1719003 | gemcitabine 1000 MG Injection |
| 1719004 | gemcitabine 2000 MG |
| 1719005 | gemcitabine 2000 MG Injection |
| 1720734 | lomustine 5 MG |
| 1720735 | lomustine 5 MG Oral Capsule |
| 1720736 | lomustine 5 MG [Gleostine] |
| 1720737 | lomustine 5 MG Oral Capsule [Gleostine] |
| 1720960 | 26.3 ML gemcitabine 38 MG/ML Injection |
| 1720975 | 52.6 ML gemcitabine 38 MG/ML Injection |
| 1720977 | 5.26 ML gemcitabine 38 MG/ML Injection |
| 1726096 | bendamustine hydrochloride 25 MG/ML |
| 1726097 | bendamustine hydrochloride 25 MG/ML Injectable Solution |
| 1726098 | Bendeka |
| 1726099 | bendamustine hydrochloride 25 MG/ML [Bendeka] |
| 1726100 | bendamustine Injectable Solution [Bendeka] |
| 1726101 | Bendeka Injectable Product |
| 1726102 | bendamustine hydrochloride 25 MG/ML Injectable Solution [Bendeka] |
| 1729351 | busulfan Injection |
| 1729353 | busulfan Injection [Busulfex] |
| 1729367 | carmustine 100 MG |
| 1729368 | carmustine Injection |
| 1729370 | carmustine 100 MG [BiCNU] |
| 1729371 | carmustine Injection [BiCNU] |
| 1731354 | cytarabine Injection |
| 1731355 | 5 ML cytarabine 20 MG/ML Injection |
| 1734339 | etoposide Injection |
| 1734340 | etoposide 100 MG Injection |
| 1734342 | etoposide 100 MG [Etopophos] |
| 1734343 | etoposide Injection [Etopophos] |
| 1734344 | Etopophos Injectable Product |
| 1734915 | cyclophosphamide 500 MG |
| 1734916 | cyclophosphamide Injection |
| 1734917 | cyclophosphamide 500 MG Injection |
| 1734918 | cyclophosphamide 1000 MG |
| 1734919 | cyclophosphamide 1000 MG Injection |
| 1734920 | cyclophosphamide 2000 MG |
| 1734921 | cyclophosphamide 2000 MG Injection |
| 1740862 | fludarabine phosphate 50 MG |
| 1740863 | fludarabine Injection |
| 1740864 | fludarabine phosphate 50 MG Injection |
| 1740865 | 2 ML fludarabine phosphate 25 MG/ML Injection |
| 1740948 | melphalan 50 MG |
| 1740949 | melphalan Injection |
| 1740951 | melphalan 50 MG [Alkeran] |
| 1740952 | melphalan Injection [Alkeran] |
| 1743702 | methylprednisolone 125 MG |
| 1743703 | methylprednisolone Injection |
| 1743704 | methylprednisolone 125 MG Injection |
| 1743705 | methylprednisolone 125 MG [Solu-Medrol] |
| 1743706 | methylprednisolone Injection [Solu-Medrol] |
| 1743707 | methylprednisolone 125 MG Injection [Solu-Medrol] |
| 1743719 | methylprednisolone 500 MG |
| 1743720 | methylprednisolone 500 MG Injection |
| 1743721 | methylprednisolone 500 MG [Solu-Medrol] |
| 1743722 | methylprednisolone 500 MG Injection [Solu-Medrol] |
| 1743725 | methylprednisolone 1000 MG |
| 1743726 | methylprednisolone 1000 MG Injection |
| 1743727 | methylprednisolone 1000 MG [Solu-Medrol] |
| 1743729 | methylprednisolone 1000 MG Injection [Solu-Medrol] |
| 1743779 | 1 ML methylprednisolone acetate 40 MG/ML Injection |
| 1743780 | methylprednisolone Injection [Depo-Medrol] |
| 1743781 | 1 ML methylprednisolone acetate 40 MG/ML Injection [Depo-Medrol] |
| 1743855 | 1 ML methylprednisolone acetate 80 MG/ML Injection |
| 1743856 | 1 ML methylprednisolone acetate 80 MG/ML Injection [Depo-Medrol] |
| 1744013 | methylprednisolone 2000 MG |
| 1744015 | methylprednisolone 2000 MG [Solu-Medrol] |
| 1744018 | methylprednisolone 40 MG [Solu-Medrol] |
| 1744020 | methylprednisolone 40 MG [A-MethaPred] |
| 1744021 | methylprednisolone Injection [A-MethaPred] |
| 1744024 | methylprednisolone 125 MG [A-MethaPred] |
| 1745086 | Evomela |
| 1745087 | melphalan 50 MG [Evomela] |
| 1745088 | melphalan Injection [Evomela] |
| 1745089 | Evomela Injectable Product |
| 1745090 | melphalan 50 MG Injection [Evomela] |
| 1791586 | ifosfamide 3000 MG |
| 1791587 | ifosfamide Injection |
| 1791588 | ifosfamide 3000 MG Injection |
| 1791589 | ifosfamide 3000 MG [Ifex] |
| 1791590 | ifosfamide Injection [Ifex] |
| 1791591 | ifosfamide 3000 MG Injection [Ifex] |
| 1791592 | ifosfamide 1000 MG |
| 1791593 | ifosfamide 1000 MG Injection |
| 1791594 | ifosfamide 1000 MG [Ifex] |
| 1791595 | ifosfamide 1000 MG Injection [Ifex] |
| 1791597 | 60 ML ifosfamide 50 MG/ML Injection |
| 1791599 | 20 ML ifosfamide 50 MG/ML Injection |
| 1794543 | pentostatin 10 MG |
| 1794544 | pentostatin Injection |
| 1794546 | pentostatin 10 MG [Nipent] |
| 1794547 | pentostatin Injection [Nipent] |
| 1804999 | bendamustine hydrochloride 100 MG |
| 1805000 | bendamustine Injection |
| 1805001 | bendamustine hydrochloride 100 MG Injection |
| 1805002 | bendamustine hydrochloride 100 MG [Treanda] |
| 1805003 | bendamustine Injection [Treanda] |
| 1805004 | bendamustine hydrochloride 100 MG Injection [Treanda] |
| 1805006 | bendamustine hydrochloride 25 MG |
| 1805007 | bendamustine hydrochloride 25 MG Injection |
| 1805008 | bendamustine hydrochloride 25 MG [Treanda] |
| 1805009 | bendamustine hydrochloride 25 MG Injection [Treanda] |
| 1806666 | clofarabine Injection |
| 1806668 | clofarabine Injection [Clolar] |
| 1828 | busulfan |
| 1919206 | thiotepa 100 MG [Tepadina] |
| 1919207 | thiotepa Injection [Tepadina] |
| 1919208 | Tepadina Injectable Product |
| 1919209 | thiotepa 100 MG Injection [Tepadina] |
| 1919210 | thiotepa 15 MG [Tepadina] |
| 1919211 | thiotepa 15 MG Injection [Tepadina] |
| 1927881 | rituximab 120 MG/ML |
| 1927882 | hyaluronidase / rituximab Injectable Product |
| 1927883 | hyaluronidase / rituximab Injection |
| 1927884 | hyaluronidase / rituximab |
| 1927885 | 11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection |
| 1927886 | Rituxan Hycela |
| 1927887 | hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML [Rituxan Hycela] |
| 1927888 | hyaluronidase / rituximab Injection [Rituxan Hycela] |
| 1927889 | Rituxan Hycela Injectable Product |
| 1927890 | 11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] |
| 1927893 | 13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection |
| 1927894 | 13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] |
| 1942738 | cytarabine liposome 100 MG |
| 1942743 | cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection |
| 1942744 | Vyxeos |
| 1942745 | cytarabine liposome 100 MG / daunorubicin liposomal 44 MG [Vyxeos] |
| 1942747 | Vyxeos Injectable Product |
| 1942748 | cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [Vyxeos] |
| 197422 | busulfan 2 MG Oral Tablet |
| 197549 | cyclophosphamide 25 MG Oral Tablet |
| 197550 | cyclophosphamide 50 MG Oral Tablet |
| 197687 | etoposide 50 MG Oral Capsule |
| 197894 | lomustine 10 MG Oral Capsule |
| 197895 | lomustine 100 MG Oral Capsule |
| 197896 | lomustine 40 MG Oral Capsule |
| 197919 | melphalan 2 MG Oral Tablet |
| 197969 | methylprednisolone 2 MG Oral Tablet |
| 197971 | methylprednisolone 32 MG Oral Tablet |
| 197973 | methylprednisolone 8 MG Oral Tablet |
| 199315 | etoposide 100 MG Oral Capsule |
| 199771 | methylprednisolone 100 MG Oral Tablet |
| 1998781 | gemcitabine 100 MG/ML |
| 1998782 | gemcitabine Injectable Solution |
| 1998783 | gemcitabine 100 MG/ML Injectable Solution |
| 2017575 | cytarabine / daunorubicin |
| 202702 | Medrol |
| 203010 | Myleran |
| 203189 | methylprednisolone sodium succinate |
| 203856 | Solu-Medrol |
| 203857 | A-MethaPred |
| 2058857 | gemcitabine 10 MG/ML |
| 2058858 | 120 ML gemcitabine 10 MG/ML Injection |
| 2058859 | Infugem |
| 2058860 | gemcitabine 10 MG/ML [Infugem] |
| 2058861 | gemcitabine Injection [Infugem] |
| 2058862 | Infugem Injectable Product |
| 2058863 | 120 ML gemcitabine 10 MG/ML Injection [Infugem] |
| 2058866 | 140 ML gemcitabine 10 MG/ML Injection |
| 2058867 | 140 ML gemcitabine 10 MG/ML Injection [Infugem] |
| 2058880 | 150 ML gemcitabine 10 MG/ML Injection |
| 2058881 | 150 ML gemcitabine 10 MG/ML Injection [Infugem] |
| 2058882 | 160 ML gemcitabine 10 MG/ML Injection |
| 2058883 | 160 ML gemcitabine 10 MG/ML Injection [Infugem] |
| 2058890 | 170 ML gemcitabine 10 MG/ML Injection |
| 2058891 | 170 ML gemcitabine 10 MG/ML Injection [Infugem] |
| 2058892 | 180 ML gemcitabine 10 MG/ML Injection |
| 2058893 | 180 ML gemcitabine 10 MG/ML Injection [Infugem] |
| 2058894 | 190 ML gemcitabine 10 MG/ML Injection |
| 2058895 | 190 ML gemcitabine 10 MG/ML Injection [Infugem] |
| 2058912 | 130 ML gemcitabine 10 MG/ML Injection |
| 2058918 | 130 ML gemcitabine 10 MG/ML Injection [Infugem] |
| 2058927 | 200 ML gemcitabine 10 MG/ML Injection |
| 2058928 | 200 ML gemcitabine 10 MG/ML Injection [Infugem] |
| 2058933 | 220 ML gemcitabine 10 MG/ML Injection |
| 2058934 | 220 ML gemcitabine 10 MG/ML Injection [Infugem] |
| 206831 | etoposide 20 MG/ML Injectable Solution [Toposar] |
| 207136 | methylprednisolone 2 MG Oral Tablet [Medrol] |
| 207137 | methylprednisolone 8 MG Oral Tablet [Medrol] |
| 207138 | methylprednisolone 16 MG Oral Tablet [Medrol] |
| 207141 | methylprednisolone 32 MG Oral Tablet [Medrol] |
| 207190 | methylprednisolone 40 MG Injection [A-MethaPred] |
| 207191 | methylprednisolone 40 MG Injection [Solu-Medrol] |
| 207192 | methylprednisolone 125 MG Injection [A-MethaPred] |
| 207193 | methylprednisolone 62.5 MG/ML Injectable Solution [Solu-Medrol] |
| 2105 | carmustine |
| 2105824 | rituximab-abbs |
| 2105825 | rituximab-abbs 10 MG/ML |
| 2105826 | 10 ML rituximab-abbs 10 MG/ML Injection |
| 2105827 | Truxima |
| 2105828 | rituximab-abbs 10 MG/ML [Truxima] |
| 2105829 | rituximab Injection [Truxima] |
| 2105830 | Truxima Injectable Product |
| 2105831 | 10 ML rituximab-abbs 10 MG/ML Injection [Truxima] |
| 2105834 | 50 ML rituximab-abbs 10 MG/ML Injection |
| 2105835 | 50 ML rituximab-abbs 10 MG/ML Injection [Truxima] |
| 212994 | carmustine 7.7 MG Drug Implant [Gliadel] |
| 217357 | Gliadel |
| 217701 | Ifex |
| 2178262 | Belrapzo |
| 2178263 | bendamustine hydrochloride 25 MG/ML [Belrapzo] |
| 2178264 | bendamustine Injectable Solution [Belrapzo] |
| 2178265 | Belrapzo Injectable Product |
| 2178266 | bendamustine hydrochloride 25 MG/ML Injectable Solution [Belrapzo] |
| 220347 | Toposar |
| 221085 | cyclophosphamide lyophilized |
| 22584 | Depo-Medrol |
| 226719 | etoposide 100 MG Injection [Etopophos] |
| 226754 | Rituxan |
| 2273510 | rituximab-pvvr |
| 2273511 | rituximab-pvvr 10 MG/ML |
| 2273512 | 10 ML rituximab-pvvr 10 MG/ML Injection |
| 2273513 | Ruxience |
| 2273514 | rituximab-pvvr 10 MG/ML [Ruxience] |
| 2273515 | rituximab Injection [Ruxience] |
| 2273516 | Ruxience Injectable Product |
| 2273517 | 10 ML rituximab-pvvr 10 MG/ML Injection [Ruxience] |
| 2273520 | 50 ML rituximab-pvvr 10 MG/ML Injection |
| 2273521 | 50 ML rituximab-pvvr 10 MG/ML Injection [Ruxience] |
| 2285806 | cytarabine / daunorubicin Injection [Vyxeos] |
| 2285807 | cytarabine / daunorubicin Injection |
| 2285813 | cytarabine / daunorubicin Injectable Product |
| 234449 | iodine-131-tositumomab |
| 235857 | melphalan hydrochloride |
| 236234 | gemcitabine hydrochloride |
| 2386858 | cyclophosphamide 200 MG/ML |
| 2386859 | cyclophosphamide 200 MG/ML Injectable Solution |
| 240416 | cytarabine 20 MG/ML Injectable Solution |
| 240573 | pentostatin 10 MG Injection |
| 245255 | cytarabine 50 MG/ML Injectable Solution |
| 24614 | etoposide phosphate |
| 24698 | fludarabine |
| 2472325 | rituximab-arrx |
| 2472326 | rituximab-arrx 10 MG/ML |
| 2472327 | 10 ML rituximab-arrx 10 MG/ML Injection |
| 2472328 | Riabni |
| 2472329 | rituximab-arrx 10 MG/ML [Riabni] |
| 2472330 | rituximab Injection [Riabni] |
| 2472331 | Riabni Injectable Product |
| 2472332 | 10 ML rituximab-arrx 10 MG/ML Injection [Riabni] |
| 2472335 | 50 ML rituximab-arrx 10 MG/ML Injection |
| 2472336 | 50 ML rituximab-arrx 10 MG/ML Injection [Riabni] |
| 249364 | 20 ML cytarabine 100 MG/ML Injection |
| 250758 | treosulfan 50 MG/ML Injectable Solution |
| 25102 | fludarabine phosphate |
| 253113 | 10 ML busulfan 6 MG/ML Injection |
| 2531369 | melphalan flufenamide |
| 2531370 | melphalan flufenamide hydrochloride |
| 2531371 | melphalan flufenamide 20 MG |
| 2531372 | melphalan flufenamide Injectable Product |
| 2531373 | melphalan flufenamide Injection |
| 2531374 | melphalan flufenamide 20 MG Injection |
| 2531376 | melphalan flufenamide 20 MG [Pepaxto] |
| 2531377 | melphalan flufenamide Injection [Pepaxto] |
| 2531379 | melphalan flufenamide 20 MG Injection [Pepaxto] |
| 2568661 | 5 ML cyclophosphamide 200 MG/ML Injection |
| 2568663 | 2.5 ML cyclophosphamide 200 MG/ML Injection |
| 259966 | methylprednisolone 4 MG Oral Tablet |
| 260330 | methylprednisolone 4 MG Oral Tablet [Medrol] |
| 262323 | ibritumomab tiuxetan |
| 263010 | tositumomab |
| 274342 | Etopophos |
| 284425 | 10 ML busulfan 6 MG/ML Injection [Busulfex] |
| 284676 | Busulfex |
| 29917 | methylprednisolone sodium phosphate |
| 3002 | cyclophosphamide |
| 3041 | cytarabine |
| 309012 | carmustine 100 MG Injection |
| 309013 | carmustine 7.7 MG Drug Implant |
| 310248 | etoposide 20 MG/ML Injectable Solution |
| 311487 | melphalan 50 MG Injection |
| 311659 | methylprednisolone 40 MG Injection |
| 314099 | methylprednisolone 62.5 MG/ML Injectable Solution |
| 315503 | busulfan 6 MG/ML |
| 315746 | cyclophosphamide 25 MG |
| 315747 | cyclophosphamide 50 MG |
| 315912 | etoposide 20 MG/ML |
| 315913 | etoposide 50 MG |
| 316160 | lomustine 10 MG |
| 316161 | lomustine 100 MG |
| 316162 | lomustine 40 MG |
| 316285 | methylprednisolone 2 MG |
| 316287 | methylprednisolone 32 MG |
| 316288 | methylprednisolone 8 MG |
| 316648 | rituximab 10 MG/ML |
| 317426 | methylprednisolone 16 MG |
| 317427 | methylprednisolone 4 MG |
| 317620 | busulfan 2 MG |
| 317646 | melphalan 2 MG |
| 328161 | methylprednisolone 16 MG Oral Tablet |
| 328431 | fludarabine phosphate 25 MG/ML |
| 329753 | etoposide 100 MG |
| 330037 | methylprednisolone 40 MG |
| 330459 | ifosfamide 50 MG/ML |
| 331779 | cytarabine 100 MG/ML |
| 332216 | methylprednisolone 100 MG |
| 332422 | cytarabine 20 MG/ML |
| 333668 | cytarabine 50 MG/ML |
| 336841 | treosulfan 250 MG |
| 340520 | carmustine 7.7 MG |
| 343027 | BiCNU |
| 346173 | methylprednisolone 62.5 MG/ML |
| 346209 | carboplatin 10 MG/ML |
| 352384 | ifosfamide / mesna |
| 362772 | methylprednisolone Injectable Solution [Solu-Medrol] |
| 362881 | etoposide Injectable Solution [Toposar] |
| 365570 | methylprednisolone Injectable Suspension [Depo-Medrol] |
| 368542 | busulfan Oral Tablet [Myleran] |
| 368772 | methylprednisolone Oral Tablet [Medrol] |
| 368873 | melphalan Oral Tablet [Alkeran] |
| 371165 | busulfan Oral Tablet |
| 371664 | cyclophosphamide Oral Tablet |
| 371676 | cytarabine Injectable Solution |
| 372132 | etoposide Oral Capsule |
| 372631 | lomustine Oral Capsule |
| 372756 | melphalan Oral Tablet |
| 372866 | methylprednisolone Injectable Suspension |
| 372868 | methylprednisolone Oral Tablet |
| 374186 | treosulfan Oral Capsule |
| 376656 | methylprednisolone Injectable Solution |
| 376666 | cyclophosphamide Injectable Solution |
| 376890 | etoposide Injectable Solution |
| 377198 | treosulfan Injectable Solution |
| 378363 | carboplatin Injectable Solution |
| 378774 | carmustine Drug Implant |
| 38508 | treosulfan |
| 393413 | fludarabine Oral Tablet |
| 393483 | treosulfan 50 MG/ML |
| 40048 | carboplatin |
| 405951 | carmustine Drug Implant [Gliadel] |
| 4179 | etoposide |
| 44151 | clofarabine |
| 486417 | clofarabine 1 MG/ML |
| 486419 | 20 ML clofarabine 1 MG/ML Injection |
| 493622 | Clolar |
| 544913 | clofarabine 1 MG/ML [Clolar] |
| 544915 | 20 ML clofarabine 1 MG/ML Injection [Clolar] |
| 544939 | cytarabine Injectable Suspension |
| 544940 | cytarabine 50 MG/ML Injectable Suspension |
| 564078 | busulfan 2 MG [Myleran] |
| 564088 | melphalan 2 MG [Alkeran] |
| 5657 | ifosfamide |
| 567639 | etoposide 20 MG/ML [Toposar] |
| 567927 | methylprednisolone 2 MG [Medrol] |
| 567928 | methylprednisolone 8 MG [Medrol] |
| 567929 | methylprednisolone 16 MG [Medrol] |
| 567932 | methylprednisolone 32 MG [Medrol] |
| 567984 | methylprednisolone 62.5 MG/ML [Solu-Medrol] |
| 572946 | carmustine 7.7 MG [Gliadel] |
| 573051 | rituximab 10 MG/ML [Rituxan] |
| 573495 | carboplatin 10 MG/ML [Paraplatin] |
| 574125 | methylprednisolone 4 MG [Medrol] |
| 574864 | busulfan 6 MG/ML [Busulfex] |
| 597195 | carboplatin 10 MG/ML Injectable Solution |
| 62136 | methylprednisolone aceponate |
| 6466 | lomustine |
| 6718 | melphalan |
| 686161 | carboplatin 10 MG/ML Injectable Solution [Paraplatin] |
| 6902 | methylprednisolone |
| 690313 | cyclophosphamide / mannitol |
| 741098 | Treanda |
| 762675 | {21 (methylprednisolone 4 MG Oral Tablet) } Pack |
| 790322 | bendamustine Injectable Solution |
| 8011 | pentostatin |
| 828705 | fludarabine phosphate 10 MG |
| 828706 | fludarabine phosphate 10 MG Oral Tablet |
| 834023 | {21 (methylprednisolone 4 MG Oral Tablet [Medrol]) } Pack [Medrol Dosepak] |
| 876399 | melphalan 50 MG Injection [Alkeran] |
| 899367 | {10 (20 ML ifosfamide 50 MG/ML Injection) / 10 (mesna 100 MG/ML Injectable Solution) } Pack |
| 900173 | {2 (60 ML ifosfamide 50 MG/ML Injection) / 6 (mesna 100 MG/ML Injectable Solution) } Pack |
| 900175 | {5 (20 ML ifosfamide 50 MG/ML Injection) / 3 (mesna 100 MG/ML Injectable Solution) } Pack |
| 93698 | carboplatin Injectable Solution [Paraplatin] |
| 968804 | cytarabine liposome |
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 10473 | thiotepa |
| 1156487 | thiotepa Injectable Product |
| 1185673 | Mylotarg Injectable Product |
| 1294580 | gemtuzumab ozogamicin |
| 1294581 | gemtuzumab ozogamicin 1 MG/ML |
| 1294582 | gemtuzumab ozogamicin Injectable Product |
| 1294583 | gemtuzumab ozogamicin Injectable Solution |
| 1294584 | gemtuzumab ozogamicin 1 MG/ML Injectable Solution |
| 1366537 | Tepadina |
| 1597258 | blinatumomab |
| 1597260 | blinatumomab Injectable Product |
| 1597262 | blinatumomab 0.035 MG Injection |
| 1597263 | Blincyto |
| 1597266 | Blincyto Injectable Product |
| 1597267 | blinatumomab 0.035 MG Injection [Blincyto] |
| 1651249 | blinatumomab 0.035 MG |
| 1651250 | blinatumomab Injection |
| 1651252 | blinatumomab 0.035 MG [Blincyto] |
| 1651253 | blinatumomab Injection [Blincyto] |
| 1660002 | thiotepa 100 MG |
| 1660003 | thiotepa Injection |
| 1660004 | thiotepa 100 MG Injection |
| 1660008 | thiotepa 15 MG |
| 1660009 | thiotepa 15 MG Injection |
| 1919206 | thiotepa 100 MG [Tepadina] |
| 1919207 | thiotepa Injection [Tepadina] |
| 1919208 | Tepadina Injectable Product |
| 1919209 | thiotepa 100 MG Injection [Tepadina] |
| 1919210 | thiotepa 15 MG [Tepadina] |
| 1919211 | thiotepa 15 MG Injection [Tepadina] |
| 1942950 | inotuzumab ozogamicin |
| 1942951 | inotuzumab ozogamicin 0.9 MG |
| 1942952 | inotuzumab ozogamicin Injectable Product |
| 1942953 | inotuzumab ozogamicin Injection |
| 1942954 | inotuzumab ozogamicin 0.9 MG Injection |
| 1942955 | Besponsa |
| 1942956 | inotuzumab ozogamicin 0.9 MG [Besponsa] |
| 1942957 | inotuzumab ozogamicin Injection [Besponsa] |
| 1942958 | Besponsa Injectable Product |
| 1942959 | inotuzumab ozogamicin 0.9 MG Injection [Besponsa] |
| 1944699 | gemtuzumab ozogamicin 4.5 MG |
| 1944700 | gemtuzumab ozogamicin Injection |
| 1944701 | gemtuzumab ozogamicin 4.5 MG Injection |
| 1944702 | gemtuzumab ozogamicin 4.5 MG [Mylotarg] |
| 1944703 | gemtuzumab ozogamicin Injection [Mylotarg] |
| 1944704 | gemtuzumab ozogamicin 4.5 MG Injection [Mylotarg] |
| 2054068 | mogamulizumab |
| 2054077 | mogamulizumab-kpkc |
| 2054078 | mogamulizumab-kpkc 4 MG/ML |
| 2054079 | mogamulizumab Injectable Product |
| 2054080 | mogamulizumab Injection |
| 2054081 | 5 ML mogamulizumab-kpkc 4 MG/ML Injection |
| 2054082 | Poteligeo |
| 2054083 | mogamulizumab-kpkc 4 MG/ML [Poteligeo] |
| 2054084 | mogamulizumab Injection [Poteligeo] |
| 2054085 | Poteligeo Injectable Product |
| 2054086 | 5 ML mogamulizumab-kpkc 4 MG/ML Injection [Poteligeo] |
| 261585 | Mylotarg |
This value set includes codes based on the following rules: